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Abstract 
 
The aim of this project was to determine the role of contraction in skeletal muscle 
development. The role of the initial spontaneous contractions observed in zebrafish 
embryos from 17 to 24 hours post fertilisation was examined. Genetic and pharmacologic 
approaches were used to study paralysis-induced disruption of skeletal muscle structure 
and function and subsequently determine the role of contraction. The structural and 
functional characteristics of developing skeletal muscles were found to be regulated by 
a dual mechanism of both movement-dependent and independent processes, in vivo. 
 
Novel data demonstrates that contraction controls sarcomere remodelling, namely 
regulation of actin length, via movement driven localisation of the actin capping protein, 
Tropmodulin1. Myofibril length was also shown to be linked to the mechanical passive 
property, stretch, with lengthening leading to an increase of the muscle’s ability to stretch. 
In addition, myofibril bundling and the myofilament lattice spacing, responsible for active 
tension generation via cross-bridge formation, were shown to be unaffected by paralysis 
and thus, movement-independent processes. Furthermore, the mechanism of the 
contraction-driven myofibril organisation pathway at the focal adhesion complexes 
(FAC), was shown to be different in zebrafish compared to mammals, with 
mechanosensing revolving around the Src protein rather than Fak. 
 
In summary, the role of contraction was established as a critical driver of myofibril 
organisation and passive tension in the developing zebrafish skeletal muscle. Passive 
tension regulates muscle function by determining its operational range ensuring that the 
needs of locomotion are met. Furthermore, investigation of FAC’s role in the contraction-
driven myofibril organisation pathway led to the discovery of a novel function for Src in 
zebrafish somitogenesis. These two findings (i) that contraction is a driver of myofibril 
organisation and (ii) that Src is a key protein of the skeletal muscle development provides 
the potential for new therapeutic approaches in humans. 
 
 
Word count: 297 
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1. Introduction 
 
1.1 Skeletal muscle 
 
1.1.1 A striated structure 
 
Muscle fibres are composed of myofibrils which contain myofilament proteins (mainly 
actin and myosin) that act as the building blocks of the sarcomere, the basic contractile 
unit. Myofibrils are composed of repeating sarcomeres that run both in series and 
parallel. The characteristic myofibril striated appearance of light and dark bands, readily 
observable by light microscopy, is the direct result of the precise alignment of the filament 
systems of the sarcomeres. The principal components of the striated muscle sarcomeres 
are the actin thin filaments that span the isotropic I band and overlap with the myosin 
thick filaments in the anisotropic A band. The actin thin filaments are anchored at the Z-
disc, which are the mechanosensitive lateral boundaries of the sarcomere. The thin 
filaments extend towards the middle of the sarcomere and act as spring linking the region 
of active force generation (A band) with the bordering Z-discs, allowing the reversible 
mechanical stretch response required for efficient contractile activity. Towards the centre 
of the sarcomere, the pointed ends of actin filaments interdigitate with the myosin 
filaments within the A band, forming the cross-bridges and allowing actin and myosin 
filaments to slide alongside (Huxley et al., 1954). In the middle of the sarcomere, the M-
band is the anchoring site of myosin filaments, where they cross link with electron-dense 
M-bridges and M-filaments (Luther et al., 1978; Obermann et al., 1996). The appearance 
of defined M-bands is considered to be the final step of myofibril assembly (Markwald 
1973; Clark et al., 2002) (Figure 1.1). 
 
Figure 1.1: Skeletal muscle striated structure. [A] Schematic representation of the serial and 
parallel structural arrangement of sarcomeres in skeletal muscle myofibril. [B] Electron 
micrograph of a longitudinal section through zebrafish myotomal muscle showing the typical 
sarcomere striations of vertebrate striated muscle (Adapted from Squire et al., 2008). 
500nm 
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1.1.2 Myofibril Assembly 
 
The regular array of identical sarcomeres observed in skeletal muscles is conserved 
across the animal kingdom, which implies that the mechanism of myofibril assembly is 
also likely to be conserved. Indeed, the ‘premyofibril model of myofibrillogenesis’ was 
established in cultured avian muscle cells and later in vivo in zebrafish, suggesting that 
myofibrillogenesis is a fundamentally conserved process (Sanger et al., 2009; Sanger et 
al., 2010). During skeletal muscle development sarcomere structure is established in a 
series of steps, starting with the initiation of actin polymerisation at the protocostameres 
(Sparrow and Schöck, 2009) and ending with the formation of the M-band (Markwald, 
1973). The later stages, which include the determination of sarcomere length, are 
regulated by muscle contraction (Figure 1.2).  
 
 
Figure 1.2: Sparrow and Schöck model of myofibril assembly. [steps 1, 2] Integrin adhesion 
sites (protocostameres) that form at random positions along the muscle cell polymerize actin 
filaments. For simplicity, only two actin filaments per adhesion site are shown. [step 3] 
Overlapping actin filaments of opposing polarity fuse through α-actinin-mediated crosslinking. 
[step 4] Laterally fused antiparallel actin filaments incorporate non-muscle myosin II, which 
displaces α-actinin. Note that several non-muscle myosin II bipolar filaments can be incorporated, 
depending on the number of actin filaments in the stress fibre. [step 5] Protocostameres recruit 
titin and more α-actinin, thereby giving rise to electron-dense Z-bodies. [step 6] Muscle myosin 
II bipolar filaments are then incorporated, perhaps with the help of titin. [step 7] Correct spacing 
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is mediated by both titin and further length maturation of thin filaments. Z-bodies that are now 
connected to Z-bodies on the other side align longitudinally in the future Z-disk plane through 
contractility-dependent maturation. [step 8] Z-bodies then coalesce laterally into Z-disks. 
Although not depicted, the distance between two protocostameres in steps 1–5 probably varies 
substantially. The final sarcomere length is mostly set from step 6 onwards, although subtle 
modulations might occur, such as thin filament elongation. Adapted from Sparrow and Schöck, 
2009. 
 
Studies have revealed that inhibition of contraction causes myofibril and sarcomere 
disassembly, whereas stimulation accelerates reassembly (De Deyne, 2000). 
Nonetheless the contribution of contraction to sarcomere assembly in vivo is not well 
understood (Sparrow and Schöck, 2009). It is this later step, contraction-dependent 
maturation and the organisation of the myofibrils and of their myofilaments that is a 
critical determinant of mature skeletal muscle contractile function. Myofibril organisation 
and mechanotransduction are critical for the maintenance of structure and function in 
mature skeletal muscle and ultimately for co-ordinated movement, as reviewed by 
Boonyarom and Inui (2006). Initial muscle immobilisation and subsequent muscle 
adaptation studies (Williams and Goldspink, 1978; Goldspink, 1998), established that it 
is both the spatial arrangement of the sarcomeres relative to the axis of force generation 
and their size that are critically important in muscle function (Bian et al., 2012). 
  
1.1.3 Muscle activation: excitation-contraction coupling 
 
The sarcomere Z-discs are the initial biomechanical sensors conducting force through 
the myofibrils via the excitation-contraction (E-C) coupling. Muscle contraction is the 
result of this signal transduction process connecting membrane depolarisation and the 
contractile event itself. The neurotransmitter acetylcholine (ACh) is released at the 
neuromuscular junction following voltage dependent Ca2+ influx in the nerve cell. The 
process of E-C coupling begins with the binding of ACh to its receptor, which induces 
the local depolarisation of the sarcolemma as positively charged sodium ions (Na+) enter 
the muscle cell via the ACh receptor, triggering an action potential. This transmembrane 
voltage depolarisation spreads through the sarcolemma and T-tubules, where it is 
sensed by a Ca2+ channel plasmalemmal voltage gated dihydropyridine receptor (DHPR) 
which triggers the opening of a second Ca2+ channel, the sarcoplasmic reticulum (SR) 
ryanodine receptor (RyR), allowing Ca2+ release from the SR. Those two channels 
present a coordinated spatial arrangement in order to achieve this physical coupling. 
DHPR complexes are formed of four subunits organized in tetrads, 1S voltage sensing 
and pore forming and 1a, 2 and γ, auxiliaries. RyR are six-transmembrane ion 
channels presenting a cytosolic four-fold symmetric ‘mushroom-like’ superstructure and 
a SR transmembrane ‘stalk’ (Zalk et al., 2015). As the RyR open, Ca2+ is released from 
the SR into the sarcoplasm, where it diffuses and binds with the troponin complex, which 
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in turn initiates a tropomyosin conformational change, uncovering the myosin binding 
sites of the actin strands. Myosin heads then bind on these exposed binding sites on 
actin, forming the cross-bridges (Figure 1.3). Myosin heads also bind ATP, whose 
hydrolysis provides the energy necessary to the myofilaments ‘power stroke’ movement. 
ATP also drives the activity of SR Ca2+ ATPase which actively pumps Ca2+ back into the 
SR, resulting in tropomyosin shielding myosin-actin binding sites and ultimately inducing 
muscle relaxation. 
 
 
Figure 1.3: Excitation-contraction coupling and cross-bridges. [A] Z-discs localisation of 
DHPR and RyR on the sarcolemma and the SR membrane respectively. [B] E-C coupling starts 
with the release of ACh and the activation of ACh receptors (AChR), followed by the entry of Na+ 
in the muscle cell and sarcolemma depolarisation. Voltage gated DHPR are then activated and 
allosterically activate RyR, which allow Ca2+ release in the sarcoplasm. [C] Ca2+ ions bind to 
troponin, which induced a conformational change of the troponin-tropomyosin complex and 
reveals the actin binding sites, otherwise blocked by tropomyosin. Myosin heads attach to the 
actin binding sites and to ATP, which hydrolysis into ADP and Pi generate the ‘power stroke’ and 
results in the actin and myosin filaments slide movement giving rise to the muscle contraction.  
 
Evidence from studies in isolated cultures has shown that contraction itself is an 
important regulator in the later stages of myofibril assembly, alignment and sarcomere 
spacing (Sparrow and Schöck, 2009; Sanger et al., 2010; Sanger et al., 2005; Fujita et 
al., 2007).  In addition, in vivo studies, have also shown that contraction regulates 
myofibril development. In C elegans, there are 4 stages of muscle development, in which 
the structural sarcomeric components initially accumulate and localised to membranes 
(Hresko et al., 1994). The final stage involves sarcomeric organisation and coincides 
with the onset of muscle twitching. These movements appear necessary for the 
maintenance of muscle structure, specifically events such as the spatial arrangement of 
cell attachments. Furthermore, actin-myosin interaction during assembly is important for 
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sarcomeric order in Drosophila (Reedy and Beall, 1993) and the excitation-contraction 
pathway controls sarcomere length during zebrafish development (Brennan et al., 2005). 
Therefore, evidence supports the fact that contraction is key for both mature and 
developing skeletal muscle structure. This project is focused on the role of contraction 
during skeletal muscle development in zebrafish. 
 
1.2 Zebrafish, an in vivo model 
 
1.2.1 Background 
 
Zebrafish, Danio rerio, from the order of the Cypriniformes and the Cyprinidae family, is 
a freshwater tropical teleost fish from the Indian subcontinent. Zebrafish is an emerging 
model for biomedical research, it’s use increased in the last decade following on initial 
studies performed by George Streisinger and his team at the University of Oregon, where 
zebrafish was the first vertebrate to be cloned (homozygous diploid clones) (Streisinger 
et al., 1981). Zebrafish have many advantages as a model for studying vertebrate 
development in vivo. Its development ex-utero is rapid, at 28.5°C cell division occurs 
every 15 minutes during the cleavage period (0-3 hours post fertilisation [hpf]), later on 
during the segmentation (10-24hpf) somites are added every 30min, by 24hpf the body 
plan is established and by 48hpf the larvae are swimming freely (Figure 1.4). This set 
sequence of events gives a very useful staging tool that provides accuracy in 
developmental studies (Kimmel et al., 1995) and the optical transparency of the embryos 
during the early stages of development allow the visualisation and imaging of the tissue 
morphogenesis. Generation time is relatively short, 2-3 month depending on the rearing 
conditions, namely density, as in an identical fish tank, fish from a smaller shoal will grow 
and mature faster than in a larger one. Spawning is easily induced in a controlled 
environment, as it is determined by the fish circadian rhythm. Furthermore, their 
reproductive rate is high, a female can lay up to 500 eggs per clutch every other day and 
they are very easy to maintain. Besides, zebrafish low economical costs and less 
problematical ethical constrains when compared to other vertebrate models, also make 
it an advantageous model organism (Ablain and Zon, 2013; Dooley and Zon, 2000). 
Additionally, teleosts make up half of the vertebrate species, they exhibit a high level of 
biodiversity which is thought to be due to the tetrapoidisation/rediploidisation that took 
place 400Myr ago (Jaillon et al., 2004). This high level of variability makes fish an 
interesting model for the study of many biological questions, specifically in evolution 
studies but also in physiology research. Hundreds of duplicate gene pairs generated 
during this genomic event have been maintained throughout evolution. Differential loss 
or subfunction partitioning of such gene duplicates might have been involved in the 
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generation of fish variability. Comparison of data generated by genome projects as well 
as complementary studies in other species will significantly contribute to our 
understanding of gene evolution and function in humans and other vertebrates (Volff, 
2005). 
 
Figure 1.4: Zebrafish, Danio rerio, life cycle. The zebrafish embryo develops as a mound-
shaped blastoderm sitting on top of a large yolk cell. It develops rapidly and by 2dpf the fish, still 
attached to the remains of its yolk, hatches, by 3 month the adults are fertile. Adapted from 
Wolpert et al. (2015). 
 
Therefore, zebrafish offers powerful possibilities to study the vertebrate gene function, 
notably involved in muscle development and diseases, even more so since genetic 
manipulations, with knockdown or over-expression, can be performed and mutagenesis 
screening and transgenic lines are accessible (Lieschke and Currie, 2007). Zebrafish 
have 25 chromosomes, the whole genome size is about half of that in humans (15 billion 
vs. 30 billion of base-pairs). Recent genome sequencing has shown that ~26000 protein 
coding genes exist in zebrafish, and that they share large conservative features with the 
mammalian genome. Specifically, ~70% of human genes have corresponding orthologs 
in zebrafish (Howe et al., 2013). The identification of zebrafish ortholog genes that match 
human developmental regulatory genes has already made it a useful model to study 
various forms of skeletal muscle dystrophy and several cardiomyopathies (Dou et al., 
2008).  
In summary, the distinctiveness of this project rests on the versatility of the zebrafish 
model. This vertebrate in vivo model enables the study of complex interactions between 
tissues. It allowed the study of myofibrils in an environment in which they are capable of 
differentiating into full range of definitive muscle-types. Further, it allowed the use of a 
wide array of techniques (genetic, imaging, molecular, mechanical, behavioural), which 
taken together give an accurate account of the physiological event considered. 
10 
10 
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1.2.2 Zebrafish muscle specificities 
 
1.2.2.1 Structure 
 
Supported by the buoyancy of water and their swim bladder, zebrafish require large 
muscles to locomote through their viscous environment. In zebrafish, skeletal muscle 
display some particularities distinguishing them from mammals. As with other 
vertebrates, two types of muscle fibres are found in the developing fish, slow and fast 
muscle fibres. However, in teleosts the slow muscle fibres derive from adaxial cells that 
elongate to span the length of the somite and then migrate radially (Figure 1.5 A-F). 
Following migration, they form a monolayer of superficial muscle cells that differentiate 
into slow muscle fibres and form a wedge-shape triangle on the lateral surface of the 
somite that specialise in maintaining a slow swimming movement (Devoto et al., 1996) 
(Figure 1.5 G). In contrast, the teleost’s fast muscle fibres arise from the lateral presomitic 
muscle cells, which remain within the deep portion of the myotome. They will provide the 
burst of rapid swimming necessary to escape or hunt (Stickney et al., 2000). Another 
unique feature of zebrafish skeletal muscle is that myofilaments bundles are more 
densely packed than in mammals. Furthermore, their optimal sarcomeric length is 
2.15m, compared to 1.85m in mammal skeletal muscle (Figure 1.5 H, I, J). Finally, fish 
skeletal muscle structure is quasi-crystalline, which is a real advantage for ultrastructural 
studies and imaging. This is the result of a structural difference of the fish A-bands, which 
are arranged in a ‘simple lattice’. This organisation reveals the identical rotation of 
myosin filaments around their long axis ensuring a simple regular structure and a long 
rotational range. This is in contrast with the higher vertebrate muscles ‘superlattice’, 
reflecting the complex irregular arrangement of their myosin filaments along their long 
axis, which are pointing in two different directions (Figure 1.5 K, L) (Squire et al., 2008; 
Dou et al., 2008). 
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Figure 1.5: Zebrafish skeletal muscle particularities. [A-F] Adaxial cells migrate radially 
away from the notochord, between other somitic cells. In the caudal trunk, migration occurs 
over approximately 7 hours. Transverse sections through the caudal trunk (somites 14-17) were 
immunolabeled with F59 to mark adaxial cells myosin and counter stained with Hoechst to reveal 
the nuclei. [A] 17hpf (16 somites) embryo. F59 immunoreactivity is present only in adaxial cells, 
the labeling is perinuclear. [B] 18.5hpf (19 somites) embryo. The adaxial cells have begun to 
move dorsally and ventrally; this is approximately the time at which these cells are elongating in 
the anterior posterior dimension. [C] 20.5hpf (23 somites) embryo. The adaxial cell population 
now extends almost the full dorso-ventral extent of the myotome. [D] 21.5hpf (25 somites) 
embryo. Radial migration of the adaxial cells has begun. [E] 23hpf (28 somites) embryo. Most of 
the adaxial cells have reached the lateral surface. [F] 24hpf embryo. The adaxial cells are now 
lateral. A subset of adaxial cells remains adjacent to the notochord, generating an hourglass 
shape to the layer of superficial muscle cells. The deep cells of the myotome are now beginning 
to express the F59 epitope weakly. In these transverse sections, dorsal is up. Scale bar, 50 mm. 
[G] Fast and slow muscle distribution in teleosts mature skeletal muscle. [H-J] Structural 
organisation of the zebrafish skeletal muscle. [H] Electron micrograph of a longitudinal section 
through zebrafish myotomal muscle showing the typical sarcomere striations of vertebrate striated 
muscle. The sarcomere [I], which extends between Z-bands (Z) and is ∼2.15μm long, consists of 
the centrally placed A-bands and the less densely packed I-bands, which extend between 
successive A-bands. The A-band are formed by an array of myosin filaments carrying myosin 
head projections and cross-link halfway along their length at the M-band (M). Each side of the M-
band are the bare regions where the myosin filament backbones appear triangular. [J] Electron 
micrograph of zebrafish myotomal muscle in cross section showing myosin filament profiles near 
to the M-band (M) and in the adjacent bare regions (BR). The triangular profiles in one bare region 
all point in the same direction indicating the presence of a simple and tight lattice arrangement. 
[K,L] Illustrations of the bare region arrangements of myosin filaments profiles in a simple 
lattice and a superlattice. [K] The simple lattice has identically oriented triangular profiles 
throughout. [L] The superlattice has two filament orientations with an irregular, statistical 
arrangement. Adapted from Devoto et al., 1996 and Squire et al., 2008.  
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1.2.2.2 The initial contractile event 
 
Zebrafish have proved useful as a model to study the development of vertebrate skeletal 
muscle, including myofibril organisation and alignment. Contractile movements in 
zebrafish embryos are initiated at 17hpf, as functional neuromuscular connections within 
the body of the fish start to form and the slow muscle fibres begin their lateral migration. 
The axons of primary motor neurons exit the spinal cord and contact the skeletal muscle, 
in the somites of the embryo. Prior to 24hpf, the primary motor neurons make contact 
with the skeletal muscle, initially with the slow muscle before spreading out through the 
somite, into the fast muscle (Figure 1.6 A). The initial movements have a very 
characteristic pattern (Figure 1.6 B), the frequency of the spontaneous body contractions 
peaks at 19hpf before tailing off by 24hpf.  
 
Figure 1.6: 17-24hpf: A contractile developmental event. [A] Functional neuromuscular 
junctions form between 17 and 24hpf, and coincide with the slow muscle fibres lateral migration 
and the onset of spontaneous body movements.  [B] Example of one cycle of spontaneous 
contractions of an agarose-restrained embryo at 19hpf. Images were captured every 15 frames 
(250 ms). The embryo was dorsal side up with the head facing the top of the image. The behaviour 
consisted of a contraction to the left followed by a contraction to the right. The length of the embryo 
was 1.4 mm. Adapted from: Brennan et al., 2005 ; Devoto et al., 1996 ; Eisen et al., 1986 ; Saint-
Amant and Drapeau, 1998. 
 
The role of these initial movements is currently unclear. There is evidence to suggest 
that these movements are important in the initiation and refinement of nerve-muscle 
connections (Brennan et al., 2005; Devoto et al., 1996; Eisen et al., 1986; Saint-Amant 
and Drapeau, 1998). Furthermore, previous work investigated the hypothesis that this 
contractile development event is necessary for myofibril organisation using both an 
irreversible paralysing pharmacological agent, Blebbistatin, (Lahne et al., 2009) and 
immotile mutant lines (nic1 and cacnb1ts25) (Brennan et al., 2005)  to disrupt the E-C 
coupling pathway. 
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1.2.3 Zebrafish motility mutants 
 
Motility mutants, such as Nic1b107 (Brennan et al., 2005; van der Meulen et al., 2005), 
sopfixe (Etard et al., 2005) or cacnb1ts25 relaxed (Schredelseker et al., 2005) , lack key 
components of the E-C coupling pathway and their skeletal muscle is unable to contract. 
Evidence from several laboratories show that a lack of E-C coupling leads to disruption 
of their muscle fibre development, myofibrils are thin and wavy and lack bundling and 
alignment (Behra et al., 2002; Brennan et al., 2005; van der Meulen et al., 2005). At the 
sarcomere level this translates into a number increase and a disruption of their spacing 
(Etard et al., 2005). At an ultrastructural level, their sarcomeres are shorter, with a shorter 
A band and prominent H band, these changes in dimension suggests that the actin and 
myosin filaments length themselves are altered in immotile mutants, as observed in the 
ACh receptor mutant, sopfixe (Etard et al., 2005) (Figure 1.7). These observations support 
the hypothesis that contraction is necessary for the organisation of myofibrils during early 
vertebrate muscle development in vivo (Brennan et al., 2005).  
 
 
Figure 1.7: Structure of myofibrils in immotile sopfixe mutants. [1] Wild‐type (A,C) and sopfixe 
(B,D) embryos were stained with antibodies against slow muscle myosin at 26hpf. 
Immunoreactivity of slow muscle myosin highlights the A band (C,D). The H band and M band 
are indicated by an asterisk and arrow, respectively. C,D: The length of the A band, (a = 1.63μm 
for wild-type [wt] C, and 1.3μm for sopfixe D) and the width of the myofibril (b = 2.3μm for wt C, 
and 1.9μm for sopfixe D) are reduced in the mutant. [2] Schematic representation of the sarcomere 
structure in wild-type and sopfixe embryos. Note the enlargement of the H band and the shortening 
of the A band. Lateral views, anterior to the left. Scale bars = 10μm in A,C ; 2.5μm in C,D. Adapted 
from Etard et al., 2005. 
 
1.2.3.1 Relaxed mutants 
 
In this study, the cacnb1ts25, relaxed mutant line was used to determine the effect of 
paralysis and explore the role of contraction during skeletal muscle development in vivo. 
This mutant line carries a G-A non-sense point mutation in exon 13 of the gene CACNB1 
encoding the DHPR1a subunit leading to premature termination at the position Trp454. 
1 2 * * 
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It is a monogenetic heredity, therefore 25% of the offspring would be homozygotes. 
These homozygotes relaxed mutants lack the DHPR1a subunit protein, preventing the 
correct targeting of DHPR to the sarcolemma and tetrad formation, disrupting the DHPR-
RyR physical interactions and the E-C coupling, therefore inducing total skeletal muscle 
paralysis (Figure 1.8). However, whether DHPR1a subunit function exclusively lies in the 
physical coupling of these two Ca2+ channels (DHPR-RyR) enabling E-C coupling or 
whether it participates in the signal transduction between voltage-sensor and Ca2+ 
release remains to be shown (Schredelseker et al., 2005).  
 
 
Figure 1.8: Relaxed, immotile mutant cacnb1ts25-/cacnb1ts25- (rr). [A] DHPR-RyR physical 
coupling. [B] In relaxed, a G-A non-sense point mutation in exon 13 of the gene CACNB1 
encoding DHPR1a 
subunit, results in its lack of expression, and DHPR is mistargeted to the 
sarcolemma. The tetrads formation is hampered and the voltage-gated Ca2+ channels cannot link 
the action potentials to Ca
2+
 release within the muscle fibres. This disruption to the E-C coupling 
pathway induces total skeletal muscle paralysis (Schredelseker et al., 2009). 
 
These immotile mutants display a disrupted myofibril phenotype. Their myofibrils are 
‘wavy’ with an obvious lack of bundling and alignment, whilst their cell boundaries are 
not affected (Figure 1.9 A-E). Evidence suggests that it is an increase in serial sarcomere 
addition rather than cell shape changes that disrupts the myofibril arrangement (Figure 
1.9 F), as no disruption of the cell boundaries nor of the myotendinous junction were 
observed when staining for β-catenin, strongly expressed in zebrafish sarcolemma 
(Lahne et al., 2009). 
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Figure 1.9: Myofibril alignment is disrupted in the relaxed mutant skeletal muscle. 
Immunostaining of myosin with F59 and confocal projections reveal myofibril organisation in (A) 
control heterozygous carriers and (B) homozygous relaxed mutants, at 24hpf. Confocal images 
of embryos labelled with a β-catenin antibody in (C) control heterozygous carriers and (D) 
homozygous relaxed mutants at 24hpf. (E) The myofibril organisation index (myofibril length / 
somite length) is significantly increased in the homozygous relaxed mutants embryos compared 
to controls (n=6 embryos) (F) Sarcomere number/10 µm was significantly increased in 
homozygous relaxed mutants compared to heterozygous carriers. Mean ± S.E.M, P* < 0.05, 
Student’s t-test. Scale bar 25µm. (Lahne et al., 2009).  
 
1.2.4 Pharmacological treatments 
 
1.2.4.1 Irreversible paralysis treatment 
 
Immotility mutants support the hypothesis that contraction is necessary for the 
organisation of myofibrils during early vertebrate muscle development in vivo. However, 
the mutant approach has several drawbacks: (i) a lack of mutant lines that carry 
mutations in the E-C coupling signaling proteins and (ii) it is not possible to manipulate 
the timing of the paralysis. An alternative method of exploring the effect of paralysis and 
the role of contraction in skeletal muscle development, is to induce paralysis in wildtype 
embryos using pharmacological agents. This method allows control of the time at which 
paralysis occurs and enables assessment of the contribution of the multiple E-C coupling 
components to myofibril organisation. Previous work used Blebbistatin (BBST) to block 
the E-C coupling, this pharmacological agent binds irreversibly to muscle and non-
muscle myosin II and prevents acto-myosin interaction. It was established that when 
paralysis coincided with neuromuscular junctions formation and the onset of embryonic 
E F 
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movement (17-24hpf), myofibril organisation was most disrupted (Lahne et al., 2009). 
This suggests that myofibril organisation is driven by the initial contractile event itself 
(Figure 1.10). This finding is in contrast to cell culture studies that support a role for 
spontaneous and activity-generated intracellular Ca2+ signals in myofibril construction, in 
particular during sarcomere formation (De Deyne, 2000). Ca2+ driven actin-myosin 
interaction (cross bridge cycling) was thought to be necessary for myofibril bundling 
rather than sarcomeric construction (Ramachandran et al., 2003). 
 
 
Figure 1.10: 17-24hpf paralysis is most disruptive to myofibril organisation. Confocal 
projections of immunohistochemically labelled slow muscle fibres in 50µM Blebbistatin treated 
zebrafish embryos. Zebrafish embryos were exposed to Blebbistatin for 7 hours from either 17-
24hpf [A], 24-31hpf [B] or 48-55hpf [C] (Anti-myosin antibody F59, scale bar 25 µm). The severity 
of myofibril misalignment of slow muscle fibres as a result of Blebbistatin exposure is correlated 
with the developmental time point at which it is applied. Myofibril disruption is most pronounced 
in A and diminishes progressively when applied later (B, C). (Lahne et al., 2009).  
 
Taken together, the observations made in the immotile mutant lines (nic1 and cacnb1ts25) 
and in pharmacological experiments, showed that when the E-C coupling pathway was 
blocked at the level of membrane depolarisation (nic1, lacking ACh receptors), at the 
DHPR-RyR physical coupling (cacnb1ts25, lacking the DHPR1a subunit), or at the actin 
myosin cross-bridges (using Blebbistatin), myofibril disruption was observed (Figure 
1.11). This establishes that during the 17-24hpf contractile event it is the actin-myosin 
interaction and the contraction itself, rather than Ca2+ alone as previously thought, that 
drives myofibril organisation (Lahne et al., 2009). 
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Figure 1.11: Exploring the excitation-contraction coupling pathway. (1) The red crosses 
represents the blockage of membrane depolarisation at the sarcolemma, resulting from the lack 
of ACh receptors of the nic1 mutants. (2) The orange crosses represents the suppression of the 
DHPR-RyR physical interaction, due to the lack of DHPR1a subunit of the relaxed mutants. (3) 
The purple crosses represents the inhibition of the acto-myosin interaction, due to the 
pharmacological agent Blebbistatin binding to myosin II (purple box). All three disruptions of the 
E-C coupling pathway, resulted in comparable myofibril disruption. The third treatment does not 
impair the Ca2+ influx within the muscle cell, and confirms that it is the contractile event that drives 
myofibril organisation. (Anti-myosin antibody F59 ; picture 1 from Brennan et al., 2005 ; pictures 
2&3 from Lahne et al., 2009) 
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1.2.4.2 Reversible paralysis treatment: a novel approach 
 
Genetic and pharmacological studies have suggested the importance of the initial 
contractile event in regards with myofibril organisation. This hypothesis was tested, in 
this study using a reversible Na+ channel blocking anaesthetic, Tricaine 
(methanesulfonate (MS222) 0.03% w/v), which temporarily induced paralysis during the 
onset of movement (17-24hpf), before allowing contractile recovery. This experimental 
design allowed the assessment of the restoration of contractile activity on paralysis-
induced disorganised myofibrils (Figure 1.12).  
 
 
 
Figure 1.12: Experimental design. [A] Excitation–contraction pathway. The blue cross 
represents the action of Tricaine which temporary blocks the Na+ channels and therefore blocks 
the E-C coupling pathway. [B] Experimental time course. Embryos were incubated in Tricaine 
(0.03% w/v) for 7 hours starting at 17hpf. At 24hpf embryos were removed, fixed and stained 
immediately or put into recovery in embryo medium and fixed and stained at 42hpf or functionally 
assessed later in development. 
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1.2.5 Mechanosensitive structure within myotendinous junctions and costameres: 
the Focal Adhesion Complex (FAC) 
 
Contraction may regulate myofibril organisation in the developing skeletal muscle, but 
the signalling system of the mechanotransduction that enables this process to occur 
remains to be described. In skeletal muscle fibres force can be transmitted laterally via 
costameres or serially via myotendinous junctions (Huijing, 1999; Monti et al., 1999; 
Ervasti, 2003). Costameres physically connect with the actin cytoskeleton at the 
sarcomere Z-disc and have been implicated as a link between mechanical stimulus and 
downstream cell signalling (Ervasti, 2003); mediating migration and adhesion in many 
cells, as reviewed in Turner (2000) and Schwartz (2001). Therefore disruption of the 
contractile-dependent myofibril organisation in the zebrafish embryo skeletal muscle 
may arise via the disruption of costameric proteins, as previously shown in γ-actin 
knockout mice which develop progressive myopathy with defects in the connectivity 
between muscle fibers and/or myofibrils or at the myotendinous junctions (Sonnemann 
et al., 2006). Costameres and myotendinous junctions are specialist transmembrane 
linkages and share a couple of protein complexes, the dystroglycan and the focal 
adhesion complex (FAC) (Figure 1.13).  
 
 
Figure 1.13: Cellular localisation and ultrastructure of costameres and myotendinous 
junctions in striated muscle. Costameres and myotendinous junctions share dystroglycan and 
focal adhesion complexes which link them to the sarcomeres Z-disc. Costameres are 
circumferential elements that physically couple peripheral myofibrils to the sarcolemma and the 
extracellular matrix (ECM) in periodic register with Z-discs (Ervasti 2003) (top insert). 
Myotendinous junctions are the distal site of connection between tendon and muscle.  
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There is evidence that the non-receptor tyrosine kinase, focal adhesion kinase (Fak), a 
major protein of the FAC, is involved in sensing and transducing mechanical forces within 
both costameres and myotendinous junction in avian and mammalian mature skeletal 
muscles (Flück et al., 1999). It was shown in mammalian cells (mouse) that Fak becomes 
activated when Tyr397 is phosphorylated, after cells have been submitted to mechanical 
loads (Durieux et al., 2009). Furthermore, Fak knockout mice embryos die with a 
mesodermal defect at a very early developmental stage (E8.5, 14-16 pairs of somites) 
illustrating the importance of Fak in early development (Furuta et al., 1995). As well as 
its scaffolding properties, Fak is involved in integrin mediated phosphorylation signalling 
cascades of many FAC proteins and most of its domains are highly conserved in 
between species. Integrin-mediated Fak autophosphorylation of its Tyr397 site generates 
a binding site for Src, which in turn phosphorylates a number of other tyrosine residues 
on Fak. Consequently, the phosphorylation state of Tyr397 is considered indicative of 
Fak’s activity and Src is another key protein of the FAC. Furthermore, Fak has been 
localised at sites of strong cell-ECM adhesion in embryos. In Xenopus and mouse 
embryos, Fak was shown to be prominent at somite borders and in the brain (Hens and 
DeSimone, 1995; Polte et al., 1994). In zebrafish embryos it was shown to be prominent 
in somite boundaries mediating their stabilisation, and in a ring like pattern connecting 
the notochord to its peripheral sheath (Henry et al., 2001; Crawford et al., 2003). Fak is 
an important component of the focal adhesion complex, it is involved in signalling 
between the extracellular matrix and the cytoskeleton and is expressed in early zebrafish 
development. These three facts make it an obvious candidate for the signalling system 
of the mechanotransduction pathway that regulates myofibril organization in vivo. As for 
Src, it is strongly associated with Fak autophosphorylation and its expression has not 
been described in zebrafish. 
 
1.2.6 Functional consequences of paralysis in zebrafish 
 
Finally, to fully explore the positive feedback loop that establishes the link between 
skeletal muscle structure and function, the functional consequences of paralysis were 
examined. This part of the project was done in collaboration with Professor Arner 
(Karolinska Institutet, Stockholm, Sweden), during a 6 weeks visit in his laboratory. 
Techniques that he pioneered to study the physiological mechanical properties of 
developing muscle in zebrafish larvae were used to examine both relaxed mutants and 
chemically treated larvae (Dou et al., 2008). In addition, the motor behaviour of fish that 
had been subjected to a period of paralysis was assessed in collaboration with Doctor 
Brennan (QMUL, London). This work informs the disruption of skeletal muscle force 
production and subsequent swimming behaviour in response to paralysis in zebrafish. 
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Hypothesis: Contraction and its signalling pathway drives myofibril organisation during 
embryonic muscle development. This will be explored using both immotile mutant and 
pharmacologically paralysed zebrafish embryos. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
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2. Materials and methods 
 
2.1 Zebrafish maintenance 
 
Wildtype zebrafish (Danio rerio) were maintained on a 14 hours light, 10 hours dark cycle 
at 28°C in UK Home Office approved facilities in the QMUL fish facility as described 
previously (Ashworth et al., 2001). The mutant zebrafish line, cacnb1ts25 (relaxed) were 
obtained from the Max Planck Institute in Tübingen, Germany. Heterozygote adults, 
motile relaxed carriers cacnb1ts25+/cacnb1ts25- (Rr) were crossed to obtain homozygous 
immotile relaxed mutant cacnb1ts25-/cacnb1ts25- (rr) embryos, identified by lack of 
movement and inability to respond to touch from 17hpf. Homozygous immotile relaxed 
mutant cacnb1ts25-/cacnb1ts25- (rr) and heterozygote motile relaxed carriers 
cacnb1ts25+/cacnb1ts25- (Rr) sibling embryos with a normal phenotype from the same 
batch of eggs were assessed, wildtype (TU) were used as controls.  Embryos were 
collected and raised at 28.5C according to standard procedures, they were staged 
according to standard references and are given in the text as standard developmental 
time, i.e. hours post fertilisation (hpf) (Kimmel et al., 1995). Live embryos were manually 
dechorionated with #5 watchmaker’s forceps at 24hpf in order to identify the homozygous 
immotile relaxed mutant cacnb1ts25-/cacnb1ts25- (rr) embryos. Embryos were touched with 
a fine pipette tip to elicit a touch-evoked swimming response, homozygous relaxed 
mutant embryos were identified by their lack of response. Aged matched sibling embryos 
were collected from adult zebrafish separated by dividers overnight and paired at a set 
time each morning (Gonsar et al., 2012).  
 
2.2 Pharmacological treatments 
 
2.2.1 Tricaine treatment 
 
Dechorionated wildtype (TU) embryos were transferred into embryo medium, EM, 
(13.7mM NaCl, 0.54mM KCl, 25.2μM Na2HPO4, 44.1μM KH2 PO4, 1.3mM CaCl2, 1mM 
MgSO4.7H2O, 10nM HEPES and 1L ddH2O) supplemented with 0.03% Tricaine 
(MS222), a reversible Na+ channel blocking anaesthetic at 17hpf, incubated for 7 hours 
at 28.5oC after which they were transferred in embryo medium. After 1 hour of treatment 
embryos were examined for their ability to move, i.e. occurrence of spontaneous 
contractions. Lack of movement was taken as the indicator that the treatment was 
successful. Control embryos were raised simultaneously. At 24hpf control and treated 
embryos were fixed and stained immediately or put into recovery (EM without Tricaine) 
and control and recovered embryos were either fixed and stained at 42hpf or mounted 
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for X-ray diffraction at 6 days post fertilisation (dpf), or mechanically assessed at 5-7dpf 
or used to assess their swimming behaviour (at 3, 5, 7 and 30dpf) (Figure 2.1).  
 
 
 
 
 
Figure 2.1: Tricaine treatment experimental protocol. [A] Tricaine, is a reversible Na+ channel 
blocking anaesthetic [B] Embryos were incubated in 0.03% Tricaine, at 17hpf for 7 hours at 
28.5oC, after which immunostaining was performed, or they were transferred in Embryo Medium 
for recovery, immunostaining was performed at 42hpf, X-ray diffraction at 6dpf, mechanical 
assessed at 5-7dpf and their swimming behaviour was recorded at   3, 5, 7 and 30dpf. 
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2.2.2 Tricaine-BTS treatment 
 
Dechorionated wildtype embryos were transferred into Embryo Medium supplemented 
with 0.03% Tricaine at 17hpf, incubated for 12 hours at 28.5oC after which they were 
transferred at 29hpf into a 50µM N-Benzyl-P-Tuloenesulfonamide, BTS (Sigma) 
(Cheung et al., 2002), a specific reversible inhibitor of fast myosin ATPase, and incubated 
at 28.5oC up to 5 days post fertilization. BTS, was dissolved in DMSO at stock 
concentrations of 50mM and subsequently diluted to 50µM in embryo medium. After 
1 hour of treatment, embryos were examined for their ability to move, i.e. occurrence of 
spontaneous contractions in embryos before 24hpf and touch response for embryos 
thereafter. Lack of movement was taken as the indicator that the treatment was 
successful. Control embryos were transferred into DMSO (1:1000) at 29hpf. Recovered 
embryos and control embryos kept in DMSO were transferred from the BTS solution into 
Embryo Medium at 5dpf. Recovered fish were assessed in X-ray experiments at 6dpf in 
mechanical studies at 5 and 7dpf, and their swimming was assessed at 3 months (Figure 
2.2). 
 
Figure 2.2: Tricaine-BTS treatment experimental protocol. [A] Tricaine, a reversible Na+ 
channel blocking anaesthetic. [B] BTS (N-Benzyl-P-Tuloenesulfonamide) specific reversible 
inhibitor of fast myosin ATPase. [C] Embryos were incubated in 0.03% Tricaine, channel blocking 
anaesthetic at 17hpf for 7 hours at 28.5oC, after which they were transferred in BTS up to 5 days 
post fertilization, before to be transferred in Embryo Medium for recovery and further assessment. 
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2.2.3 PP2 treatment 
 
Dechorionated wildtype embryos were transferred into Embryo Medium supplemented 
with a DMSO solvent and PP2 (1‐tert‐Buty;‐3‐(4chlorophenyl)‐1H‐pyrazolo [3,4‐
d]pyrimidin‐4‐amine), tyrosine kinase inhibitor (Abcam Biochemicals) at 17hpf and 
incubated at 28.5°C. For the experiments five PP2 concentrations were used: 100uM, 
50uM, 25uM, 12.5uM, 6.25uM. Mobility was assessed at 24, 42 and 48hpf, by touching 
each embryo with a fine pipette tip to elicit a touch-evoked response. Lack of movement 
was taken as the indicator that the treatment was successful. The embryonic phenotype 
was recorded by photography using a microscope equipped with a Thorlabs DCC1645C 
High resolution CMOS camera connected to a PC equipped with Thorlabs DCx camera 
software (Figure 2.3). 
 
 
Figure 2.3: PP2 treatment experimental protocol. [A] PP2, tyrosine kinase inhibitor binds to 
Src, [B] Embryos were incubated in 50uM, 25uM, 12.5uM, 6.25uM PP2 respectively at 17hpf for 
21 hours at 28.5oC, touch-evoked response was assessed at 24, 42 and 48hpf. 
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2.3 Immunohistochemistry 
 
Zebrafish embryos were collected and dechorionated before being fixed overnight at 4°C 
in 500µL BT fix (4% para-formaldehyde, 0.15mM CaCl2, 4%sucrose in 0.1 M PO4 
buffer), as described previously (Ashworth et al., 2001; Westerfield, 1993). The following 
day, three 10 minutes washes in 500µL phosphate buffer (PB) were performed to remove 
any excess PFA,  followed by a 5 minute acetone permeabilisation at -20°C and a further 
two 5 minute washes in 500µL PB. A block was then performed using 10% goat serum 
(GS) in 500µL phosphate buffer with 0.8% triton (PBT) samples were incubated on the 
shaker for 1 hour. Primary antibody was then added as well as PBT with 1% GS saline 
solution (PBST) and incubated at room temperature on the shaker overnight. The 
following day, five 30 minutes washes in 500µL PBT were performed to remove any 
remnants of the primary antibody. The embryos were then incubated overnight on the 
shaker (in darkness) with their respective secondary antibody (anti-mouse or anti-rabbit), 
diluted at 1:1000 in PBT with 1% GS. The following day, phalloidin actin labelling was 
performed, by incubating the samples in either Alexa Fluor 488 phalloidin (Invitrogen) 
diluted at 1:40 in PBT, or Rhodamine phalloidin, for 1 hour on the shaker. Following on 
Alexa Fluor 488 phalloidin labelling, four 30 minutes washes were then performed in PBT 
on the shaker. After Rhodamine phalloidin labelling, three 15 minutes washes were 
performed. Embryos were then either stored in a 50% glycerol - 50% PBS solution ready 
for mounting to view in a lateral position on glass slides in 100 % glycerol, or directly 
mounted in Dako (Dako Sweden AB, Stockholm Sweden). The details of primary 
antibodies and respective secondary antibodies used in this study are found in the tables 
below (Table 2.1 & 2.2). 
 
 
Table 2.1: Details of Primary Antibodies. 
 
 
 
Primary Antibody 
Species  
raised in 
Concentration 
 (in PBST 1%GS) 
From Chapter 
F59 Mouse 1:100 
DSHB by Stockdale, Frank E. 
(DSHB Hybridoma Product) 
3 & 4 
Tropomodulin 1 Rabbit 1:100 Gift from Pr.Fowler Laboratory 3 
Tropomodulin 4 Rabbit 1:25 Gift from Pr.Fowler Laboratory 3 
Phospho-Src (Tyr416) Rabbit 1:250 Cell Signaling 4 
β‐sarcoglycan Mouse 1:250 Novo Castra Laboratories 4 
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Table 2.2: Details of Secondary Antibodies. 
 
2.4 Confocal imaging 
 
Images from whole mount embryos were acquired using a Zeiss META 510 confocal 
microscope (excitation 543nm, emission 560-615 band pass filter, using 20 or 40 x 
lenses) at 5dpf and z-stack images up to 2dpf were acquired using a Leica (Leica SP5). 
Alexa 488 labelled specimens were excited with 488nm laser line and emitted light was 
collected at 500-550nm band pass filter using 60x lens. Secondary Cy5 labelled 
antibodies were excited with 633nm HeNe laser. For a comparative approach images 
were acquired from somites that were positioned in a region aligning with the yolk 
extension, immediately below the point of attachment with the yolk ball.  
 
2.4.1 Standardisation of somite length measurements 
 
In Chapter 4, the measurements of somite length was standardised to compare between 
experiments. This was achieved by measuring between the boundaries at the level of 
the horizontal myoseptum, between the two apexes of the chevron shaped somite 
boundaries. A 30μm line was drawn perpendicular to the horizontal myoseptum 
measurement both ventrally and dorsally, this was followed by another perpendicular line 
from the 30μm readings to give rise to three parallel measurements equally spaced along 
the somite. For embryos that lacked a clear horizontal myoseptum, a line was drawn as 
best fit, but was not recorded as a measurement, from this line of best fit two parallel 
readings were taken if the somite boundaries were clear. Final measurements (Figure 
4.13) are a mean of the three measurements taken from the somite length shown in 
Figure 2.4. 
 
Figure 2.4: Measurement of somite length of 48hpf PP2 treated embryo. Somite boundaries 
stained with a β-sarcoglycan antibody. 
Secondary Antibody 
Species  
raised in 
Concentration 
 (in PBST 1%GS) 
From 
Associated 
Primary Ab 
goat anti rabbit IgG 
Alexa Fluor 488 
Goat 1:1000 Invitrogen 
Tropomodulin 1 
Tropmodulin 4 
Phospho-Src 
goat anti mouse  
Cy™5-linked Goat 1:1000 GE HealthCare Uk Ltd. 
F59 
β‐sarcoglycan 
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2.4.2 Standardisation of myofibril length measurements 
 
In Chapter 3, myofibrils waviness was obtained by tracing lines using the “open free 
shape curve drawing mode” in the Imaris software (Bitplane). In addition end-end length 
measurements (i.e. between myosepta in the trunk muscles) were taken from a straight 
line that connected the starting and end points of the curved line. The myofibril length 
was normalised to the end-end length as an index for myofibril alignment (Figure 2.5). 
 
 
 
Figure 2.5: Measurement of myofibril length on 24hpf relaxed mutant. Immunostaining of 
myosin with F59 and confocal projections reveal myofibril organisation. 
 
2.4.3 Standardisation of myofibril width measurements 
 
The width of the myofibrils was taken perpendicularly to the median plan of the somite 
which was first established by measuring the width of the somite (as described in 2.5.1) 
and joining the centre of these measurements, using the Leica LAS AF software (Figure 
2.6). 
 
 
Figure 2.6: Measurement of myofibril width on wildtype 24hpf embryo. Immunostaining of 
myosin with F59 and confocal projections reveal myofibril organisation. 
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2.4.4 Standardisation of actin length measurements 
 
The length of the actin myofilaments was estimated by measuring phalloidin stained actin 
filaments between the boundaries of adjacent H zones, H-H measurement, five 
measurements were taken per fish, using the Leica LAS AF software (Figure 2.7).  
 
 
 
Figure 2.7: H-H measurement. [A] Confocal image of actin filaments stained with phalloidin 
(1/40) [B] Measurement were made in between H bands, across Z-discs and sarcomeres. 
 
2.4.5 Standardisation of cross-sectional area measurements 
 
Cross-sectional area of transversal sections through dorsal region of the somite of 
phalloidin stained embryos was estimated by multiplying transversal and longitudinal 
measurements, using the Leica LAS AF software, as depicted in Figure 2.8. 
 
 
Figure 2.8: Cross-sectional measurement in 5dpf wildtype embryo. Confocal image of actin 
filaments stained with phalloidin (1/40). 
  
A B 
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2.5 Molecular analysis 
 
2.5.1 RNA Extraction 
 
A Micro-Fast track 2.0 Invitrogen kit was used for the mRNA extraction. mRNA was 
extracted from several batches of wildtype frozen embryos varying in size, ie. 100, 92, 
45, 25 and 20 embryos. ‘Twin’ batches of embryos, one of homozygotes relaxed 
mutants, the other of their sibling’s heterozygotes and wildtypes controls, were assessed. 
The mRNA concentration was determined by spectrophotometry using the Nanoview GE 
Healthcare. 
 
2.5.2 PCR and electrophoresis 
 
RTPCR was conducted following the protocol of the Access RT-PCR kit and DNase I 
obtained from Promega UK (282071), in order to perform both cDNA synthesis and 
PCR in one step to reduce possible inaccuracies due to manual handling, as pipetting 
errors.  Three pairs of primers were used to amplify respectively fak1a, fak1b and actin 
(Table 3). actin was chosen as a positive control in order to check the presence of RNA. 
The wildtype total RNA was used as a primer positive control for the three pairs of 
primers. Furthermore, DEPC water was run as a negative control for each set of primer, 
and the kit’s positive control (RNA/primer) was also run. A gel electrophoresis was then 
performed, 5µL aliquot of the PCR products were mixed to 1µL of Loading Buffer and 
run on a 1% agarose/TAE gel for 35min. at 80V, along with a 100bp ladder (Biolabs), to 
determine fak1a, fak1b and actin weight, which is respectively 353bp, 346bp and 
238bp.  
 
2.5.3 qRTPCR 
 
2.5.3.1 Embryo collection for qRTPCR 
 
Zebrafish embryos were collected and pooled at different developmental stages, 10 
embryos at 24hpf, 3 embryos at 48hpf, 2 embryos at 72hpf and 2 embryos at 96hpf 
respectively. Embryos were pooled in that way after optimisation of the qRTPCR 
technique, to ensure that there was a similar amount of mRNA in each sample. They 
were immersed in 200μL of Lysis Buffer (Invitrogen Dynabeads mRNA Direct Kit) in 
1.5mL eppendorf tubes and immediately frozen on dry ice. They were then kept at -80C 
prior to mRNA extraction. 
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2.5.3.2 mRNA extraction and  oligonucleotides 
 
Poly-A+ mRNA was extracted directly from embryos using the Dynabeads® mRNA 
DirectTM kit (Invitrogen), and purified mRNA was then reverse transcribed into cDNA 
using the Reverse Transcription System kit (Promega). Oligonucleotide pairs for use as 
qRTPCR primers were designed for fak1a (GenBank ID: AF348085.1), fak1b (GenBank 
ID: AT196213.1), foxm1 (Uniprot: HFH11b mRNA (U74613), GAPDH (NCBI Reference 
Sequence: NM_001115114.1), βActin (GenBank: AF057040.1), using the Roche primer 
design webtool (Table 2.3).  
 
Gene of interest ID Primer sense Primer Sequence 
fak1a 
AF348085.1 
Forward GGC GAG CGT CTG GCT ATG CC 
Reverse GAG AGC AGG CCA TGT GGG CC 
fak1b 
AT196213.1 
Forward CCA CCG ACA GGA GCC TCC CA 
Reverse ATA GCT GTC GGC CGG GCT CA 
foxm1 
HFH11b mRNA (U74613) 
Forward CCT CAG ATC CCA CAA GTT GC 
Reverse GCT TCA TCT TCC TCT CTG TGC 
GAPDH 
NM_001115114.1 
Forward GTG GAG TCT ACT GGT GTC TT 
Reverse GTG CAG GAG GCA TTG CTT ACA 
βactin 
AF057040.1 
Forward AAG CAG GAG TAC GAT GAG TC 
Reverse TGG AGT CCT CAG ATG CAT TG 
Table 2.3: fak1a, fak1b, foxm1, GAPDH, βActin sequences designed using the Roche 
primer design webtool. 
 
2.5.3.3 qRTPCR 
 
For quantification of fak1a, fak1b and foxm1 mRNA transcripts, the pairs of primers 
fak1aF/R, fak1bF/R and foxm1F/R were used for PCR amplification (Hybaid MultiBlock 
System) from a pooled cDNA sample of zebrafish embryos, this confirmed that each 
primer pair produced a single PCR band. The PCR product was purified after gel 
electrophoresis and quantified using a spectrophotometer. A serial dilution of fak1a, 
fak1b and foxm1 cDNA was used to generate a standard curve (109 to 102 copies of 
fak1a, fak1b and foxm1 mRNA per 2μL) using the LightCycler. The mRNA copy number 
of fak1a, fak1b and foxm1 in each sample was determined from the standard curve using 
the LightCycler quantification software. The zebrafish GAPDH and βActin were used as 
a reference housekeeping genes for all quantification of fak1a, fak1b and foxm1 mRNA 
levels. The GAPDH and βActin primers were used to PCR amplify a fragment of 173bp 
and 238bp respectively from a cDNA sample of zebrafish embryos. Similarly, a standard 
titration curve for GAPDH and βActin was performed, and the mRNA copy number of 
GAPDH and βActin in each sample was determined as described above. The amount of 
fak1a, fak1b and foxm1 mRNA in each sample was normalized against the combined 
42 
 
amount of GAPDH and βActin mRNA in the same sample and subsequently expressed 
as the mRNA copy number of fak1a, fak1b or foxm1 per 1000 copies of GAPDH and 
βActin mRNA.  
Real-time quantitative PCR was performed using a LightCycler 480 (Roche Diagnostics) 
in which PCR reactions were performed in a 10μL volume of FastStart DNA Master 
SYBR Green I mix (Roche Diagnostics Ltd.), containing 5μM primers, dH2O and Taq 
DNA polymerase, DNA double-strand specific SYBR Green I dye, nucleotides, and 
buffer. A typical protocol comprised an initial denaturation at 95°C for 5 min, followed by 
45 cycles of 95°C for 10 s, 65°C annealing for 6 s, and 72°C elongation for 7s, 
fluorescence was measured at 2/3°C below specific melting peak of each product. At the 
end of the 45 cycles, samples were subjected to a melting analysis to confirm 
amplification specificity of the PCR products. During this step, samples were heated from 
72 to 95°C at a steady rate of 4.4°C/s, and fluorescence was measured continuously 
throughout this period (Teh et al., 2002). Melting analysis of fak1a, fak1b, foxm1, GAPDH 
and βActin of all cDNA samples amplified, consistently (both intra- and inter-experiment) 
gave single melting peaks of 88.8 ±0.07°C (mean ± SE of n = 12, randomly chosen 
samples from three independent experiments), 90.8 ±0.07°C, 83.9 ±0.07°C, 84.7 
±0.06°C and 85.4 ±0.06°C respectively. PCR products were further confirmed by gel 
electrophoresis. 
 
2.6 Mounting for mechanical experiments and X-ray diffraction analysis 
 
The larvae were held in Embryo Medium, at pH 6.8–6.9. Prior to the experiment, a 5-
7dpf larva was transferred to Embryo Medium containing 0.017% Tricaine (3-amino 
benzoic acid ethylester). When the larva was anaesthetised, the head was crushed and 
the preparation mounted using aluminium clips (Dou et al., 2008; Li et al., 2013). These 
were folded around the head and tail portions of the larvae, providing a defined and 
stable attachment. Small holes were made in the aluminium foil for attaching the 
preparation between the extended arm of an AE801 force transducer (SensoNor, a.s., 
Horten Norway) and a fixed pin for length adjustment using a micrometer screw (Figure 
2.9). For mechanical experiments the preparation held horizontally in a 0.5mL Perspex 
organ bath at room temperature (22°C). For X-ray diffraction experiments the preparation 
was mounted between a fixed hook and a hook on a micrometer screw, for length 
adjustment. The experiments were performed at 22oC in MOPS buffered physiological 
solution (in mM: 118 NaCl, 24 MOPS, 5 KCl, 1.2 MgCl2, 1.2 Na2HPO4, 1.6 CaCl2, and 10 
glucose) at 22°C, pH 7.4. 
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Figure 2.9: Zebrafish larvae preparation. [A] Schematic illustration of preparation attachment 
using aluminium foil clips at both ends of the larvae. The aluminium foil is folded along the dashed 
lines as shown on the left clip. A small hole is made in each clip for mounting. [B] Photograph of 
the preparation mounted on the microscope stage (Dou et al., 2008). 
 
2.7 Small angle X-Ray diffraction 
 
Small angle X-ray diffraction was used to determine the interfilament distances in the 
zebrafish larvae, as described previously (Dou et al., 2008), at beamline I911-SAXS at 
the MAX II ring of the MAX IV Laboratory in Lund, Sweden (Li et al., 2013; Labrador et 
al., 2013). The larvae were euthanised and mounted horizontally as described above 
between two hooks in a Kapton cuvette in the MOPS buffered physiological solution and 
stretched to different lengths (L) relative to slack (Ls). In a few experiments the MOPS 
buffered solution was supplemented with 5mM NaCN to induce metabolic inhibition and 
a rigor state. The camera length was 230cm and calibrations of the X-ray patterns were 
made using diffraction from rat tail collagen. The diffraction patterns were recorded using 
a PILATUS 1M detector (DECTRIS Ltd.) with exposure times between 5 and 10s. For 
analysis of diffraction patterns in living and non-stretched preparations, the larvae were 
anesthetised with Tricaine and kept in Embryo Medium in a cuvette. Equatorial patterns 
were recorded and the spacing and intensities of the 1.0 and 1.1 reflections were 
evaluated using background subtraction by fitting a polynomial function, determining the 
centre position (lattice spacing) and the integrated the area (intensity) under the peaks 
(Figure 2.10).   
 
 
Figure 2.10: Skeletal muscle lattice and small-angle X-ray diffraction patterns. Left: 
Transverse view of thick and thin filament lattice and equatorial reflections in X-ray diffraction of 
skeletal muscles. Right: Graphical representation of the reflection pattern of skeletal muscle at 
rest, during contraction and in rigor and their densitometer traces. Modified from Millman, 1998. 
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2.8 Mechanical analysis 
 
The larval preparations were mounted as described above at slack length and then 
stimulated (single twitches) with 0.5ms electrical pulses (supramaximal voltage) at 2 min 
intervals via two platinum electrodes placed on both sides of the preparation. Length (L) 
was increased in steps between the contractions, from the slack length (Ls) to a length 
above the maximal for active force (Lopt). At each length, active and passive force were 
recorded. Force signals were recorded and analysed using LabChart® (ADInstruments 
Ltd, Oxford, UK). Using this procedure the Lopt, as well as the shape of the passive and 
active length-force relationships, were determined.  
 
2.9 Sarcomere length measurements and volume calculation 
 
In one series of experiments we mounted muscle preparations in a cuvette with a glass 
window enabling analysis of sarcomere length using a 40x objective on an inverted 
microscope. Muscles were stretched in a similar manner as in the force and X-ray 
diffraction experiments to different lengths relative to slack.  This data enabled us to 
relate the extent of stretch to sarcomere length. Using the sarcomere length data, the 
sarcomere volume was estimated. The cross-sectional area of one sarcomere is 
composed of 6 equal sided triangles, where 2/3*d
10
 is the side (Figure 11). (d
10
)
2
 * 2 / √3 
is the area of the sarcomere cross section and Volume = Area * sarcomere length, i.e. 
(D
10
)
2
 * 2/√3 * Sarcomere length (SL). If we plot 1/ (D
10
)
2
 vs. SL and get the slope, the 
volume can be calculated as Volume = (1/slope) * 2 / √3, as described by (Millman, 1998) 
(Figure 2.11). 
 
 
 
Figure 2.11: Filament lattice with the d10 and d11 spacings. The cross-sectional area of one 
sarcomere, composed of 6 equidistant triangles, is indicated with the red dotted line (Millman, 
1998). 
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2.10 Behavioural analysis 
 
Optical analysis of larval swimming behaviour can be used as a semi-quantitative 
method to identify major motility problems (Granato et al., 1996). Swimming basal 
behaviour was assessed by recording the distance travelled and number of rotations of 
both control and drug treated embryos over 2 min trials at 3, 5, 7, 30 days and 3 months 
post fertilisation using an automated behavioural analysis system, an Image Source 
DMK camera linked to the tracking software Ethovision™. The Ethovision™ tracking 
software presented the results as a numerical value based on displacement from the 
initial start point, there were 120 data points from the 2 minute experiment (Figure 2.12). 
 
 
 
Figure 2.12: Schematic representation of swimming basal behaviour recordings. The 
embryos were tested during 2 minutes in a 6 well plate, with each of the wells forming an arena 
for the zebrafish embryos to be tested in. Swimming variables distance travelled and number of 
rotation were recorded using an Image Source DMK camera linked to the Ethovision™ tracking 
software on a PC.  
 
2.11 Statistical analysis 
 
Statistical analysis in this study were performed with the Graphpad Prism, SPSS and R 
softwares. 
 
2.11.1 Statistical analysis of the swimming behaviours recorded with 
Ethovision™  
 
Larvae were filmed from above for 2 minutes, allocated into 1 second bins. Distance 
travelled (mm/sec) and rotations (n/sec) were assessed as a function of age (4 levels: 
72hpf, 120hpf, 168hpf and 732hpf) and Tricaine treatment (2-levels: Tricaine treated vs. 
control). Distance travelled data were entered into a random intercept linear mixed 
effects model, with individual ID nested in batch as a random effect. Denominator 
degrees of freedom were estimated using the Satterthwaite approximation. Initial null 
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model fits indicated that the errors were non-normal, but this was corrected by a log 
(base-10) transformation. Rotations data were overdispersed (zero-inflated) and fitted to 
a mixed effects model with a negative-binomial (generalised linear mixed effects model). 
As before, individual ID nested in batch was added as a random effect. The contribution 
of ‘time’ to the variance was assessed by likelihood ratio test from the null models, but 
this was omitted from final models. This analysis was performed using the R ‘lme4’ 
package. 
 
2.11.2 Statistical analysis of the PP2 study 
 
Using the SPSS software, one‐way and two‐way ANOVA were used to reject the null 
hypothesis, then a post hoc LSD (least significant difference) test was used to test for a 
dose effect. Dose effect was calculated by comparison of the LSD between the 
concentrations of treatment. For the staining analysis the different experiments were 
used as a random factor, to see if there was any variation of somite length between the 
experiments. 
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CHAPTER 3 
 
EFFECT OF PARALYSIS ON MYOFIBRIL  
STRUCTURE AND ORGANISATION 
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3. Effect of paralysis on myofibril structure and organisation 
 
3.1. Introduction 
 
Skeletal muscle fibres are composed of myofibril bundles, which contain the contractile 
machinery (i.e. the sarcomeres). The correct formation of myobrils, myofibrillogenesis, 
is therefore critical for skeletal muscle function. Striated skeletal muscle structure is 
conserved across the animal kingdom implying that myofibrillogenesis and the 
mechanism of myofibril assembly is a fundamental process (as reviewed by Sanger et 
al., 2010). Contraction is key for myofibril differentiation and assembly (Chapter 1 Figure 
1.2); however, the underlying mechanism of this process is not well defined. The internal 
structure of the skeletal muscle fibres is maintained in part by their own intrinsic 
contractile activity (Boonyarom and Inui, 2006). Evidence from studies in isolated 
cultures has shown that contraction is an important regulator in the later stages of 
myofibril assembly, alignment and sarcomere spacing (Sparrow and Schöck, 2009; 
Sanger et al., 2005; De Deyne, 2000; Fujita et al., 2007). In addition, in vivo studies, in 
C elegans (Hresko et al., 1994; Moerman and Williams, 2006) and Drosophila (Reedy 
and Beall, 1993), have also shown that contraction regulates myofibril development. In 
zebrafish, the excitation-contraction pathway was shown to control sarcomere length 
(Brennan et al., 2005). 
Zebrafish have proved useful as an in vivo model to study the development of vertebrate 
skeletal muscle, including myofibril organisation and alignment. Contractile movement in 
zebrafish embryos is initiated at 17hpf, as functional neuromuscular connections within 
the body of the fish start to form (Chapter 1 Figure 1.6). Zebrafish motility mutants (which 
lack components of the excitation-contraction coupling pathway) contain skeletal muscle 
that is unable to contract and development of the muscle fibres is disrupted (Behra et al., 
2002; Brennan et al., 2005; van der Meulen et al., 2005). Evidence from several 
laboratories show that, a lack of E-C coupling in the skeletal muscle of immotile zebrafish 
embryos disrupts (i) myofibril alignment (thin wavy myofibrils) and (ii) sarcomere width 
and filament length (in the A and possibly M band). These studies show that contraction 
is necessary for the organisation and refinement of myofibril structure during early 
vertebrate muscle development. 
There is evidence that it is the contractile event itself rather than upstream signalling 
events, such calcium release that is important for myofibril alignment (Lahne et al., 2009) 
(Chapter 1 Figure1.11). This has led to the hypothesis that contractile activity is driving 
myofibril organisation; however, this has not been tested directly in vivo. Furthermore, 
the severity of myofibril misalignment in paralysed embryos was shown to correlate with 
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specific developmental time points. The most pronounced effect being observed when 
embryos were paralysed from 17-24hpf rather than later on (24-41hpf and 48-55hpf) 
(Chapter 1 Figure 1.10) (Lahne et al., 2009). This time window (17-24hpf) coincides with 
the initiation of the spontaneous contractile activity (Chapter 1 Figure 1.6). These initial 
spontaneous contractions are proposed to be an endogenous developmental event that 
play a key role in the organisation of myofibrils during early skeletal muscle development.  
Actin filaments are the most abundant protein in myofibrils, they anchor at the Z disc, 
span the I band and extend towards the middle of the sarcomere (Chapter 1 Figure 1.1). 
The I band, as well as containing structures, notably actin, has several essential 
functions, including linking the region of active force generation (the A band, where the 
myosin cross links) with the Z-discs ensuring sarcomere linkage, and acting as a spring 
for the reversible mechanical stretch response required for efficient contractile activity. 
To ensure the spring like action and maintenance of tension through the sarcomeres, 
myofibril and ultimately the skeletal muscle, the length of thin filaments is very precise. 
Actin length is proposed to be regulated via several remodelling mechanisms, mainly 
through interactions with the template protein nebulin and capping proteins 
(tropomodulins and CapZ), that sequester monomeric actin, sever actin filaments, and/or 
promote actin polymerization and depolymerisation, as reviewed by Clark and Trinick 
(Clark et al., 2002; Trinick, 1994; Gokhin and Fowler, 2013). While the classic nebulin 
ruler model that determines actin length was appealing in its simplicity, recent studies 
have shown that this model was incorrect. Thin filaments are more accurately modeled 
as bipartite structures with the following concatenated segments: (i) a constant-length, 
nebulin-coated thin filament core region (‘proximal segment’) starting at the Z-line and 
continuing to a distance of ~0.95 µm away from the Z-line; (ii) a variable-length, nebulin-
free, thin filament extension (‘distal segment’) starting at ~0.95 µm away from the Z-line 
and continuing to the thin filament pointed end, which is capped by Tmod. The constant 
length of the nebulin-coated proximal segment excludes the possibility of a ruler function 
for nebulin, since thin filament lengths vary across different muscles (Gokhin et al., 2012; 
Gokhin et al., 2010; Castillo et al., 2009; Littlefield et al., 2002; Ochala et al., 2012; 
Ringkob et al., 2004). While the variable length of the distal segment implicates Tmod-
mediated pointed-end actin dynamics as the chief determiner of skeletal muscle-specific 
thin filament lengths in vivo (Gokhin and Fowler, 2013). 
Actin filaments have distinct polarity and, in the sarcomere are orientated so that the 
positive or barbed ends are anchored to the Z-bands, whereas the negative or pointed 
ends are not attached to any structure but capped by capping proteins, notably 
tropomodulins (Tmod) and Leiomodins (Lmod). These capping proteins, which control 
actin polymerisation at the actin pointed ends, have a critical role in regulating thin 
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filament length (Littlefield and Fowler, 2008) sarcomeric structure and organisation 
(Chereau et al., 2008). The importance of Tmod is highlighted by their presence in all 
metazoans, with four isoforms of Tropomodulins expressed in mammalian cells (Gokhin 
and Fowler, 2011), the isoforms that regulate actin filaments in skeletal muscle are 
Tmod1 and Tmod4  (Gokhin et al., 2010).  Lmods are evolutionarily related to Tmods 
and display tissue-specific patterns of expression distinct from, but overlapping with, the 
expression of Tmod isoforms (Conley, 2001). By capping the pointed ends of actin 
filaments, Tmods and Lmods control actin filament assembly, length, and stability. 
Studies have shown that overexpression of Tmods shortens thin filaments, whereas 
knockdown or inhibition of the capping activity of Tmods results in the elongation of thin 
filaments (Gokhin and Fowler, 2011; Gregorio et al., 1995; Littlefield et al., 2001; 
Mardahl-Dumesnil and Fowler, 2001; Ono, 2010). Furthermore Lmod2 and 3 are 
expressed in skeletal muscle and their interaction with Tmods appears to modulate actin 
nucleation activity and localisation (Skwarek-Maruszewska et al., 2010). 
Studies have shown that during muscle paralysis in zebrafish embryos, disruption to the 
myofibril structure is accompanied by rearrangements at the ultrastructural level, within 
the filaments of the sarcomeres themselves, namely changes in length (Brennan et al., 
2005). Furthermore, evidence from mammalian work suggests that actin filament 
remodeling, specifically lengthening, may have a direct impact on myofibril organisation 
(as reviewed by Ono, 2010) (Gokhin et al., 2010) and function, as thin filaments 
determine the optimal sarcomere length for force generation (Littlefield and Fowler, 
2008). This has led to the hypothesis that contraction may regulate actin length and 
associated capping protein distribution during zebrafish myofibril organization.  
In order to study the importance of contraction in skeletal muscle development, namely 
myofibril organisation, a combination of genetic and pharmacological approaches were 
established. An immotile mutant line (cacnb1ts25, relaxed), which lacks functional voltage-
gated calcium channels (dihydropyridine receptors) in skeletal muscle, and treatment of 
embryos with a reversible anaesthetic (Tricaine and BTS) allowed the study of paralysis 
(in mutants and anaesthetised fish) and recovery of movement (reversal of anaesthetic 
treatments). The effect of paralysis on skeletal muscle structure at both myofibril and 
myofilament level in early embryos (aged between 17-24hpf) was determined using 
immunostaining and confocal microscopy, as well as small angle X-ray diffraction.  
Furthermore, the consequences of paralysis and recovery on the localisation of the actin 
capping proteins Tropomodulin 1 and 4 was also assessed to establish if contractility 
was necessary to their correct positioning and actin regulatory activity. 
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Hypothesis: Myofibril elongation has been observed in immotile mutant zebrafish 
embryos leading to the hypothesis that contraction is necessary for the regulation of 
myofibril length (Brennan et al., 2005). This hypothesis was tested in this chapter by 
determining whether paralysis-induced lengthening of myofibrils can be rescued by 
reimposing movements in living zebrafish embryos using a reversible anaesthetic. In 
addition, once the process of myofibril regulation was established, the underlying 
mechanisms were investigated. Sarcomere and myosin shortening occur as a result of 
paralysis, however the effect on actin myofilament length is unknown. Thus, it was 
proposed that contraction drives actin length, this hypothesis was tested in this chapter 
using the same technique as described above for myofibrils. 
 
3.2 Results  
 
An experimental paradigm was developed to investigate whether reinstalling contraction 
would lead to a recovery of myofibril organisation. Myofibril organisation has been shown 
to be most disrupted when paralysis occurs between 17 and 24hpf, a time coinciding 
with the formation of neuromuscular junctions and the onset of initial embryonic 
movement (Lahne et al., 2009). This suggests that the initial 17-24hpf contractile event 
itself, drives myofibril organisation during early development and is therefore important 
for the establishment of skeletal muscle structure and function in the zebrafish embryo. 
Wildtype embryos were treated with a reversible anaesthetic (Tricaine) to induce 
paralysis between 17-24hpf (as described in Chapter 2 Figure 2.1). Staining at 24hpf 
demonstrated that the wavy phenotype observed in relaxed mutant embryos could be 
reproduced in chemically paralysed embryos. Subsequently, at 24hpf, embryos were 
removed from anaesthetic to enable recovery of movement and staining at 42hpf (18 
hours after paralysis) revealed that the myofibril recovery was possible (Figure 3.1).  
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Figure 3.1: 17-24hpf paralysis disrupts myofibril organisation, movement recovery 
restores it. Confocal projections of immunohistochemically labelled slow muscle fibres anti-
myosin antibody F59. Zebrafish embryos were exposed to Tricaine for 7 hours from 17-24hpf, 
before recovery was allowed in Embryo Medium up to 42hpf (Scale bar 25 µm). Movement 
restoration after paralysis leads to skeletal muscle structure recovery. 
 
3.2.1 Early paralysis-induced myofibril organisation disruption is partially 
restored by the recovery of contractile movement 
 
Paralysis between 17 and 24hpf in either chemically treated or immotile mutants lead to 
the development of a ‘wavy’ myofibril phenotype in paralysed embryos (Figure 3.2 G, J) 
when compared to controls at 24hpf (Figure 3.2 A, D). Staining at 42hpf, after 18 hours 
of recovery and movement, revealed a partial structural recovery of myofibril organisation 
in chemically paralysed embryos (Figure 3.2 H), as compared to controls (Figure 3.2 B). 
Further, structural recovery appeared to be sustained at 5 days post fertilisation (Figure 
3.2 I), whereas the myofibrils in immotile relaxed mutants remained wavy throughout the 
experimental period (Figure 3.2 K, L).  
 
Tricaine 
17hpf 
EM 
24hpf 42hpf 
paralysis recovery 
20µm 20µm 
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Figure 3.2: Paralysis-induced disruption of myofibril organisation is partially reversed by 
restoring movement in developing skeletal muscle. Control embryos (Embryo Medium alone) 
and treated embryos (Embryo Medium with Tricaine) were incubated for 7 hours starting at 17hpf. 
At 24hpf embryos were removed and control (A) and treated embryos (G) were fixed and stained 
immediately or put into recovery (Embryo Medium without Tricaine) and (B) control and (H) 
recovered embryos fixed and stained at 42hpf. Some embryos were kept in recovery from 24hpf 
up to 5 days before fixation and staining of both control (C) and recovered larvae (I). Relaxed 
immotile mutants were fixed and stained at 24hpf (J), at 42hpf (K) and 5 days (L) as well as motile 
carriers controls at 24hpf (D), 42hpf (E) and 5 days (F). Anti-myosin antibody (F59) in 
A,B,D,E,G,H,J,K, and Rhodamine phalloidin actin labelling in C,I,F,L reveals slow muscle fibres, 
scale bars corresponds to 20µm. For consistency, the somite imaged were taken at the level 
where the yolk sac and the yolk sac extension join. 
 
Structural recovery of myofibrils, as observed by imaging, was evaluated in more detail 
using a method to quantify myofibril length and width in both chemically paralysed 
wildtype zebrafish embryos and paralysed relaxed mutants at 24 and 42hpf. At 24hpf, 
Tricaine treated embryos showed a significant increase in myofibril length and a 
decrease in myofibril width compared to control embryos (Figure 3.3 A). At 42hpf, motile 
recovered Tricaine treated embryos, placed into Embryo Medium from 24hpf, showed 
no significant difference in myofibril length and a small but significant difference in 
myofibril width compared to controls (Figure 3.3 A). In summary, the Tricaine-induced 
paralysis lead to a decrease in myofibril width and an increase in length, the later being 
restored after recovery of movement at 42hpf, when compared to controls. At 24hpf the 
myofibrils in relaxed immotile mutant showed a very significant increase in myofibril 
length and a decrease in width compared to motile carriers, in a similar manner to the 
Tricaine treated embryos (Figure 3.3 B). However, at 42hpf, the myofibrils in relaxed 
embryos remained significantly elongated compared to motile carriers, whereas their 
width had recovered to control values (Figure 3.3 B).  
In summary, these results show that inhibition of contraction between 17 and 24hpf 
causes a significant increase in length and decrease in width of the myofibrils. The 
restoration of contractile movement leads to a full recovery of myofibril length but not 
width. Furthermore, it is noticeable that in the complete absence of movement myofibril 
width but not length fully recovers. These observations show that regulation of myofibril 
length depends on contractile activity whereas myofibril width does not.  
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Figure 3.3: Disruption of myofibril organisation during paralysis is reversed by restoring 
movement in developing skeletal muscle. [A] Immediately after treatment at 24hpf, a very 
significant increase in myofibril length/end-end (***p<0.001) and decrease in myofibril width 
(***p<0.001) in Tricaine treated compared to control embryos was observed (length: controls n=6, 
treated n=6 and width: controls n=17, treated n=36, ANOVA, Kruskal-Wallis). After recovery by 
42hpf, no significant difference (ns) in the myofibril length/end-end and a small but slightly 
significant difference in myofibril width (*p<0.05) in control versus recovered embryos was 
observed (length: controls n=18, treated n=6, width: controls n=57, treated n=23, ANOVA, 
Kruskal-Wallis). [B] At 24hpf immotile relaxed mutants (rr) showed a very significant increase in 
myofibril length/end-end (***p<0.001) and decrease in myofobril width (***p<0.001) compared to 
motile carriers (Rr) (length: Rr n=5, rr n=5 and width: Rr n=10, rr n=10, ANOVA, Kruskal-Wallis). 
At 42hpf immotile relaxed mutants (rr) myofibril length/end-end was still slightly significantly  
elongated (*p<0.05)  but there was no significant difference in the myofibril width (ns) compared 
to motile carriers (Rr) (length: Rr n=5, rr n=5 and width: Rr n=13, rr n=13, ANOVA, Kruskal-Wallis).   
 
3.2.2 Filament lattice spacing is not affected by paralysis 
 
In the previous section, the regulation of myofibril width was found to be independent of 
movement. As myofibrils are composed of myofilaments (actin and myosin), it is likely 
that the lateral spacing of the myofilament within the lattice is also a movement 
independent process. Furthermore, in mice, motility mutants (Myh4arl) were shown to 
have similar lattice pattern to wildtypes (Lindqvist et al., 2013). Taken together, these 
evidences suggests that myofilament spacing will be unaffected by paralysis in vivo. 
Myofibril architecture, namely myofilament bundling, was assessed in immotile embryos 
at 6dpf using small angle-X-ray diffraction. This technique, has proved effective in 
exploring the zebrafish myofilament lattice in wildtype fish (Dou et al., 2008), but has 
never been used to assess immotile zebrafish muscle. Interfilament spacing was 
measured in 6dpf muscle preparations of the immotile relaxed mutants and their control 
0 0 
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siblings, to explore if the complete lack of contractile activity during development, and 
the disrupted thin filament lengths (as determined at 2dpf, see 3.2.3) affect the lateral 
arrangement of myofilaments in the sarcomere. We also examined the filament structure 
in larvae recovered after Tricaine immobilisation between 17 and 24hpf, in comparison 
with their control at 6dpf. For these experiments, we used small-angle X-ray diffraction 
and determined (i) the lattice spacing from the 1.0 and 1.1 equatorial reflections (Figure 
3.4) and (ii) sarcomere volume using the sarcomere length data examined in detail in 
Chapter 5 (Figure 5.7). 
 
Figure 3.4: Skeletal muscle lattice and small-angle X-ray diffraction patterns. Left: 
Transverse view of thick and thin filament lattice and equatorial reflections in X-ray diffraction of 
skeletal muscles. Right: Graphical representation of the reflection pattern of skeletal muscle at 
rest, during contraction and in rigor and their densitometer traces (Modified from (Millman, 1998). 
The equatorial 1.0 and 1.1 reflections were clearly visible in all groups (Figure 3.5 A-E) 
demonstrating that even in the completely immotile relaxed larvae a regular filament 
lattice is assembled. X-ray patterns were recorded at different degrees of stretch and the 
spacing of the equatorial reflections evaluated (Figure 3.5 F, G). Stretch of the muscles 
resulted in an outward movement of the reflections reflecting shrinkage of the filament 
lattice suggesting a constant sarcomere volume is maintained in all groups. The spacing 
of the 1.0 reflection was similar in the four groups at all degrees of stretch. Similar data 
was found for the spacing of the 1.1 reflection (Appendix A). The inner 1.0 reflection was 
strong with a low 1.1/1.0 intensity ratio of about 0.2-0.4 in all groups (Figure 3.5 G), 
reflecting that cross-bridges are positioned close to the thick filament backbone with no 
major differences between the examined groups, even in the relaxed immotile mutants. 
In a separate series we measured the sarcomere length at different degrees of stretch 
in immotile relaxed mutants and their siblings, and found a linear relationship between 
stretch and sarcomere length, although the sarcomere length values were markedly 
shorter in the relaxed mutants (Figure 3.5 H). In Panel I, 1/(d10)2 is plotted against 
sarcomere length, a straight line through the origin would reflect a constant-volume 
behaviour. Using this equation on our data we then estimated the sarcomere volume as 
described by Milman 1998 (Millman, 1998) (See 2.9). The value of the sarcomere lattice 
volume in siblings (3.36 x 10-3 µm3) is close to that found in other muscles studies 
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(Millman, 1998). At shorter and longer lengths, the sarcomere volume value of the 
relaxed mutated muscles showed deviations from a constant volume behaviour. The best 
fit to the data gave a 15% lower volume of approximately 2.89 x 10-3 µm3. Immotile 
relaxed larvae cannot develop an active contraction, an event that is dependent on actin 
myosin cross-linking. Therefore, myosin cross bridges attachment to actin was tested by 
introducing a rigor state in the relaxed mutants. A larva was anesthetised and examined 
after 2.5 hours in Embryo Medium in the presence of 5mM NaCN.  As seen in Figure 3.5 
E, this resulted in a significant change in the intensity ratio with an increase in the 1.1 
intensity and a relative weakening of the 1.0, demonstrating for the first time that actin 
and myosin myofilament were capable of cross linking in 6dpf immotile relaxed mutants. 
A result supported by the fact that contraction can be elicited in skinned relaxed mutants 
using caffeine (Zhou et al., 2006). The data suggest that the relaxed mutants have a 
smaller sarcomere volume, associated with shorter sarcomere length, but with 
essentially unaltered inter filament spacing. 
 
Figure 3.5: Small angle X-ray diffraction of Tricaine treated and relaxed mutant larvae. 
Tricaine treated larvae 17-24hpf, recovered until 6dpf (B, black circles), controls kept in EM until 
6dpf (A, white circles), immotile relaxed mutants (D and E, black squares), and their motile 
siblings (C, white squares) at 6dpf, A-E show the equatorial X-ray patterns, 1.0 and 1.1 reflections 
are indicated. F shows the spacing of the 1.0 reflection (d10) at different degrees stretch, 
expressed as length (L) relative to slack length (Ls). G shows the intensity ratio of the 1.1 and 1.0 
reflections at different degrees of stretch. In H sarcomere length is determined at different degrees 
of stretch and in I 1/(d10)2 is plotted as a function of sarcomere length (predicted from data in 
Panel H and degree of stretch). The line through the data of the motile siblings corresponds to a 
constant volume of 3.36 x 10-3 µm3. The data from the relaxed mutants did not fully follow 
constant-volume behaviour and the line indicates a volume of 2.89 x 10-3 µm3. n= 4-6 except in 
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the controls kept in EM until 6dpf, where n=1. E shows a relaxed immotile mutant sample in rigor, 
displaying an increase in the outer 1.1 reflection; the 1.1/1.0 intensity ratio was 3.67 compared to 
about 0.4 in samples under normal conditions (D, G). 
 
One limitation of the small angle X-ray diffraction technique is that it only allows for testing 
of zebrafish larvae from 4dpf. We therefore redesigned our paralysis protocol in order to 
test the chemically paralysed embryos at later stages, during paralysis at 5dpf and after 
recovery at 6dpf. We used Tricaine (reversible Na+ channel blocking anaesthetic) and 
BTS (specific reversible inhibitor of fast myosin ATPase) to inhibit contraction in wildtype 
embryos up to 5 days. Movements in zebrafish embryos prior to 24hpf are driven 
primarily by slow muscle, therefore Tricaine, rather than BTS, was found to be most 
effective at inhibiting the initial embryonic movements up to 29hpf. BTS was then used 
from 29hpf until 5dpf to inhibit active contractions (Dou et al. 2008), before drug washout 
allowed the larvae to recover.  During this long-term chemical paralysis BTS is a more 
effective reversible paralysing agent than Tricaine (supplementary data in Appendix F). 
The Tricaine-BTS treated larvae muscles lattice was found to be significantly 
compressed (Figure 3.6 A-D). This compression was maintained in both treated and 
recovered larvae up to 6dpf despite the fact that the latter group moved and had begun 
to swim. In addition, plotting the square of the spacing d2 against the reverse of the 
sarcomere length revealed that sarcomere volume (figure 3.6 D) was smaller in Tricaine-
BTS treated fish.  Long term chemical paralysis with BTS resulted in myofilament lattice 
compression from 5dpf, these results are discussed further in Chapter 5. 
 
 
 
Figure 3.6: Small angle X-ray diffraction of Tricaine-BTS treated larvae. [A&B] Spacing 
between myofilaments is shown by the two equatorial reflections d10 and d11. Spacing data is 
plotted against stretch (L/Lslack= Lamda), i.e. 100, 110 ad 130% of the slack length. Tricaine-
BTS treated larvae (black circles) showed a significantly compressed lattice (i.e spacing) 
compared to DMSO controls (white circles), those held in EM (blue squares) and the recovered 
group (i.e 17-24hpf Tricaine treated larvae, followed by EM, white squares). The lower spacing of 
Tricaine-BTS treated larvae was maintained when larvae were held in BTS for 6dpf (green 
triangle) and did not recover when larvae were held 24h in EM after BTS treatment and recovered 
swimming (pink square). 
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In summary, these results show that the lattice spacing is unaffected by paralysis 
(relaxed mutants) and paralysis followed by recovery (Tricaine treatment) and is 
therefore regulated independently of movement. Results also revealed that prolonged 
paralysis (Tricaine-BTS treatment) caused irreversible compression of the lattice, even 
after the restoration of movement.  
 
3.2.3 Paralysis leads to actin lengthening 
 
Paralysis is known to alter myofibril arrangement in developing skeletal muscle, this is 
dependent on myofilament structure, specifically actin length (Clark et al., 2002). The 
effects of paralysis and the subsequent recovery of movement on actin length was 
examined using immunohistochemistry and confocal scanning microscopy. Actin 
remodeling was assessed by measuring actin myofilament length during paralysis at 24 
and 42hpf and after movement recovery at 42hpf, in both Tricaine treated and immotile 
relaxed mutant embryos. Immotile relaxed mutants showed a very significant 
lengthening of actin filaments at 24hpf and 42hpf in comparison to motile carriers (Figure 
3.7 D). Tricaine paralysis also caused a significant lengthening of actin filaments at 24hpf 
and 42hpf (17-42hpf paralysis), in comparison to motile controls (Figure 3.7 C). This 
implies that inhibition of movement causes significant lengthening of actin filaments in 
the developing skeletal muscle. Furthermore, 42hpf recovered embryos (17-24hpf 
paralysis followed by movement recovery) showed a complete rescue of actin length 
(Figure 3.7 C). This suggests that movement contributes to the regulation of actin 
filament length. However, it is also interesting to note that in embryos that remained 
paralysed throughout the experiment (17-42hpf), both mutant and paralysed embryos, 
showed a significant shortening in actin filament length between 24 and 42hpf. This 
indicates that an additional component of the mechanism regulating actin length is 
independent of movement.  
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Figure 3.7: Paralysis leads to actin lengthening in both relaxed mutant and Tricaine treated 
embryos, subsequent movement restoration in recovered embryos leads to actin length 
complete rescue. [A&B] H-H measurement. Confocal images of actin filaments stained with 
phalloidin (1/40) were taken, measurement were made in between H bands, across Z discs and 
sarcomeres. [C] 17-24hpf paralysis caused a significant lengthening of actin filaments H-H at 
24hpf (*p<0.05) (n=20 in 5 controls, n=15 in 3 treated embryos, t test). At 42hpf, recovered 
embryos (17-24hpf paralysis) showed a full recovery (n=50 in 10 control embryos, n=40 in 8 
recovered embryos, unpaired t-test), in contrast with treated embryos (17-42hpf paralysis) which 
did not recover (n=50 in 10 control embryos, n=135 in 27 treated,*p<0.05). [D] Immotile relaxed 
mutants, rr, showed a very significant lengthening of actin filaments H-H at 24hpf (***p<0.001) 
(n=115 in 23 immotile relaxed mutants rr, n=120 in 24 motile carriers Rr) and at 42hpf (***p<0.001) 
(n=105 in 21 immotile relaxed mutants rr, n=135 in 27 motile carriers Rr). Interestingly, in contrast 
with the Tricaine treated immotile embryos, the immotile relaxed mutant (rr) actin is still very 
significantly longer than the motile carrier (Rr) actin at 42hpf. It is noticeable that in the complete 
absence of movement up to 42hpf actin filaments showed a significant shortening between 24 
and 42hpf in between both treated and control embryos and immotile relaxed mutants and motile 
carriers respectively (n=15 in 3 24hpf treated, n=135 in 27 42hpf treated embryos, *p<0.05 
unpaired t-test ; and n=115 in 23 24hpf immotile mutants rr, n=105 in 21 immotile relaxed mutants 
rr, *p<0.05 unpaired t-test). 
 
In summary, in the absence of contraction, actin filaments elongate and therefore their 
length appears to be regulated via contraction. However, results also show that the 
paralysis-induced elongation of actin at 24hpf appears to partially recover by 42hpf, 
indicative of a regulatory component that occurs independently of contraction.  
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3.2.4 Paralysis selectively affects the localisation of the actin-capping protein 
Tropomodulin 1 but not Tropomodulin 4 
 
Actin filament elongation was observed in immotile embryos and is likely to be controlled 
via capping proteins, specifically Tropomodulins (Tmod). Therefore the expression and 
localisation of Tmod1 and 4 in both relaxed mutant and pharmacologically treated 
embryos was assessed in immotile embryos. In control embryos, Tmod1 was located in 
the nucleus of skeletal muscle fibres prior to movement at 17hpf (Figure 3.8 A) but by 
24hpf the distribution of the protein had changed, it had left the nucleus and migrated 
into the cytosol (Figure 3.8 B). By 42hpf the staining appeared punctate, linear and 
regularly arranged within the cytoplasm of the myofibrils themselves (Figure 3.8 C). In 
contrast to control embryos, Tricaine treated immotile embryos displayed nuclear 
localisation of Tmod1 at both 24hpf (Figure 3.8 D) and 42hpf (Figure 3.8 E) exclusively. 
Whereas in recovered motile embryos (Figure 3.8 F) at 42hpf, Tmod1 was found to be 
displayed in a similar cytosolic linear staining pattern to control embryos. In summary, 
prior to movement (initiated at 17hpf) and in immotile embryos (at 24 and 42hpf) Tmod1 
staining is observed within the nucleus, whilst in motile embryos it is located in the 
cytoplasm of the myocytes. These observations were investigated further within the 
skeletal muscle of the immotile relaxed mutant line cacnb1ts25. Carrier motile embryos 
already display cytosolic Tmod1 staining at 20hpf (Figure 3.8 G) which was conserved 
up to 42hpf (Figure 3.8 H) and was similar to the patterns observed in control and 
recovered motile embryos. Immotile relaxed mutant embryos display a nuclear 
localisation of Tmod1 at both 20hpf (Figure 3.8 I) and 42hpf (Figure 3.8 J), similar to that 
observed in Tricaine treated immotile embryos. In summary these results suggest that 
the relocation of Tmod1 from the nucleus to the cytoplasm of the myocytes is driven by 
embryonic movement in zebrafish. 
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Figure 3.8: Tropomodulin 1 localisation within the fast skeletal muscle cell from 17hpf up 
to 42hpf in immotile and control embryos. In control embryos [A,B,C] Tmod1 is initially located 
in the nucleus of the skeletal muscle cell at 17hpf (orange arrow) [A] and then migrate into the 
skeletal muscle cell cytosol at 24hpf (empty nuclei, white arrow) [B] where it stays and get 
organised linearly by 42hpf (orange box) [C]. Tricaine treated immotile embryos [D,E] display a 
nuclear localisation of Tmod1 at both 24hpf [D] and 42hpf [E] (orange arrows). Recovered motile 
embryos [F] display at 42hpf a similar cytosolic linear pattern of Tmod1 as control embryos 
(orange box). Carrier motile embryos [G,H] display a cytosolic pattern of Tmod1 from 20hpf [G] 
(empty nuclei, white arrow) which is linearised by 42hpf [H] (orange box) as control and recovered 
embryos. Immotile relaxed mutants embryos [I,J] display a similar nuclear localisation of Tmod1 
at both 20hpf [I] and 42hpf [J] as Tricaine treated embryos (orange arrows).  
 
We then addressed the distribution of Tmod4 in both immotile models (Tricaine treated 
and relaxed mutant). In control embryos, Tmod4, is located initially in the nucleus of the 
muscle cell at 17hpf (Figure 3.9 A) but by 24hpf (Figure 3.9 B) the protein had left the 
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nucleus and appeared in a striated staining pattern within the cytosol of the myocytes, 
where it remained at 42hpf (Figure 3.9 C). In Tricaine treated immotile embryos, Tmod4 
displays a cytosolic localisation from 24hpf onwards (Figure 3.9 D&E) and recovered 
motile embryos (Figure 3.9 F) also display cytosolic staining of Tmod4 at 42hpf. Both 
heterozygote motile and homozygote immotile relaxed embryos also display Tmod4 
within the myocytes cytosol from 20hpf onwards (Figure 3.9 G-J). In summary, these 
results suggests that the relocation of Tmod4 from the nucleus to the cytoplasm of the 
myocytes is independent of embryonic movement.  
 
Figure 3.9: Tropomodulin 4 localisation within the fast skeletal muscle cell from 17hpf up 
to 42hpf in immotile and control embryos. In control embryos [A,B,C] Tmod4 is initially located 
in the nucleus of the skeletal muscle cell at 17hpf (orange arrow) [A] and then migrate into the 
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skeletal muscle cell cytosol at 24hpf [B] where it remains up to 42hpf (empty nuclei, white arrows) 
[C]. Tricaine treated immotile embryos [D,E] display a cytosolic localisation of Tmod4 at both 
24hpf [D] and 42hpf [E] (empty nuclei, white arrows). Recovered motile embryos at 42hpf [F] 
display a similar cytosolic localisation of Tmod4 as control and Tricaine treated embryos (empty 
nuclei, white arrows). Carrier motile embryos [G,H] display a cytosolic localisation of Tmod4 from 
20hpf [G] which is maintained up to 42hpf [H] (empty nuclei, white arrows). Immotile relaxed 
mutants embryos [I,J] display a similar cytosolic localisation of Tmod4 as carrier embryos at both 
20hpf [I] and 42hpf [J] (empty nuclei, white arrows). 
 
In summary, the results showed that during normal development Tmod1 and 4 are 
located in the nuclei of skeletal muscle cells, prior to the initiation of movement at 17hpf. 
After the onset of movement, at 24hpf and later at 42hpf Tmod1 and 4 are no longer 
concentrated at the nucleus but show a strong cytosolic expression in the developing 
skeletal muscle. Paralysis selectively affects the localisation of the actin-capping protein 
Tmod1, which is retained in the myocyte nuclei, rather than in the cytosol; this suggests 
that the initial contractile events drive the translocation of this actin-capping protein from 
the nucleus into the cytosol of the developing myofibrils. In contrast, the expression of 
Tmod4 was unaffected by paralysis and its cellular localisation is not dependent of 
movement. 
 
3.3 Discussion 
 
An experimental paradigm to explore how the restoration of contraction after paralysis 
affects myofibril organisation in developing zebrafish was established. Inhibition of 
contraction between 17 and 24hpf caused a significant increase in length and decrease 
in width of myofibrils. The restoration of contractile movement led to a full recovery of 
myofibril length but not width, whereas in the absence of movement myofibril width but 
not length fully recovered. Lattice spacing at the myofilament level was unaffected by 
both paralysis (relaxed mutants) and paralysis followed by recovery (Tricaine). In the 
absence of contraction, actin filaments were observed to elongate; however, the 
paralysis-induced elongation of actin at 24hpf was shown to recover by 42hpf. 
Examination of the capping proteins Tmod1 and 4 revealed localisation in the nuclei of 
skeletal muscle cells, prior to the initiation of movement at 17hpf. After the onset of 
movement at 24hpf, and later at 42hpf, Tmod1 and 4 are no longer concentrated at the 
nucleus but show a strong cytosolic expression. Paralysis selectively affects the 
localisation of the actin-capping protein Tmod1, which is retained in the myocyte nuclei, 
rather than in the cytosol. In contrast, the expression of Tmod4 was unaffected by 
paralysis and it underwent relocation from the nucleus to the cytosol. Overall, the results 
show that during zebrafish embryogenesis the later steps of myofibrillogenesis are 
regulated by a dual mechanism, of which only one is driven by movement.  
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(1) Movement-dependent regulation of myofibril assembly 
 
In mature mammalian muscles, immobilised muscle has been shown to adapt by 
adjustment of sarcomere number and length, resulting in optimum overlap of myosin and 
actin filaments (Williams and Goldspink, 1978). These studies highlight the importance 
of these parameters for force generation in the muscles, which ultimately allows normal 
growth to occur (Williams and Goldspink, 1971). This process appears to be true for 
developing muscle as in zebrafish, immobility generates an increase myofibril length 
alongside shortening of sarcomeres and sarcomere addition (Brennan et al., 2005; 
Lahne et al., 2009). Evidence in avian (Kagawa et al., 2006), amphibian (Ramachandran 
et al., 2003) and cell culture (Soeno et al., 1999; De Deyne, 2000) studies, show that 
muscle contractility is required for sarcomere assembly. Indeed contraction has been 
proposed to be key during the later stages of myofibril assembly (Sparrow and Schöck, 
2009). In this study inhibition of contraction between 17 and 24hpf causes a significant 
increase in myofibril length, as shown previously (Brennan et al., 2005), furthermore the 
restoration of movement leads to a full recovery. This later work is the first direct evidence 
that the restoration of movement regulates myofibril length in vivo.  
Actin is a key protein of the sarcomere thin filaments, which allow the spring like action 
necessary for force transmission along the myofibrils. In this study, results revealed that 
in the absence of contraction actin filaments elongate and therefore their length appears 
to be regulated via contraction. This data fits with our observations at the myofibril level 
and suggests that movement-induced regulation of actin polymerisation and thin filament 
length may be an underlying factor of myofibril organisation, namely elongation during 
development. Previous work has shown that myofilaments and sarcomere length are 
disrupted by paralysis (Etard et al., 2005) and our observations of actin lengthening 
during paralysis are consistent with this idea.   
Actin length regulation was examined by assessing the effect of paralysis on Tmod1 and 
4 localisation.  Tmod1 and 4 are actin-capping proteins that promote polymerisation and 
depolymerisation (Littlefield and Fowler, 2008). Tmod1 has been shown to regulate actin 
filament length in mice (Gokhin et al., 2014). It’s over expression leads to a decrease in 
actin incorporation and shortening, whilst it’s under expression has the reverse effect 
(Gokhin and Fowler, 2011). It is argued that its normal role in muscle fibres is to control 
length by inhibiting polymerisation and lengthening of filaments. We observed an initial 
expression of Tmod1 in the nuclei of the muscle cells and subsequent movement-
dependent translocation to the cytosol. Contraction-driven movement in different cellular 
compartments has been demonstrated for other sarcomeric proteins (Lange et al., 2006; 
Clark et al., 2002). Furthermore, in immotile embryos Tmod1 is absent from the cytosol 
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and this correlates with a significant lengthening of actin filaments. Taken together these 
observations suggest that the absence of movement and the lack of Tmod1 in the cytosol 
results in elongation of actin filaments. In conclusion, Tmod1 appears to act to limit 
contraction-driven actin regulation during sarcomere maturation. Furthermore, Tmod1 is 
directly involved in skeletal muscle contractility regulation by enhancing actomyosin 
crossbridge formation (Ochala et al., 2014), thus creating a positive feedback loop: 
contractility leading to Tmod1 localisation and Tmod1 regulating contractility. 
Tmod4, shows an early nuclei localisation followed by translocation into the cytosol, 
which occurs simultaneously with Tmod1. The expression of Tmod4 was unaffected by 
paralysis and its cellular localisation is not dependent of movement. However, although 
Tmod4 is not regulated by contraction, its translocation still occurs concurrently with 
Tmod1, which suggests that another signal induces its transfer at this specific 
developmental stage. Therefore the shortening of actin observed between 24 and 42hpf 
in immotile embryos is very likely to be the result of the regulating action of Tmod4, as in 
these embryosTmod1 is missing at the actin pointed ends. In contrast, actin shortening 
in the motile recovered embryos can be attributed to both Tmod1 and Tmod4, which are 
capping actin pointed ends. This could explain why the recovered embryos are the only 
one to restore actin length to its normal size, suggesting that both Tmod1 and 4 are 
required to complete this process.  
This study showed that during normal zebrafish skeletal muscle development, Tmod1 
and 4 are located in the nuclei of skeletal muscle cells prior to the onset of movement at 
17hpf. The nuclear transport of Tmod was described previously in mammals and 
suspected to be a conserved phenomenon across species (Kong and Kedes, 2004; Kong 
and Kedes, 2006). Our data in zebrafish suggests indeed that the transport of Tmod to 
the nucleus may be conserved at least in vertebrates. This initial nuclear localisation 
could indicate additional roles for Tmod in the myocyte; for example, they might be 
interacting with actin filaments in this location. Nuclear Tmod has also been proposed to 
have a role in the regulation of proliferation and differentiation processes in skeletal 
muscle cells (Kong and Kedes, 2004). Similar interactions have been described in 
cardiac muscle where tropomodulins are associated at the plasma membrane before 
they locate to the sarcomeres (Ehler et al., 2004; Chu et al., 2003). Tropomodulins, by 
controlling actin length, ultimately control the regular array of sarcomeres within the 
skeletal muscle myofibrils, leading to proper myofibril organisation.  
 
 
 
 
66 
 
(2) Movement-independent regulation of myofibril assembly 
 
The results showed that inhibition of contraction between 17 and 24hpf causes a 
significant decrease in width of the myofibrils; however, over time the data revealed that 
recovery occurs independently of movement. This finding indicates that, from 24hpf 
onwards, there is also a movement-independent mechanism that regulates myofibril 
width during zebrafish embryonic skeletal muscle development. This hypothesis of a 
myofibril regulation mechanism independent of movement is supported by previous 
study in our laboratory that showed that the disruption of myofibril organisation in 
chemically paralysed embryos was milder when the drug was applied at later 
developmental stages (Lahne et al., 2009) (Chapter 1 Figure 1.10). These milder 
phenotypes could be due to the fact that when the drug was applied later during 
development, the 17-24hpf contractile development event had occurred preventing 
myofibril disorganisation. If the 17-24hpf contractile development event is the only event 
regulating myofibril organisation, the later phenotypes should show a similar level of 
disruption. However, this is not the case as the later the drug is applied the milder the 
phenotype, suggestive of movement independent myofibril organisation regulatory 
mechanisms that appear from 24hpf onwards and counterbalancing the immobility-
induced myofibril disruption. It is most likely that myofibril organisation is regulated by a 
combination of both contraction and contractile independent mechanisms.   
At the myofilament level, the lattice spacing was found to be regulated independently of 
movement. Results also show that the paralysis-induced elongation of actin at 24hpf 
appears to partially recover by 42hpf, indicative of a regulatory component that occurs 
independently of contraction. These findings support the observations of the myofibril 
width recovery, which is also independent of movement. Furthermore, the X-ray data 
indicates that by 6dpf, myofilaments lattice spacing is not disrupted by paralysis. It is 
assembled and allows attaching of cross bridges even in immotile relaxed mutants which 
do reach rigor state in the presence of cyanide. A possible mechanism could involve the 
filament protein Desmin which wraps around the Z-disc thus stabilising this structure, as 
proposed in Costa et al., 2004 review. Although the expression of Desmin in zebrafish 
embryos has not been shown, its emerging presence from 24hpf onwards may be one 
of the factors that prevents paralysis-induced disruption via the stabilisation of the 
sarcomeric structure. Further work could include Desmin labelling throughout 
embryogenesis to identify the onset of its expression in skeletal muscle. This 
demonstrates that the actin and myosin myofilament lattice spacing is regulated 
independently of movement, as is myofibril bundling.  
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3.4 Conclusion 
 
These observations suggest that myofibril organisation is regulated by a dual mechanism 
involving movement-dependent and movement-independent processes. The initial 
contractile event itself drives the localisation of Tmod1 to its sarcomeric position, capping 
the actin pointed ends, ultimately regulating actin length. This process is an underlying 
factor of myofibril length regulation and contributes to myofibril organisation, which is 
necessary for establishing proper skeletal muscle structure and function during 
development in vivo in zebrafish. However, our study also revealed that contraction is 
not the only driver of myofibril organisation, additional mechanisms independent of 
movement are involved in other aspects of myofibril organisation, namely myofibril 
bundling. Movement independent processes are also observed at the myofilament level 
with the movement independent assembly of the myofilament lattice, and the 
translocation of Tmod4 into its actin capping position allowing some actin length 
regulation to occur even in immotile embryos. 
 
3.5 Future work 
 
The ‘two segment model for thin filament architecture’ (Gokhin and Fowler, 2013) is 
based on the action of tropomodulins, another capping protein, CapZ, and the ruler 
protein nebulin. This zebrafish tropomodulin study would be enhanced by the analysis of 
both CapZ and nebulin. Antibodies raised against fish nebulin were tested in 24 and 
48hpf zebrafish, but no staining was observed, suggesting a lack of specificity. Antibodies 
raised against CapZ are also available but have not been tested in zebrafish to date. 
This part of the project would benefit from improved access to zebrafish specific 
antibodies raised against sarcomeric proteins. 
Tmod4 translocation from the nucleus to the cytosol occurs at the same time as Tmod1 
and it is shown to be independent of movement. The mechanism that drives Tmod4 
relocation to the cytosol is unknown but the data from this study suggests that it is an 
important developmental step in the organisation of actin myofilaments. The contribution 
of Tmod4 could be investigated by inhibiting expression of the protein (either by knock-
down or knock-out studies). These models would allow the investigation of Tmod1 alone 
and enable the assessment of the relative importance of the mechanisms that drive both 
Tmod1 and Tmod4 translocation on myofilament organisation. It would also further test 
our finding that Tmod1 and 4 are required for the actin length to be established correctly 
in vivo. A further complication is the functional equivalence of Tmod4 and Lmod3 during 
sarcomere assembly (Nworu et al., 2015), therefore investigating the nuclear transport 
of Lmod3 as well as Tmod4 would provide a better insight into the mechanism that drives 
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Tmod4 relocation. Ultimately, this work would improve our understanding of the 
importance of mechanotransduction versus an alternative developmental event on actin 
regulation and myofibril organisation. In mature muscle (as in other tissues) function 
rather than form, is a critical evolutionary determinant (Russell et al., 2000). These 
studies would also establish to what extent form follows function during skeletal muscle 
development.  
We have established that movement is a driver of myofilament and myofibril elongation 
ultimately allowing the correct patterning of the skeletal muscle and muscle function. 
Determining how the muscle cells senses the mechanical stretch signals and 
establishing which mechanotransduction pathways are involved is crucial. The 
involvement of Fak and Src proteins of the focal adhesion complexes of costameres and 
myotendinous junction, structures known as tension sensors, will be investigated in the 
next chapter. 
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CHAPTER 4 
 
THE ROLE OF FOCAL ADHESION COMPLEXES (FAC)  
IN MECHANOTRANSDUCTION-DRIVEN  
MYOFIBRIL ORGANISATION 
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4. The role of Focal Adhesion Complexes (FAC) in mechanotransduction-driven 
myofibril organisation 
 
4.1 Introduction 
 
Mechanotransduction, the translation of external mechanical signals into cellular 
chemical signals, is already known to play a key role in maintaining the structure of 
mature striated muscle (Boonyarom and Inui, 2006). In zebrafish, previous work has 
shown that the inhibition of the excitation-contraction pathway disrupts both sarcomere 
and myofibril length (Brennan et al., 2005). This suggests that intrinsic contractile activity 
contributes to the maintenance of the skeletal muscle fibres structure. This study has 
established that a contraction-driven myofibril organisation pathway exists during 
zebrafish development (Chapter 3). However, the contraction-driven signals that 
regulate the cytoskeletal architecture within the developing muscle fibre (i.e. myofibril 
formation) are not well defined. The contractile event itself has been proposed as the 
primary regulator of myofibril length regulation during embryogenesis in vivo, i.e. 
movement rather than Ca2+ signalling is necessary for myofibril organisation (Lahne et 
al., 2009) (Chapter 3). The components of the mechanotransduction pathway that 
contribute to skeletal muscle development remain undefined and will be investigated in 
this chapter. 
In mature skeletal muscle, mechanical force and regulatory signals are sensed and 
transmitted from the extracellular matrix into the cell interior (cytoplasm) via specialist 
transmembrane linkages, myotendinous junctions and costameres, which connect the 
sarcolemma with the cytoskeleton (as reviewed in Clark et al., 2002). These linkages are 
made up from membrane/cytoskeletal junctions, large macromolecular complexes, one 
of which is the integrin-based focal adhesion complex (FAC) (Figure 4.1). The FAC 
integrin transmembrane receptors physically connects the actin cytoskeleton of the cells 
to the ECM at focal adhesions, and thus, mediates migration and adhesion in many cells 
(as reviewed in Turner, 2000 and Schwartz, 2001). The role of mechanotransduction in 
skeletal muscle development will be explored by examining the expression and role of 
identified proteins of FAC.  
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Figure 4.1: Schematic representation of a costamere. Two laminin receptors, a dystroglycan 
complex and focal adhesion complex (integrin receptor complex) are among the sarcolemmal 
structures (Pardo et al., 1983) that link the contractile apparatus of muscle fibres with the 
surrounding basal lamina. Components of both receptors, i.e. both dystrophin and the integrin-
associated cytoskeletal proteins (talin, vinculin, α-actin), co-localise in subsarcolemmal 
complexes (Pardo et al., 1983) which connect through γ-actin and the intermediate-filament 
proteins desmin to the Z-disk of skeletal muscle fibres (Patel and Lieber, 1997); (Rybakova et al., 
2000). 
 
It was proposed that the mechanosensitive FACs are the structures through which 
contraction regulates myofibril organisation, specifically length, within skeletal muscle. 
FAC are known to have key roles in responding to external and internal forces by 
changing their size and signalling activity (Wolfenson et al., 2011). Over 50 different 
proteins reportedly localise to FAC, they are arranged by function, and include 
cytoskeletal proteins (e.g. vinculin, paxillin), tyrosine kinases (e.g. Fak, Src) and other 
enzyme groups (Zamir and Geiger, 2001). In this study, we focused on the role of non-
receptor tyrosine kinases already known to be implicated in mechanotransduction, 
namely focal adhesion kinase (Fak) and the protein kinase Src.  
 
4.1.1 Focal adhesion kinase (Fak) 
 
Fak is a 120kDa protein, non-receptor tyrosine kinase that binds paxillin. As well as its 
scaffolding properties, Fak plays a role in the phosphorylation of many proteins within 
the FAC. Integrin-mediated Fak autophosphorylation of its Tyr397 site generates a binding 
site for Src, which in turn phosphorylates a number of other tyrosine residues on Fak 
(Figure 4.2). Consequently, the phosphorylation state of Tyr397 is considered indicative 
of Fak’s activity. There is also evidence that Fak, located on the sarcolemma, is involved 
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in sensing and transducing the mechanical forces in skeletal muscle. Durieux et al. have 
shown in mammalian cells (mouse) that Fak becomes activated and Tyr397 is 
phosphorylated, after cells have been submitted to mechanical loads (Durieux et al., 
2009). Further study by Flück et al. highlighted Fak’s preferential localisation at 
myotendinous junctions and costameres, important sites of mechanotransduction (Fluck 
et al., 1999). Furthermore, Fak knockout mice embryos die with mesodermal defects at 
a very early developmental stage (E8.5, 14-16 pairs of somites) illustrating the 
importance of Fak in early development (Furuta et al., 1995). 
 
Figure 4.2: Schematic representation of the focal adhesion complex (FAC).Integrin-based 
FACs bridge cortical γ-actin to the extracellular matrix (ECM). Integrin in the sarcolemma of the 
muscle fibre acts as an anchor for the actin fibres in the sarcomere. Actin is bound to vinculin, 
which is then attached to the integrin β-subunit through focal adhesion kinase (Fak).The inset 
indicates schematically the proposed involvement of Fak in the formation of FACs. Occupancy of 
integrins with ECM ligand (1) causes phosphorylation (red circle) of integrin-associated Fak (2) 
which, in turn, promotes recruitment of both cytoskeletal (paxillin, vinculin, talin and γ-actin) and 
signalling molecules (e.g. MAPK and Src kinase) to integrins (3) (Miyamoto et al., 1995; Durieux 
et al., 2009). Adapted from Fluck et al., 2002. 
 
Fak is involved in integrin mediated phosphorylation signalling cascades and many of its 
domains are highly conserved in between species (Figure 4.3). However, as a result of 
the teleost genome duplication, zebrafish has two fak genes and divergent Fak proteins 
(Jaillon et al., 2004), fak1a is segmentally expressed in somites throughout the 
embryogenesis and fak1b is expressed ubiquitously as the dominant isoform during early 
development (Crawford et al., 2003).  
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Figure 4.3: Diagram showing the main conserved regions of the focal adhesion kinase. The 
amino acid sequence of zebrafish fak1b is 69% identical compared with zebrafish fak1a or with 
human FAK1. The kinase domain is very highly conserved being 94% identical to zebrafish fak1a 
and 93% identical to human FAK1. The focal adhesion-targeting domain (FAT) of zebrafish fak1b 
is also highly conserved, 93% with zebrafish fak1a and 92% with human FAK1. The proline-rich 
Cas binding domain (amino acids 714–724) is identical between all three FAK sequences. The 
FERM2 phosphotyrosine binding domain, NYFY at amino acids 144–147, is identical for fak1a 
and fak1b and similar to Hum FAK (NFFY) (Garcia-Alvarez et al., 2003). Of importance, is that 
the SH2 binding sites surrounding Tyr397 and Try925 are identical for zebrafish fak1a, fak1b, and 
human FAK1 and that the SH2 binding sites for Tyr576/7 and Tyr861 are identical except for a few 
conservative changes. Although the SH2 binding sites are similar for the zebrafish and human 
FAK proteins, there are significant differences between them and the SH2 binding sites of human 
FAK. Those areas that differ most significantly between zebrafish fak1a, fak1b, and human FAK 
are the N-terminal ends, two areas of the FERM3 domain, and the areas between the proline-rich 
Cas binding domain and the FAT domain. These areas are not usually conserved between 
species. Zebrafish fak1b maps to linkage group 19 (LG19), which is a duplicate of LG 16 
containing fak1a (see AAK31154 and AY196213). Both LG19 and LG16 share syntenies with the 
distal tip of human chromosome 8, the site of the human FAK locus. (Diagram modified from 
Crawford et al., 2003). (Furuta et al., 1995). 
 
Furthermore, in mammals, Fak is essential to mesodermal development (Furuta et al., 
1995), and has been localised at sites of strong cell-ECM adhesion in embryos. 
In Xenopus and mouse embryos Fak was shown to be prominent at somite borders and 
in the brain (Hens and DeSimone, 1995; Polte et al., 1994). In early zebrafish 
development, at the time of gastrulation (5hpf) Fak Tyr397residue, localised within SH2 
binding site of Fak, is increasingly phosphorylated, indicative of Fak activation allowing 
a strong adhesion between the cell and the extracellular matrix. At 24hpf phosphorylated 
Fak is found at the somite boundaries where it mediates their stabilisation, and in a ring 
like pattern connecting the notochord to its peripheral sheath (Figure 4.4). Also, it is 
noticeable that during somitogenesis, the abundance of fak1a increases (Henry et al., 
2001; Crawford et al., 2003). 
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Figure 4.4: Phosphorylated Fak are concentrated at somite boundaries and in the 
notochord, at sites of cell-matrix adhesion. [A] Lateral views of 24hpf embryos stained with 
anti-pY861Fak shows somite boundaries (dorsal up). [B] Projection of confocal sections of the 
notochord of a 24hpf embryo stained with anti-pY861Fak shows circumferential striations (anterior 
up, dorsal to the right). Adapted from Crawford et al.,2003. 
 
As stated previously, work in this chapter is aimed at exploring the role of 
mechanotransduction in skeletal muscle development by identifying the components of 
the FAC components implicated in the regulation of myofibril organisation in vivo, using 
the zebrafish as a model. Fak meets several of these criteria as it (i) is an important 
component of the focal adhesion complex, (ii) is involved in signalling between the 
extracellular matrix and the cytoskeleton and (iii) is expressed in early zebrafish 
development.  
 
4.1.2 Src protein 
 
Src, a tyrosine kinase, was also examined, because of its key role in Fak 
phosphorylation. Src kinases are a family of non‐receptor kinases, responsible for the 
phosphorylation of tyrosine residues on many molecules. The Src kinase family consists 
of nine members: Src, Yes, Fyn, Fgr, Lck, Hck, Blk, Lyn and Frk (Koegl et al., 1994). Src 
kinases have been shown to be involved in B‐cell antigen receptors, cell adhesion, cell 
motility and morphology, bone reabsorption and focal adhesion complexes (FAC) 
(Kurosaki et al., 1994; Roskoski, 2004). The Src family proteins have a conserved 
domain organisation which is very important for the Src function (Figure 4.5). The SH3 
and SH2 domains are the binding sequences of the protein. The SH2 domain binds to 
pYEEI protein sequences in the target protein. The SH3 domain binds to a left handed 
helical motif in target proteins, this is due to a rich proline sequence usually found in the 
helical motif. The SH3 binding affinity is less sequence specific, this is due to the 
secondary structure, the left handed helix, of the protein. Src is found to phosphorylate 
several components in the focal adhesion complexes of muscle fibres, which suggests 
an important role for this protein in skeletal muscle. 
A B 
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Figure 4.5: Domain Structure of Src family kinases. Members of the Src family exhibit a 
conserved domain organisation, which includes a myristoylated N-terminal segment, followed by 
SH3, SH2, linker and tyrosine kinase domains, and a short C-terminal tail. Src activity is regulated 
by intramolecular interactions controlled by tyrosine phosphorylation, SH2 and SH3 domains 
mediate protein–protein interactions with sequences containing phosphotyrosine and proline-rich 
motifs. Adapted from Parsons and Parsons, 2004. 
 
Unlike Fak, the localisation and role of Src has not been explored to any great extent in 
skeletal muscle, nor in zebrafish development and it is not currently known whether it is 
involved in mechanotransduction. The relevance of Src protein in zebrafish skeletal 
muscle development was therefore explored. 
Hypothesis: Fak and Src proteins are known to be involved in mechanosensing 
processes in mammals. However, their role in zebrafish muscle development is unclear. 
This chapter has explored the proposal that Fak and Src proteins are involved in the 
mechanotransduction pathway driving myofibril organisation in zebrafish. Fak is already 
known to be expressed in zebrafish embryos (Crawford et al., 2003), in this study its 
expression levels were assessed in both motile and immotile embryos in order to 
evaluate its involvement in mechanosensing. In contrast, Src expression remains 
undocumented in zebrafish, therefore its expression pattern and its mechanosensing 
role was established in immotile versus motile embryos. 
 
4.2 Results 
 
The role of Fak in contraction-driven muscle development was initially addressed by 
examining its developmental expression levels in motile versus immotile zebrafish 
embryos. This study will characterise changes of fak expression levels in the relaxed 
mutant line compared to wildtype controls. These observations will allow us to test 
specific hypotheses about the function of Fak, in the mechanosensitive pathway driving 
myofibril organisation and movement (Stickney et al., 2000).  
 
4.2.1 fak expression levels in relaxed mutants vs. controls, preliminary study 
 
The first aim was to determine whether there was a difference in fak expression levels in 
between motile controls and immotile relaxed mutant embryos. A preliminary study 
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investigated the expression of fak1a, fak1b and βactin using RTPCR, in both 
homozygotes relaxed mutants and heterozygotes controls at 24hpf, as well as in wild 
type total RNA (Figure 4.6).  
 
Figure 4.6: RTPCR of fak1a, fak1b and βactin in homozygote relaxed mutant, heterozygotes 
control and wildtype 24hpf whole embryo. L: Ladder 100bp, 1: fak1a – relaxed mutant, 2: 
fak1a – heterozygote control,  3: fak1a – wildtype total RNA, 4: fak1a – DEPC H2O, 5: fak1b – 
relaxed mutant, 6: fak1b – heterozygote ‘normal’, 7: fak1b – wildtype total RNA, 8: fak1b – DEPC 
H2O, 9: βactin – relaxed mutant, 10: βactin – heterozygote control, 11: βactin – wildtype total 
RNA, 12: βactin – DEPC H2O, 13: kit positive control. (fak1a: 353bp, fak1b:346bp, βactin: 238bp) 
 
We found that fak1a is expressed at a very low level in homozygotes relaxed mutants, 
but is found strongly expressed in both heterozygotes controls and in wildtype total RNA, 
the negative control is clear. fak1b is not expressed in homozygotes relaxed mutants, 
and very low levels of expression are observed in both heterozygotes controls and in 
wildtype total RNA, the negative control is clear. Finally, our housekeeping gene, β-actin, 
is strongly expressed in both homozygotes relaxed mutant and heterozygotes controls, 
a little less in wildtype total RNA, the negative control is clear. The positive control 
provided by the kit is positive. 
In summary, differences in fak1a and fak1b expression were observed in between 
immotile relaxed mutants and their controls.  
 
4.2.2 At 24hpf, the levels of fak expression are comparable in immotile relaxed 
mutants and motile wildtype embryos 
 
The RTPCR pilot study pointed to differences between fak expression in the immotile 
relaxed mutant compared to controls. These findings were explored further, variations in 
the fak1a and fak1b gene expression within immotile relaxed mutant embryos versus 
wildtype and motile relaxed carriers were assessed using qRTPCR at 24hpf. This is one 
of the most powerful and sensitive gene analysis techniques available. It measures PCR 
amplification as it occurs, rather than to collect the results once the reaction is complete 
as in traditional PCR, this allows determination of the starting concentration of nucleic 
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acid. In addition to fak1a and fak1b we also analysed the expression of foxm1 a human 
proto-oncogene known to play a key role in human embryonic development (Teh et al., 
2002). The foxm1 gene was included as a qRTPCR control as the conditions of the 
qRTPCR for this gene have already been defined. Furthermore, foxm1 is a transcription 
factor expressed mainly in epidermal cells and unlikely to be found at high levels in 
skeletal muscle. Therefore, we assumed that foxm1 gene expression will not be affected 
by paralysis and will remain at a constant level within the three genotypes, acting as a 
positive control of the technique. In addition, zebrafish GAPDH and βActin genes were 
used as reference housekeeping genes for quantification of fak1a, fak1b and foxm1 
mRNA levels. The data showed that at 24hpf, there is no significant difference in fak1a, 
fak1b and foxm1 expression levels in between the three genotypes (immotile relaxed 
mutants, motile relaxed carriers and wildtypes embryos) (Figure 4.7).  
Figure 4.7: fak1a, fak1b and foxm1 expression levels in the immotile relaxed mutant 
cacnb1ts25-/cacnb1ts25- (rr) and the motile relaxed carrier cacnb1ts25+/cacnb1ts25- (Rr) do not 
differ from wildtype (TU) at 24hpf. Expression of fak1a, fak1b and foxm1, in immotile relaxed 
mutant cacnb1ts25-/cacnb1ts25- (rr) and motile relaxed carrier cacnb1ts25+/cacnb1ts25- (Rr) embryos 
is shown as fold increase compared to gene expression in wildtype embryos (TU) at 24hpf. A 
dotted line indicates where the fold increase is one and no differential expression exists between 
the immotile relaxed mutant (rr), the motile relaxed carrier (Rr) and the wildtype (TU) at 24hpf. 
RNA extracted from whole embryos.(Mean ±SEM, fak1a rr n=7, Rr n=7, TU n=9, p=0.6917 ; fak1b 
rr n=11, Rr n=7, TU n=11, p=0.7733 and foxm1 rr n=7, Rr n=10, TU n=10, p=0.7560, ANOVA). 
 
4.2.3 fak expression patterns are comparable throughout development in 
immotile relaxed mutants and motile wildtype zebrafish 
 
Initially, Fak was proposed to be involved in mechanotransduction during the 17-24hpf 
contractile development event in zebrafish, and its expression levels thought to be 
movement dependent. However, as demonstrated in the previous section, no differential 
expression of fak1a and fak1b in the absence of movement was observed at 24hpf. 
Evidence from mammalian studies suggests that Fak is involved with 
mechanotransduction signalling in skeletal muscle and these initial results suggest that 
the role of Fak in zebrafish is different to that in mammals. This is based on observations 
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from one early time point and did not take into account the fact that fak expression levels 
may be affected later during development. Therefore, the expression of the fak genes 
was determined at later developmental stages, specifically 24hpf, 48hpf, 72hpf and 
96hpf. 
Firstly, the expression of endogenous foxm1, an important factor in mitotic division, was 
assessed. As development progressed and cell division rate decreased, foxm1 
expression showed an extremely significant decrease for the three genotypes as 
expected (Figure 4.8 A, B, C). Although all three genotypes exhibit the same pattern of 
foxm1 expression throughout development it is interesting to notice that at 96hpf the 
immotile relaxed mutant display a significant decrease compared to both its motile 
relaxed carrier siblings and the wildtypes. It is also important to note that for both motile 
genotypes, carriers and wildtypes, the level of expression of foxm1 are similar at 96hpf 
(Figure 4.8 D). This difference possibly reflects a slowing down of mitotic division rate in 
the immotile relaxed mutant (Appendix D). 
Using in situ hybridization, Crawford et al. has shown that in zebrafish embryos fak1b is 
initially expressed ubiquitously whereas fak1a is expressed much more specifically later 
in developing skeletal muscle (Crawford et al., 2003). Therefore, in this study the mRNA 
levels of fak1a and fak1b were predicted to reflect the spatial expression described in 
these in situ studies. Specifically, the low level of fak1a expression observed in the early 
phases of development will increase and that the high level of fak1b expression will 
decrease. Results showed that between 24 and 96hpf, the level of fak1a expression 
significantly increased in wildtypes (Figure 4.8 F) but not in relaxed mutants and carriers 
embryos. At 96hpf the level of expression was found to be similar in immotile relaxed 
mutant compared to motile carrier but was significantly down regulated compared to 
wildtype embryos (Figure 4.8 D, E). Finally, the overall level of fak1a expression in the 
motile carrier appeared lower than both its sibling’s immotile relaxed mutants and the 
wildtypes (Figure 4.8 E), but this was only found to be significantly different when 
compared to the wildtype at 96hpf. These results are in contrast with the pilot study and 
the drawbacks of using RTPCR against qRTPCR are discussed in Appendix B. 
Furthermore, it should be noted that in both the immotile relaxed mutants and the motile 
carriers, wide variations in the expression levels of fak1a were observed and this made 
statistical comparisons difficult (Figure 4.8 D, G). Considerations about the use of 
heterozygotes against wildtypes embryos as controls in molecular studies are examined 
in Appendix B. The levels of fak1b expression were compared over the four 
developmental time points and were found to be the same and to decrease in a 
significant manner in the wildtype, motile carrier, and immotile relaxed mutants (Figure 
4.8 H, I, J). 
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Figure 4.8: foxm1, fak1a and fak1b expression overtime for the relaxed mutant rr, the 
carrier Rr and the wildtype TU. Level of expression (Cp) of foxm1 (blue), fak1a (red), fak1b 
(purple) in the immotile relaxed mutant rr [A,D,H], the motile carrier Rr [B,E,G,I] and the wildtype 
TU [C,F,J] at 24hpf, 48hpf, 72hpf and 96hpf. The level of expression of foxm1 significantly 
decreases overtime for all three genotypes (rr p=0.0026, Rr p<0.0001, TU p<0.0001, ANOVA). 
At 96hpf, the level of expression of foxm1 is comparable for Rr and TU (p=0.3460, t test) however 
it is significantly lower in rr compared to Rr (p=0.0052, t test) and TU (p=0.0683, t test). The level 
of expression of fak1a significantly increases overtime for TU (p=0.0002, ANOVA) but not for rr 
(p=0.4381, ANOVA) and Rr (p=0.4163, ANOVA) respectively. However, at 96hpf the levels of 
fak1a expression are significantly different in rr (p=0.0142, t test) and Rr compared to TU 
(p=0.0237 t test). Note that graph G is similar to graph E, showing fak1a Rr expression but on an 
expanded y-axis. Levels of fak1b expression decreased for TU (p=0.025), for Rr (p<0.0001) and 
for rr (p=0.0954). There were no significant differences of the level of expression of fak1b for all 
three genotypes at each time point (0.1511<p<0.8954, t-test). 
 
4.2.4 Switch of prevalence of fak1a and fak1b expression levels throughout early 
zebrafish development 
 
Crawford et al. showed, using mRNA in situ hybridisation, that fak1b is ubiquitously 
expressed in the embryos from 5hpf (start of gastrulation), whereas fak1a is exclusively 
expressed in the developing skeletal muscle from 14hpf (10 somites) (Crawford et al., 
2003). The spatial expression of these genes suggests that at 24hpf the levels of fak1b, 
which is ubiquitously expressed, would be higher than fak1a, which is confined to one 
tissue type. We found here that the level of fak1b expression is significantly higher 
0
0.01
0.02
0.03
0.04
0.05
0.06
24hpf 48hpf 72hpf 96hpf 24hpf 48hpf 72hpf 96hpf
0
0.1
0.2
0.3
0.4
0.5
0.6
24hpf 48hpf 72hpf 96hpf 24hpf 48hpf 72hpf 96hpf 24hpf 48hpf 72hpf 96hpf
0
0.1
0.2
0.3
0.4
0.5
0.6
24hpf 48hpf 72hpf 96hpf 24hpf 48hpf 72hpf 96hpf 24hpf 48hpf 72hpf 96hpf
0
0.01
0.02
0.03
0.04
0.05
0.06
24hpf 48hpf 72hpf 96hpf
24hpf 48hpf 72hpf 96hpf
rr Rr TU 
foxm1 
fak1a 
fak1b 
Le
ve
l o
f 
e
xp
re
ss
io
n
 (
C
p
) 
Le
ve
l o
f 
e
xp
re
ss
io
n
 (
C
p
) 
Le
ve
l o
f 
e
xp
re
ss
io
n
 (
C
p
) 
Le
ve
l o
f 
e
xp
re
ss
io
n
 (
C
p
) 
A B C 
D E F 
G 
H I J 
80 
 
(approximately three fold) than fak1a expression in all three genotypes at 24hpf (Figure 
4.9 A). Based on the in situ data as described by Crawford et al., we predicted that this 
expression ratio would reverse as development progressed (Crawford et al., 2003).  
Therefore we examined the quantitative expression ratio at 96hpf, compared to that at 
24hpf. Our data showed that at 96hpf, overall the relative expression level of fak1b 
compared to fak1a is very significantly lower. Furthermore, the levels of fak1a expression 
were significantly increased in wildtype embryos compared to both immotile relaxed 
mutants and motile carriers. The results also showed that the level of foxm1 expression 
was significantly higher at the early stages of development, for all three genotypes, the 
immotile relaxed mutants, the motile carriers and the wildtypes (Figure 4.9 B). This is in 
accordance with evidence showing that foxm1 expression levels will be highest when 
the mitotic activity is at its maximum level during early development (Teh et al., 2002). 
Furthermore, although the level of foxm1 expression decreases throughout development 
for all three genotypes, at 96hpf it is significantly lower for the immotile mutant against 
both motile genotypes the carriers and the wildtypes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: fak1a, fak1b and foxm1 differential expression levels at 24hpf and 96hpf. [A] At 
24hpf, fak1a expression level is significantly lower than fak1b, p=0.0007 and [B] foxm1 is highly 
expressed for all three genotypes (TU blue, Rr green and rr yellow). [C] At 96hpf, fak1a 
expression level is significantly higher than fak1b p=0.0035, the levels of fak1a compared to fak1b 
expression were significantly increased in the immotile relaxed mutant (rr, p=0.0134, t test) in the 
wildtype (TU, p=0.0069 t test) and in the motile carrier (Rr, p=0.0659, t test). At 96hpf fak1a 
expression level in the immotile relaxed mutant and the motile carrier is significantly lower 
compared to the wildtype (TU) (rr p=0.0142, Rr p=0.0237). [D] At 96hpf foxm1 expression level 
is very significantly decreased compared to that at 24hpf, and its expression level for the immotile 
relaxed mutant (rr) is significantly lower than for both the motile carrier (Rr, p=0.0052) and the 
wildtype (TU, p=0.0683). 
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In summary, the results show a steady decrease of fak1b expression through the first 
four days of development which is unaffected by paralysis. A steady increase of fak1a 
expression was also observed during this time period. The fak1a expression levels were 
found to be highly variable in the relaxed mutant line (both in mutants and carriers) and 
therefore it is difficult to state categorically whether fak1a expression is affected by 
paralysis. 
 
4.2.5 Src is expressed in the sarcolemma and at the somite boundaries in 
developing embryos 
 
Preliminary data has shown that zebrafish embryos treated with PP2, a Src kinase 
inhibitor, displayed disrupted embryonic tail formation, myofibril organisation (wavy 
misaligned myofibrils), and movement (Ashworth & Punn, personal communication). 
This suggested that Src is involved in muscle development; however Src expression and 
localisation in zebrafish embryo has yet to be described. Based on the structure of focal 
adhesion complexes from other systems, where Fak interacts with a variety of proteins 
including Src, it would be reasonable to propose that these proteins will also be present 
in zebrafish muscle. Whole mount immunohistochemical staining, using a 
phosphorylated Src antibody, was used to assess whether the protein was expressed in 
the developing somites during skeletal muscle formation from 24hpf. Results revealed 
phosphorylated Src expression at the plasma membrane of cells located within the 
mesoderm of the extreme rostral region of the embryo (Figure 4.10 A). In addition, within 
anterior somites phospho-Src is expressed at the sarcolemma of differentiated muscle 
fibres, with particularly strong expression at the somite boundaries (Figure 4.10 B&C). 
The specific localisation of the Src protein suggests that, along with focal adhesion 
kinase, it is part of FAC in both costameres and myotendinous junctions within zebrafish 
developing muscle. 
 
Figure 4.10: Src expression in the presomitic mesoderm and developing skeletal muscle 
within zebrafish embryos. Zebrafish embryos were fixed at 24hpf and stained with a phospho-
Src antibody and Alexa Fluor® 488 Goat Anti-Rabbit IgG. Images were taken using laser scanning 
confocal microscopy and viewed with an X63 objective (HCX PL APO CS 63.0x1.30 GLYC 21°C 
UV) and (A&B) X1 and (C) X3 zoom. [A] Arrow denotes boundary of last forming somite. [B] 
Arrow denotes accumulation of the phospho-Src at the myotendinous junction. [C] Arrow denotes 
accumulation of phospho-Src along the sarcolemma. Anterior towards the right and dorsal 
towards the top of the images. (Scale bar is 50µm in A&B, 25µm in C) 
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4.2.6 Inhibition of Src disrupts tail development and embryonic movement in 
developing embryos 
 
Previous work in our laboratory had indicated that treatment with PP2, a tyrosine kinase 
inhibitor, disrupted embryonic tail formation and possibly movement in zebrafish 
embryos (Ashworth & Punn, personal communication). We set out to investigate this 
phenotype disruption in more detail. The mechanism of action of PP2 is not fully 
understood, but it is thought that it binds to an ATP binding pocket on the Src domain 
preventing full activation of the protein. PP2 was selected over other kinase inhibitors 
due to its potency to inhibit Lck and Fyn kinases (Src family kinases), its low potency for 
EGFR (epithelial growth factor receptor), and as it does not activate PKA (protein kinase 
A), JAK2 and ZAP-70 (Karni et al., 2003).  
The toxicity of PP2 on embryonic survival was tested initially to determine an optimal 
sub-lethal dose to use in experiments, as described in supplementary data (Appendix 
C). At 24hpf, after a 7 hours exposure to PP2 the tail of PP2 treated embryos appeared 
to be shorter and wider than controls. By 42hpf, after a 20 hours exposure to PP2, the 
PP2 treated embryos have developed a distinctive curve in their tails, compared to 
control embryos whose tails have straightened as expected (Kimmel et al., 1995). By 
48hpf, the embryos have been exposed to PP2 for 26 hours, the phenotypes of the PP2 
treated embryos are comparable to the 42hpf, but they also displayed pericardial 
oedema. Furthermore, PP2 treatment did produce a dose dependent disruption in 
embryonic development, the ‘tail flip’ phenotype is more prominent at higher PP2 
concentrations (Figure 4.11).   
 
Figure 4.11: Treatment with PP2 disrupts tail formation in zebrafish embryos.  Zebrafish 
embryos were treated with PP2 from 17hpf and images were taken at 24hf, 42hpf and 48hpf. At 
24hpf after 7 hours of exposure to PP2, the embryos showed little variance in phenotype 
compared to controls. The embryos at 42hpf started to show a variance in detail, as the rear third 
of the tail has begun to “flip”, and there seems to be signs of dose effect. At 48hpf the embryos 
had been exposed to 31 hours of PP2, and the phenotype is distinctive. Embryos exposed to the 
same concentration across the three time points show progression of tail flip and worsening of 
cardiac oedema. 
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The effect of the PP2-induced tail flipping was investigated further by examining the 
motility of the PP2 treated embryos when exposed to a light touch, namely the touch-
evoked escape response. At 24hpf, control and treated embryos responded to touch by 
displaying a weak tail flip without travel. At 42hpf the embryos were more active and the 
motion varied, the control and DMSO embryos were able to escape with very strong 
rapid movements in response to touch. In contrast, treatment revealed a dose effect, 
with embryos incubated in lower concentrations showing either a normal escape 
response or a tail flip and higher concentrations showing a weak tail flip or no escape 
response. At 48hpf the control and DMSO embryos had a very rapid escape response 
and the PP2 treated embryos showed a dose effect, with those incubated in lower 
concentrations showing a tail flip and those in higher concentrations lacking escape 
response altogether. In summary, the pharmacological inhibition of Src show a dose 
dependent disruption of embryonic tail development and movement, with a progressive 
decrease in spontaneous and touch-evoked escape. 
 
4.2.7 Inhibition of Src disrupts boundaries and somite patterning 
 
Tail straightening in the developing embryo depends on several processes, of which 
somitogenesis is a key factor. Therefore observation that tail formation was affected by 
PP2 treatment suggests that the process of somitogenesis may be disrupted. Somite 
boundary formation was investigated by assessing the expression of β-sarcoglycan, 
which is expressed in the myotendinous junctions. Control and DMSO embryos showed 
sharp, well defined and continuous expression of β-sarcoglycan at the somite 
boundaries, in contrast in PP2 treated embryos the boundary structure was diffuse, 
undefined and fragmented. This effect was dose dependent, with a loss of the boundary 
apex for the higher concentrations of PP2 (Figure 4.12). This interesting observation 
suggests that Src plays a role in somite boundary formation, as its inhibition leads to the 
dispersion of β-sarcoglycans.  
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Figure 4.12: Prevalence of boundaries at increasing PP2 concentrations. Embryos kept at 
25°C were put into their respective PP2 concentrations at 17hpf and further incubated at 28.5°C 
for 24 hours. The embryos were then fixed in paraformaldehyde and stained with a β-sarcoglycan 
with a Cy-5 linked secondary antibody. [A] Control embryo kept in Embryo Medium have clear 
somite boundaries, a solid line with no visible breaks. [B] DMSO control embryo shows similar 
boundary characteristics as the control embryo. [C] Embryo incubated in 6.25μM PP2, display a 
reduction of boundary prevalence at its apex (white arrow). [D] Embryo incubated in 12.5μM PP2 
shows a reduction of its ventral boundary structure (white arrow). [E] Embryo incubated in 25μM 
PP2 shows a reduction in boundary prevalence at its apex and his ventral boundary as well as 
his dorsal boundary (white arrow). [F] Embryo incubated in 50μM PP2 displays the same 
boundary defects as the 25μM embryos and his ventral boundaries have lost the tight structure 
seen in the controls (white arrow). [G] Embryos incubated at 100μM displays all the boundary 
defects observed in the 25μM embryo and the dorsal boundaries have lost their tight structure 
(white arrow).Scale bars 100μm. 
 
The role of Src on somite patterning was explored further, to assess whether somite 
length was disrupted by PP2 treatment. In zebrafish, the first somite furrow can be 
observed from 10hpf and somites appear sequentially with the anterior ones developing 
first. Somite addition at a standard temperature of 28.5°C occurs at a set rate and 
provides a useful staging tool, so that by 17hpf zebrafish embryos have a total of 16 fully 
formed somites (see Chapter 1). In our experiments, PP2 was introduced at the 17hpf 
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stage and somite length was measured in somites 15 to 19 (Figure 4.13). Somite 15 and 
16 will have formed just prior to drug treatment, whereas somites 17 to 19 will have 
formed post PP2 treatment. PP2 treatment produced a significant shortening in somite 
length of approximately 10µm at every somite number (* p<0.01). This effect was dose 
dependent, higher concentration of PP2 leading to shorter somites. Notably, the 
gradients of the graphs were similar to controls (-2.5708 σ = ±0.275), which indicates 
that the rate of somite elongation and their size remains proportional in the PP2 treated 
embryos. Furthermore, the overall somite number was also conserved. This suggests 
that whilst PP2 slows down the rate of somite elongation, it does not disrupt the timing 
of somite addition. 
Figure 4.13: Effect of PP2 on somite development. Embryos were put into their respective PP2 
concentrations at 17hpf and further incubated at 28.5°C for 24 hours. The embryos were then 
fixed in paraformaldehyde and stained with a β-sarcoglycan with a Cy-5 linked secondary 
antibody. Somite length was measured from boundary to boundary. The control and DMSO 
embryos showed no significant difference, and the embryos kept in PP2 showed a negative dose 
effect for somite length, the higher the concentration the shorter the somite (F (6,897) =134.072 
p<0.01, 4 embryos/treatment n=3). The overall somite number showed no interaction with PP2 
treatments, therefore somite addition is independent of the PP2 treatments (F (28,897) =0.738 
p=0.836, 4 embryos/treatment, n=3). 
 
In summary, PP2 treatment affects both the initial stages of somite formation, namely 
boundary generation, and somite elongation, indicative of a later role for Src in somite 
maturation. Further this gross alteration of somite shape might be ultimately responsible 
for the ‘tail flip’ phenotype. 
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4.2.8 Inhibition of Src disrupts myofibril organisation 
 
Our study showed that Src is expressed in the skeletal muscle of zebrafish possibly in 
FACs of both costameres and myotendinous junctions, and that its inhibition leads to 
both structural and functional defects of the skeletal muscle. These findings are 
indications of its possible involvement in mechanotransduction. Therefore, we 
investigated whether it was contributing to the contraction-driven myofibril organisation 
pathway in the developing zebrafish skeletal muscle. Results showed that at 48hpf, after 
a 26 hours exposure to PP2, the myofibril organisation is disrupted and the myofibrils 
appeared wavy and disorganised compared to control embryos. Furthermore, a positive 
dose effect can be observed when comparing the embryos exposed to increasing PP2 
concentration, the myofibril disorganisation is more prominent at higher PP2 
concentration (Figure 4.14).  In summary, Src inhibition leads to myofibril disorganisation. 
 
Figure 4.14: Treatment with PP2 causes disruption to myofibril organisation. At 17hpf 
embryos were incubated at 28.5°C in their respective PP2 concentrations. The embryos were 
then fixed and stained with phalloidin at 42hpf. (Scale bar is 20µm)  
 
4.2.9 Inhibition of Src disrupts swimming behaviour 
 
This study has shown that PP2 treatment disrupts myofibril organisation, somite 
patterning and ultimately tail formation leading to the ‘tail flip’ phenotype. These structural 
defects impact on the embryo’s motility and a reduction of embryonic movement, namely 
touch-evoked escape response, was observed up to 48hpf (see 4.2.6).  
The impact of PP2 treatment on movement was further assessed by a detailed analysis 
of swimming behaviours in PP2 treated compared to control larvae at 72hpf, using the 
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Ethovision™ tracking software. Three different measurements (i) the total distance 
travelled (ii) rotations about one axis, and (iii) mean angular frequency were collected. 
PP2 treated larvae displayed a significant dose dependent decrease in the total distance 
travelled compared to controls and DMSO treated larvae (Figure 4.15). In addition, PP2 
treated larvae also displayed a reduction of their rotations and of their mean angular 
velocity. A tank effect was also tested for and established that there was no significant 
environmental/tank effects that potentially could have arisen from the fish housing or the 
Ethovision™ tracking system. This confirmed that the differences observed in swimming 
behaviour were due to PP2 treatment and no other external conditions. In summary, PP2 
treated larvae showed a dose dependent decrease of their swimming behaviour when 
compared to controls at 72hpf. 
 
 
Figure 4.15: Effect of PP2 treatment on zebrafish swimming behaviour. Embryos were put 
into their respective PP2 concentrations at 17hpf and incubated at 28.5°C for 55 hours. Their 
swimming behaviour was then monitored during 2 minutes using a camera equipped with the 
Ethovision™ tracking software. PP2 treated embryos total distance travelled was reduced 
compared to controls embryos (one-way ANOVA F(6,27114)=79.473 p<0.01), in an inversely 
proportional manner to the PP2 concentrations applied (compared by a LSD post hoc test). 
Rotations and mean angular velocity were also reduced compared to control embryos (F(6, 
27114)=123.247 p<0.01 and (F(6,27114)=575.617 p<0.01 respectively).  
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4.3 Discussion 
 
Expression of fak1b mRNA decreases, whereas expression of fak1a mRNA increases 
throughout the first four days of embryonic zebrafish development. fak1b expression was 
found to be unaffected by paralysis. Pharmacological inhibition of Src revealed a dose 
dependent disruption in embryonic tail development, swimming behaviour, somite 
formation and myofibril organisation. Overall, the results indicate that Fak is unlikely to 
be involved in the mechanotransduction pathway that regulates skeletal muscle 
development, specifically myofibril organisation. In contrast Src has been shown to have 
a role in somitogenesis and myofibril organisation during embryonic skeletal muscle 
development. 
 
(1) The role of Fak in myofibril organisation 
 
In mammals, Fak is known to be a key component of FAC and is essential to the 
mechanotransduction pathways linking extracellular matrix to the cytoskeleton (Durieux 
et al., 2007; Durieux et al., 2009; Klossner et al., 2009). In zebrafish embryos Fak is 
located at the somite borders and in notochord cells (Henry et al., 2001; Crawford et al., 
2003) and is proposed to play a role in mechanotransduction. The role of Fak in 
contraction-driven myofibril organisation in zebrafish was initially assessed in immotile 
relaxed mutant embryos versus motile wildtype controls. If Fak was involved in the 
mechanotransduction driven pathway regulating myofibril elongation, its level of 
expression would be diminished in immotile embryos; however, the levels of fak 
expression were similar at 24hpf and remained constant throughout development up to 
96hpf. At 96hpf a significant decrease in expression levels of fak1a was detected in 
carriers and relaxed mutants compared to wildtypes. However, this result was attributed 
to embryonic death, as the mitotic indicator foxm1, used as a control, was also reduced 
(Appendix D). In summary, this data suggests that, in zebrafish, fak expression is not 
dependent on contraction.  
Furthermore, preliminary data from our laboratory has also revealed that treatment of 
wildtype embryos with a Fak inhibitor that prevents autophosphorylation at Tyr397 (Fak 
inhibitor 14) (Crawford et al. 2003) at the onset of movement (17-24hpf), did not disrupt 
myofibril alignment or body movement at 24hpf (Figure 4.16) (Ashworth and 
Karunarathna, personal communication).  
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Figure 4.16: Treatment of wildtype embryos with Fak inhibitor, Inhibitor 14, did not affect 
muscle development at 24hpf. Skeletal muscle morphology of Inhibitor 14 treated wildtype 
embryos. [A] Non treated wildtypes, controls. [B] 100μM Inhibitor 14 treated wildtypes. Embryos 
were fixed and stained with myosin antibody (F59) and fluorescent secondary antibody. 
(Ashworth and Karunarathna, personal communication).  
 
The normal, undisrupted phenotype in the Fak inhibitor treated embryos suggests that 
Fak is not involved in skeletal muscle development at this stage. However, there are 
several caveats that still need to be addressed. We know that zebrafish fak1a and fak1b 
are highly conserved (93% identical to human FAK1) and it is therefore likely that 
Inhibitor 14, initially designed and used for mammalian studies, will bind and inhibit 
zebrafish Fak; however, this was not tested directly. Furthermore, uptake of the drug into 
the embryo was not examined.  
Taken together, experimental issues aside, both of these studies suggest that, in 
zebrafish, fak1a and fak1b are unlikely to be sensors of the mechanotransduction 
pathway driving myofibril organisation. These results do not fit with the evidence from 
mammalian studies that have shown that Fak is involved in mechanosensitive signalling 
and suggests that there may be mechanistic differences in the way in which zebrafish 
skeletal muscle operates. One interpretation of this data could be explained by the fact 
that the teleost genome duplication has led to genetic divergence and a change in protein 
function (Jaillon et al., 2004). Zebrafish, indeed teleosts in general, have two divergent 
isoforms of the Fak protein, Fak1a and Fak1b, which are similar in terms of their 
sequence but display entirely different expression and localisation patterns within the 
embryo. fak1a is segmentally expressed in somites throughout embryogenesis, whereas 
fak1b is expressed ubiquitously as the dominant isoform during early development 
(Crawford et al., 2003). The divergent expression of these two fak isoforms suggest that 
they may have different roles. Further, in mammals Fak initiates activation of signalling 
within the focal adhesion complex; however, in zebrafish Fak may reside downstream 
and play a secondary role. If this is the case, and Fak only has a minor role in zebrafish, 
Fak inhibition would not result in a major disruption of muscle phenotype. It would be 
worth exploring these dissimilarities in more detail as they could lead to the discovery of 
novel signalling and/or sensing mechanisms of the contraction-driven myofibril 
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organisation pathway. Zebrafish work can indeed potentially inform studies in mammals 
and lead to a better understanding of muscle function and organisation, uncovering 
unknown evolutionary breakpoints that occurred in the human genome in the past 
450 Myr (Jaillon et al., 2004) and ultimately enhance medical research in humans (Sato 
et al., 2009). 
 
(2) The role of Src in myofibril organisation 
 
Evidence from this study suggests that the mechanotransduction signalling pathway in 
mammalian FAC may be different to that in zebrafish. Potentially, although similar protein 
signalling molecules are present their function may differ. Most relevant to this study was 
the investigation of their overall contribution to contraction-driven myofibril organisation 
in zebrafish. Src kinase was chosen as a key candidate because of its activation role 
within the phosphorylation cascade in FACs in mammals. This protein is known to be 
part of the focal adhesion complexes (FAC) and to co-operate with Fak and Paxillin to 
regulate cell adhesion and motility (Kratimenos et al., 2014; Moroco et al., 2014). We 
initially established that Src was present in zebrafish at the sarcolemma and at the somite 
boundaries where it colocalised with Fak and Paxillin (Kratimenos et al., 2014; Brown et 
al., 2005) (Figure 4.17). 
 
Figure 4.17: Colocalisation of Fak, Paxillin and Src at the somite boundaries. In 24hpf 
zebrafish embryo Fak [A] and Paxillin [B] are localised at the somite boundaries (Crawford et al., 
2003), and in this study Src colocalises at the somite boundaries and is also found at the 
sarcolemma [C] (see 4.2.5.). 
 
Src localisation at the FAC of costameres and myotendinous junction led to the 
hypothesis that, in zebrafish, it might be Src rather than Fak that would be involved in 
skeletal muscle development, namely in the mechanotransduction pathway regulating 
myofibril organisation. 
 
The role of Src was investigated using a pharmacological inhibitor and the disruption of 
skeletal muscle structure and function was analysed. Our results revealed that Src may 
have multiple roles in skeletal muscle development, as discussed below. 
A B 
100µm 
C 
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Somitogenesis disruption was observed in PP2 treated embryos, which displayed 
shorter somites. This suggests that Src has a role in somite maturation and is involved 
in the somite elongation process. This process occurs during the later stages of the clock 
and wave front mechanism for somite formation (Baker et al., 2006). This rhythmic 
phenomenon is a gene regulatory network that operates in the presomitic mesoderm of 
developing vertebrate embryos and generates transcriptional oscillations that direct the 
rhythmic and sequential formation of body segments in concert with embryonic 
elongation (Schroter et al., 2012). In the case of PP2 treated embryos, disruption to 
somite elongation gave rise to shorter somites. This could be explained by two different 
alterations of the mechanism. Either, the somite clock mechanism is accelerated and 
shorter somites formed faster, due to a reduced amount of elongation. Although, 
considering that the control and treated embryos had an equal number of somites, that 
would also mean that the somite clock mechanism is altered in another way, allowing for 
a time delay in between elongation and the formation of the next somite, to avoid 
supernumerary somites. Or, another simpler and more likely interpretation would be that 
somite elongation is solely slowed down, which involves only one defect of the somite 
clock mechanism. 
Another aspect of skeletal muscle disruption following Src inhibition was the reduction of 
the somite boundary prevalence, observed on β-sarcoglycan immunostaining. This 
suggests that Src kinase has a role during somite boundary formation. A reduction and 
dispersion of the somite boundary protein, β-sarcoglycan, was observed in PP2 treated 
embryos. β-sarcoglycans are part of the dystrophin/glycoprotein complex and have no 
direct interaction with Src kinase which is part of the integrin complex, FAC. However, 
both these complexes are part of specialist transmembrane linkages, myotendinous 
junctions and costameres. These linkages transmit mechanical forces and regulatory 
signals from the extracellular matrix into the cell interior (cytoplasm) via co-localised 
subsarcolemmal complexes (Pardo et al., 1983) which connect through γ-actin and the 
intermediate-filament protein Desmin to the Z-disk of skeletal muscle fibres (Patel and 
Lieber, 1997) (Figure 4.18). Therefore there is an indirect link between β-sarcoglycan 
and Src kinase. Src inhibition generated somite boundary disruption, this might be the 
result of FAC not forming a connection between the Fak and Vinculin. This disruption of 
FAC might have caused a distortion of Desmin and α-actinin resulting in an irregular 
dispersion in β-sarcoglycan. Therefore, the diffuse somite boundary observed in PP2 
treated embryos (Figure 4.12G) suggests that Src inhibition induced a decrease in the 
affinity in between FAC and dystrophin/glycoprotein complex. 
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Figure 4.18: Schematic model of the PP2 induced disruption of the cytoskeletal filament 
linkages at the sarcolemma of striated muscle:  integrin-based focal adhesion complex 
(FAC) and dystroglycan complex (DGC). Integrin-based FAC and the DGC act as 
transmembrane receptors for ECM components and link the ECM with the actin cytoskeleton. 
Integrins associate with Talin, α-actin and Vinculin to form a strong mechanical link to actin 
filaments. The DGC consists of the transmembrane complex β-dystroglycan, Dystrophin, the 
sarcoglycans, and other components not depicted here. Importantly, these linkage complexes 
bind to the submembraneous Actin (γ-actin) and are probably interlinked through this association 
as well as other unknown interactions. It is this association that might be disrupted in PP2 treated 
embryos, inducing a decrease of FAC and DGC affinity. Adapted from Clark et al., 2002. 
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Furthermore, actin staining revealed that Src inhibition disrupted myofibril organisation, 
which appeared increasingly wavy with both the drug concentration and the incubation 
time. Taken together with its localisation, this suggests that Src has a role in the 
contraction-driven myofibril organisation pathway. However, this disruption of the 
myofibrils could also be linked to the somitogenesis disruption observed in PP2 treated 
embryos. Therefore, we cannot conclude whether myofibril misalignment is directly 
linked to Src activity.  
Src inhibition led to a disruption of myofibril organisation, somite boundaries and 
somitogenesis, and is accountable for the gross anatomical disorder first noted, the ‘tail 
flip’ phenotype. Defective tail straightening is often associated with disruption of somite 
development (Stickney et al., 2000). Taken together with the fact that Src inhibition also 
disrupts skeletal muscle function, with a reduction in swimming behaviour, this suggests 
that Src plays a key role in skeletal muscle development. 
 
4.4 Conclusion 
 
Our results show that paralysis does not affect the expression level of fak during early 
zebrafish development and it is therefore unlikely to be a gene candidate involved in the 
mechanotransduction pathway that regulates myofibril organisation in zebrafish. This 
result is in contrast with mammalian studies, which have implicated Fak in skeletal 
muscle development. Src, on the other hand, was shown to be present in the costameres 
and found in the myotendinous junctions at the somite boundaries in zebrafish. 
Furthermore, Src was found to be involved in several aspects of muscle structure and 
function during development. In contrast to mammalian studies, in zebrafish Src appears 
to have a major role in skeletal muscle development whereas Fak does not, this is a 
novel finding and could be explained by a remodelling of FAC in teleosts, with a shift in 
the relative importance of the signalling proteins. 
 
4.5 Future work 
 
Following on from this study, future work could address the experimental caveats 
identified. Pharmacological inhibition of Fak needs to be confirmed, by ensuring that 
Inhibitor14 does binds to Fak in zebrafish and stops its autophosphorylation activation 
mechanism. This could be addressed by immunostaining using both Fak and 
phosphorylated-Fak antibodies, a down regulation of the latter would be expected. In 
addition, this work could be combined with experiments using newly developed more 
specific Src-family kinase inhibitors, such as Saracatnib, Bosuntib, Dasantanib or KX2-
391 (Lieu and Kopetz, 2010). These Src inhibitors are more specific to one type of Src 
rather than PP2, which is effective for multiple Src-family kinases. Another possibility to 
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study the action of Src during development is the use of morpholinos. This would enable 
the suppression of a specific Src-family kinase mRNA from being transcribed. DNA 
encoding Src-family kinases have been identified in the zebrafish genome, ‘she’ gene 
(accession number: BX470239) codes for a Src-family kinase that has shown high levels 
of expression in striated muscle in mice, and is the only Src-family kinase to date 
expressed in muscle (Table 4.1). Zebrafish is a prime candidate for morpholino studies 
on striated muscle, both skeletal and cardiac, as they are able to survive up to 5dpf 
without a functioning heart as gases can diffuse through the skin. The advantage of using 
morpholinos as compared to pharmacological inhibitors is that it enables specific 
inhibition of the protein kinase of interest. Furthermore, emerging technologies, such as 
CRISPR/Cas9 allow to introduce genome modifications at the targeted genomic locus of 
interest. This new and powerful genome editing technique, would be perfectly suited to 
Src knockdown (Hisano et al., 2014). 
 
Src family kinase 
gene  
Accession 
number 
Function 
CSK BC125943 Epidermal growth factor signalling 
fynA BC075763  
fynB BC098534 T‐Cell receptor signalling 
SHC1 ‐ Antagonise cell proliferation 
SHC2 BX470234 ‐ 
SHC3 ‐ Found in nucleus accumbens (dopaminergic?) 
shda BX24831 Calcium release from sarcoplasmic  
reticulum shdb BX470234 
SHF -   - 
she BX470239 Expressed in heart, lung, brain and skeletal 
muscle skap1 BC129162 T cell adapter protein 
skap2 BC057253 Expressed in Thymus and T cells, interacts with 
SLAP‐130 sla1 BC103485 Lymphocyte  migration 
sla2 BC155558 Bone marrow macrophages 
sla3 ‐ Ubiquitously expressed in cardiac and 
smooth muscle SRC BC116544 Pulmonary microvascular endothelial cells 
SRCIN1 ‐ ‐ 
Table 4.1: 17 Src kinase genes in the zebrafish genome. The function of these proteins is not 
fully known in zebrafish, the function indicated here refers to the function of ortholog genes found 
in other model organisms.  
 
Finally, the identification of additional signalling proteins of the mechanotransduction 
pathway and their associated role would facilitate the understanding of contraction-
driven skeletal muscle development. Prior to this project a microarray approach had been 
used to compare immotile relaxed mutant and motile carriers with the aim of identifying 
novel genes affected during paralysis. Further details of this work can be found in 
Appendix E.  
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CHAPTER 5 
 
MYOFIBRIL DISRUPTION AND FORCE TRANSDUCTION 
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5. Myofibril disruption and force transduction 
 
5.1 Introduction 
 
The zebrafish has proved useful as a vertebrate model to explore the loss of E-C coupling 
on subsequent skeletal muscle development in vivo. Previous studies have shown that 
paralysis disrupts myofibril and sarcomere organisation (Behra et al., 2002) (Brennan et 
al., 2005; van der Meulen et al., 2005; Lahne et al., 2009). One advantage of the in vivo 
approach is that it enables the study of physiological events allowing complex 
interactions between tissues, here nerve and muscle, to be examined. My work has now 
shown that contraction driven increase of myofibril length can be rescued by recovery of 
movement. This can be taken as evidence that skeletal muscle function, that is 
contraction, can regulate structural organisation. Further to this, studies in other models 
have shown that the structural organisation of myofibrils will affect its functional 
properties, ultimately controlling force generation and movement (Williams and 
Goldspink, 1978). Thus, it can be argued that there is a positive feedback loop whereby 
function regulates structure and vice versa. It is likely therefore that the paralysis driven 
disruption to myofibrils observed in zebrafish developing muscle will affect its mechanical 
properties. However, the impact of altered structure on muscle function in zebrafish has 
not been explored in detail.  
One parameter of muscle function, extensively studied in mammalian systems is their 
passive and active force generation. Normally in mammalian systems, muscle fibres are 
isolated in order to mount them on force transducers with the aim of manipulating their 
environment. Despite the size of zebrafish larval muscle fibres, it has proved possible to 
isolate them and to measure force (Iorga et al., 2011). However, of greater advantage 
has been the development of a technique in Professor Arner’s laboratory that allows the 
mounting of whole larval fish, enabling muscle properties to be explored in intact animals 
(Dou et al., 2008; Li et al., 2013). Using this approach skeletal muscle can be assessed 
in an environment in which they are capable of differentiating into the full range of 
definitive muscle-types. Zebrafish larvae were mounted in a physiological bath, using 
aluminium clips trapping their head and tail (Figure 5.1). Within the bath they are 
mounted on one side on a force transducer and on the other side on a micrometer screw 
allowing length adjustments. Stimulations were performed using platinum electrodes.  
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Figure 5.1: Zebrafish larvae preparation. [A] Schematic illustration of preparation attachment 
using aluminium foil clips at both ends of the larvae. The aluminium foil is folded along the dashed 
lines as shown on the left clip. A small hole is made in each clip for mounting. [B] Photograph of 
the preparation mounted on the microscope stage (Dou et al., 2008). 
 
In this chapter we examined, in collaboration with Professor Arner (Karolinska Institutet, 
Stockholm, Sweden), the functional consequences of paralysis using the technique he 
pioneered to study the mechanical properties of developing muscle in zebrafish larvae 
(Dou et al., 2008; Li et al., 2013). Immotile relaxed mutants, and pharmacological 
treatments were used to assess the effect of paralysis and recovery on the developing 
skeletal muscle mechanical properties. However, due to technical limitations, larvae 
could only be mechanically assessed from 4-5dpf. Therefore, comparison of muscle 
function between immotile, recovered and control fish was established by exploring 
length-force relationships at 5 and 7dpf. Passive force measurements were taken in all 
fish by stretching the muscle and active force was measured in recovered compared to 
control embryos. In addition, sarcomere length was determined using light microscopy 
to assess whether, as shown in the motility mutants nic1 (Brennan et al., 2005), zebrafish 
immotile relaxed mutants and pharmacologically treated fish displayed shorter 
sarcomeres. 
Finally, to complete the assessment of the positive feedback in between muscle structure 
and function, the effect of paralysis on zebrafish subsequent swimming behaviour was 
also assessed, using the Ethovision™ tracking software. Previous studies have shown 
that immobilisation of embryos did not appear to disrupt subsequent swimming 
behaviours of developing zebrafish larvae (Saint-Amant and Drapeau, 1998). However, 
this study has revealed that whilst paralysis-induced myofibril disorganisation is 
reversible, this process takes several days to fully recover (Chapter 3). The delay in 
myofibril structural recovery, as observed in this study, may well have a knock-on effect 
on the swimming behaviour in developing larval fish.  
 
The aim of this chapter is to analyse the disruption of sarcomere length and force 
production in the zebrafish skeletal muscle and ultimately swimming behaviour, in 
response to paralysis. 
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Hypothesis: Work from chapters 3 and 4 have shown that paralysis leads to structural 
disruption, causing myofibril disorganisation. As the structure of muscle fibres is critical 
to the maintenance of function, it was proposed that paralysis-induced disruption will 
impact on force production and ultimately swimming behaviour. In this chapter the 
hypothesis was tested using force measurement and a swimming tracking system. 
 
5.2 Results 
 
5.2.1 Active and passive tension measurements in 5dpf carrier control larvae 
 
Passive and active tensions were measured at different degrees of stretch relative to 
slack length (Ls) in 5dpf (Figure 2). The length of the samples (L) was increased in steps 
from slack length (Ls) and at each relative stretch (L/Ls) active and passive tension were 
recorded as a voltage and converted into force measurements (mN). To generate active 
tension, muscle were stimulated at supramaximal voltage (10% above the maximal) with 
single pulses (0.5ms) to give rise to a single twitch contraction via direct stimulation of 
the whole fibre (Figure 5.2 A). The active tension was measured at the peak of the single 
twitch contraction. Passive tension was measured just before the electrical stimulus and 
stretch increment (Figure 5.2 B).  
 
 
 
Figure 5.2: Active and passive tension recorded in a 5dpf carrier control larvae. To examine 
the mechanical function of immobilised and recovered larvae, larval muscle preparations were 
mounted for force recording. [A] Active tension: single twitch contraction at 40% stretch, 
contraction occurs after a short delay after the stimulus (black arrow) and reaches a peak in about 
10-20ms. [B] Passive tension was measured just before the electrical stimulus (top black 
arrows) and stretch increment (bottom blue arrows). 
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5.2.2 Paralysis and passive tension 
 
It was proposed that myofibril disorganisation affects the mechanical properties of 
skeletal muscle. Thus, changes in the passive elastic properties in paralysed versus 
control embryos were examined by measuring passive length force relationships at 
different degrees of stretch using both the immotile relaxed mutant line and 
pharmacologically treated larvae, during paralysis and after recovery. 
 
 
5.2.2.1 Effect of paralysis on passive tension in relaxed mutant muscle 
 
At 5dpf, immotile relaxed mutants, were found to have a similar passive tension to their 
motile carrier siblings, up to 30% stretch. When stretched above 50% of the slack length, 
motile carriers muscle teared off (often at the attachment of the aluminium clips), 
whereas immotile relaxed mutants muscle allowed up to 100% of the slack length. 
However, this final increase in stretch did not result in an associated increase in the 
passive tension of the immotile relaxed mutant muscles, which plateaued (Figure 5.3 A). 
The increase in stretch above 50% in immotile relaxed mutants muscle could be due to 
a number of factors (i) an increase in muscle size, (ii) myofibril disorganisation 
(lengthening) and (iii) sarcomere elasticity. Relaxed immotile mutants have similar cross-
sectional area to carrier motile controls indicative that muscle size has not changed 
(Figure 5.3 B). Myofibrils, are long and wavy at both slack length and 30% stretch (Figure 
5.3 C). The average stretch (L/Ls) at the point where force is maximal is similar in both 
carriers and relaxed mutants, indicative of similar sarcomere elasticity (Figure 5.3 D). In 
summary, the results show that it is the paralysis-induced myofibril lengthening, rather 
than gross muscle size or sarcomere elasticity, that potentially contributes to the ability 
of the relaxed mutant muscle to undergo further stretch above 50% without an associated 
increase in passive tension.  
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Figure 5.3: Measurement of passive tension and associated factors in the relaxed mutant 
muscle at 5dpf. [A] Passive tension (Force mN) was plotted against stretch at different lengths, 
relative to slack length (L/Ls), carriers (Rr, white), relaxed mutants (rr, black). Controls tended to 
break at stretches above 1.5. Whereas relaxed mutants were able to stretch without breaking, up 
to twice the slack length, without an associated increase in passive tension (above about 1.5-
1.6). [B] Cross-sectional area was measured on transversal sections through the dorsal region of 
the somite. Relaxed mutants (yellow), carriers (green). (n=9, p=0.54655, ns) [C] Actin within the 
somites stained with rhodamine phalloidin to demonstrate the myofibril phenotype in 1: carrier at 
slack, 2: carrier at 30% stretch, 3: relaxed mutant at slack, 4: relaxed mutant at 30% stretch. [D] 
Average stretch (L/Ls) at the point where force is maximal in both carriers (white) and relaxed 
mutants (black) (n=7 relaxed mutants & 8 carriers, p=0.0948, NS) (Scale bar is 100µm). 
 
5.2.2.2 Effect of paralysis and subsequent recovery on passive tension in drug 
treated larvae 
 
In order to be able to assess the same batch of fish during paralysis and once movement 
is restored, the pharmacological protocol was adapted and the embryos were paralysed 
up to 5dpf. Movements in zebrafish embryos prior to 24hpf are driven by slow muscle, 
therefore the Na+ channel blocking anaesthetic Tricaine, rather than BTS, was found to 
be most effective at inhibiting the initial embryonic movements (up to 29hpf). Conversely, 
BTS, specific reversible inhibitor of the fast muscle myosin II ATPase, was shown to be 
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a more effective reversible paralysing agent and to have a better survival rate compared 
to Tricaine from 29hpf up to 5dpf, (Appendix F).  
At 5dpf, immotile Tricaine-BTS treated fish were found to have a similar passive tension 
compared to the motile DMSO control fish, up to 60% stretch. As with the relaxed 
mutants and their carriers, when stretching further, motile DMSO control fish muscle 
teared off (often at the attachment of the aluminium clips), whereas immotile Tricaine-
BTS treated fish muscle allowed up to 100% of the slack length. However, in contrast 
with the relaxed mutant data, the Tricaine-BTS treated larvae showed a continuous 
associated increase of their passive tension above 60% stretch (Figure 5.4 A).  As for 
the immotile relaxed mutants, possible factors involved in stretch increase were 
explored, i.e. increase in muscle size, myofibril disorganisation (lengthening) and 
sarcomere elasticity. Tricaine-BTS treated immotile larvae have similar cross-sectional 
area to DMSO motile control larvae, indicative that muscle size has not changed (Figure 
5.4 B). However, although myofibril waviness was observed at slack length, it was less 
apparent in Tricaine-BTS treated fish than in relaxed mutants, and disappeared at 30% 
stretch (Figure 5.4 C). Furthermore, the average stretch (L/Ls) at the point where force 
is maximal is similar in both Tricaine-BTS treated and DMSO control larvae, indicative of 
similar sarcomere elasticity (Figure 5.4 D). In summary, the results show that, as with 
the relaxed mutant data, it is the paralysis-induced myofibril lengthening, rather than 
gross muscle size or sarcomere elasticity, that potentially contributes to the ability of the 
Tricaine-BTS treated larvae muscle to undergo further stretch above 50%. However, in 
contrast to the relaxed mutant data, stretch in the Tricaine-BTS treated larvae muscle is 
accompanied by an associated increase in passive tension.  
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Figure 5.4: Measurement of passive tension and associated factors in the Tricaine-BTS 
treated and DMSO control larvae at 5dpf. [A] Passive tension (Force mN) was plotted against 
stretch at different lengths, relative to slack length (L/Ls), DMSO controls (DMSO 5d, white), 
Tricaine-BTS treated (BTS 5d, black). DMSO controls tended to break at stretches above 1.6. 
Whereas the Tricaine-BTS treated larvae were able to stretch without breaking, up to twice the 
slack length. [B] Cross-sectional area was measured on transversal sections through dorsal 
region of the somite. Tricaine-BTS (yellow), DMSO control (blue) (n=9, p=0.558354, ns). [C] Actin 
within the somites stained with rhodamine phalloidin to demonstrate the myofibril phenotype in 1: 
slack Tricaine-BTS slack, 2: 30% stretch BTS, 3: relaxed mutant at slack, 4: relaxed mutant at 
30% stretch. [D] Average stretch (L/Ls) at the point where force is maximal in both DMSO controls 
(white) and Tricaine-BTS treated larvae (black) (n=5 BTS & 6 DMSO, p=0.347274, ns) (Scale bar 
is 100µm). 
 
The next step in the experimental approach was to test whether the effect of paralysis 
remained when movement was restored. The effects of two paralysis protocols were 
compared, the combined Tricaine-BTS paralysis up to 5dpf followed by 2 days recovery 
and the initial 17-24hpf Tricaine alone paralysis followed by 6 days recovery. Myofibril 
structure and cross-sectional surface area were compared at 5dpf, prior to Tricaine-BTS 
recovery. Myofibril structure was compared at slack length, Tricaine-BTS immotile 
treated larvae were the only group to display a mild wavy myofibril phenotype. Motile 
Tricaine recovered larvae presented a similar myofibril structure to both the motile DMSO 
and Embryo Medium (EM) controls (Figure 5.5 A). Cross-sectional areas were similar in 
all groups, however it is noticeable that Tricaine-BTS treated larvae displayed wider 
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variations, which might be accountable for their thinner appearance, as observed in 
Figure 5.5 A1 (Figure 5.5 B). 
 
 
Figure 5.5: Effect of paralysis and recovery on myofibril structure and muscle volume in 
drug treated larvae at 5dpf. [A] Actin within the somites stained with rhodamine phalloidin to 
demonstrate the myofibril phenotype in (1) Tricaine-BTS treated larvae, (2) DMSO control larvae, 
(3) Tricaine recovered larvae, (4) EM control larvae. Scale bar 100µm. [B] Cross-sectional area 
was measured on transversal sections through dorsal region of the somite. Tricaine-BTS 5d 
(orange), DMSO controls (grey), Tricaine recovered (yellow), EM controls (blue) (n=4, p=0.74572, 
ns) (Scale bar is 100µm). 
 
Passive tension was assessed, at 7dpf, once movement recovery had occurred in both 
Tricaine-BTS recovered and Tricaine recovered larvae. Motile Tricaine-BTS recovered 
larvae passive tension was assessed, after 5 days paralysis and 2 days recovery. Their 
muscle could be stretched up to 110% of the slack length, against 90% for the DMSO 
controls (Figure 5.6 A). In both Tricaine-BTS recovered and DMSO controls passive 
tension increased continuously. Passive tension was assessed in motile Tricaine 
recovered larvae, after 17-24hpf paralysis and 6 days recovery. Their muscle could be 
stretched up to 100% of the slack length, against 50% for the EM controls (Figure 5.6 B). 
Their passive tension increased continuously up to 50% stretch before plateauing. 
Furthermore, these larvae muscles displayed a significantly higher passive tension from 
30% of stretch onwards compared to EM controls (Figure 5.6 C). The average stretch 
(L/Ls) at the point where force is maximal is similar in Tricaine-BTS and DMSO larvae, 
and in Tricaine and EM control larvae indicative of similar sarcomere elasticity (Figure 
5.6 D).  
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Figure 5.6: Measurement of passive tension and associated sarcomere elasticity in the 
Tricaine-BTS recovered, Tricaine recovered, DMSO and EM control larvae at 7dpf. [A] 
Passive tension (Force mN) was plotted against stretch at different lengths, relative to slack length 
(L/Ls), Controls (DMSO 7d, white), Tricaine-BTS recovered larvae (BTS Recovered 7d, black). 
[B] Average stretch (L/Ls) at the point where force is maximal, DMSO controls (DMSO 7d, white), 
Tricaine-BTS treated (BTS Recovered 7d, hatched) (n=6 BTS Recovered & 5 DMSO, 
p=0.669042, ns). [C] Passive tension (Force mN) was plotted against stretch at different lengths, 
relative to slack length (L/Ls), Tricaine recovered larvae (Tricaine Recovered 7d, black symbols), 
embryo medium control larvae (EM, white symbols). Higher passive tension was observed from 
30% stretch in Tricaine recovered larvae [D] Average stretch (L/Ls) at the point where force is 
maximal, EM controls (EM 7d, white), Tricaine recovered (Tricaine Recovered 7d, grey) (n=4 EM 
& 10 TR, p=0.476036, ns). 
 
In summary, the results show that the drug treated and recovered larvae muscle have 
an increase ability to undergo further stretch. Another paralysis-induced effect was also 
unveiled in the Tricaine recovered muscle, as 17-24hpf paralysis leads to a significantly 
higher passive tension from 30% of stretch. This data shows that the increase in stretch 
observed during drug induced paralysis at 5dpf remains evident after movement 
recovery at 7dpf. Furthermore, myofibril structure was found to be restored after 
movement. Taken together, this data indicated that the increase stretch observed after 
recovery is unlikely to be due to myofibril disruption.  
0
0.5
1
1.5
2
St
re
tc
h
 L
/L
s
DMSO 7d
BTS
Recovered
Stretch (L/Ls)
0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2
F
o
rc
e
 (
m
N
)
0.0
0.1
0.2
0.3
0.4
0.5
BTS Recovered 7d
DMSO 7d 
Stretch (L/Ls)
0.8 1.0 1.2 1.4 1.6 1.8 2.0
P
a
s
s
i v
e
 f
o
r c
e
 (
m
N
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Stretch (L/Ls)
0.8 1.0 1.2 1.4 1.6 1.8 2.0
A
c
ti
v
e
 f
o
rc
e
 (
m
N
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Stretch (L/Ls)
1.0 1.2 1.4 1.6 1.8 2.0
P
a
s
s
i v
e
 f
o
rc
e
 (
m
N
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Stretch (L/Ls)
0.8 1.0 1.2 1.4 1.6 1.8 2.0
A
c
ti
v
e
 f
o
rc
e
 (
m
N
)
0.0
0.2
0.4
0.6
A B
C D
Passive
Stretch (L/Ls)
0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2
F
o
rc
e
 (
m
N
)
0.0
0.1
0.2
0.3
0.4
0.5
EM 7 d
Tricaine Recovered 7d
Fo
rc
e 
(m
N
) 
Stretch (L/Ls) 
0
0.4
0.8
1.2
1.6
2
St
re
tc
h
 L
/L
s
EM 7d
Tricaine
Recovered 7d
B A 
C D 
Fo
rc
e 
(m
N
) 
Stretch (L/Ls) 
105 
 
5.2.3 Paralysis and sarcomere length 
 
Paralysed larvae, showed an overall increase of their passive tension, as their muscles 
allowed up to 50% additional stretch for the relaxed mutants (Figure 5.3 A) and 40% for 
the Tricaine-BTS treated larvae (Figure 5.4 A). In both cases, data suggest that it is the 
elongation of the myofibrils during paralysis that is accountable for the increased ability 
to undergo further stretch. It was previously established that the lack of E-C coupling in 
the skeletal muscle of immotile zebrafish also led to a shortening of the sarcomere and 
to an increase in sarcomere number within the elongated myofibrils (Brennan et al., 
2005). Therefore, using light microscopy, the sarcomere length was determined at 
different degrees of stretch for the immotile relaxed mutants, their motile siblings and the 
motile Tricaine-BTS treated larvae at 5dpf. The results show that the sarcomere length 
increased linearly against stretch in each groups (as shown in figure 5.7). Furthermore, 
individual sarcomere stretch is proportional to that of whole muscle in all groups (with 
correlation coefficient for carriers of r=0.9808, for relaxed mutants of r=0.9631 and for 
Tricaine-BTS treated larvae of r=0.9024). However, sarcomere length was significantly 
shorter at all degrees of stretch in both the immotile relaxed mutants and Tricaine-BTS 
treated larvae at 5dpf compared to the motile carriers controls (Figure 5.7). Furthermore, 
the sarcomere elasticity of both immotile relaxed mutant and Tricaine-BTS treated 
larvae, allowed an additional 20% stretch compared to the motile carrier controls. 
 
Figure 5.7: Sarcomere length at each degree of stretch for relaxed mutants, carriers, and 
Tricaine-BTS treated larvae. Sarcomere stretch is proportional to muscle stretch (carriers 
r=0.9808, relaxed mutants r=0.9631 and Tricaine-BTS treated larvae r=0.9024). At stretches 
above 60% the controls (carriers, Rr) tended to break. The Tricaine-BTS and relaxed mutant 
larvae were possible to stretch significantly further without breaking, up to 80%. However, the 
sarcomere length did not increase further above 70%. Sarcomere length is shorter in immotile 
relaxed and Tricaine-BTS treated larvae. Carriers (Rr, green), relaxed mutants (rr, orange), and 
Tricaine-BTS treated larvae (BTS, yellow). 
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In summary, paralysis induces sarcomere shortening in the immotile muscles of relaxed 
mutants and Tricaine-BTS treated larvae. This data has shown that myofibril lengthening 
is associated with shorter sarcomeres and potentially enables their muscle fibres to 
stretch up to an extra 20% stretch. 
 
5.2.4 Paralysis and active tension 
 
In addition to passive tension, active tension was measured. Active tension is elicited in 
response to an electrical impulse, which allows assessment of the ability of the muscle 
to generate force in response to stimulation. Active tension was measured in immotile 
relaxed mutants and drug treated larvae, during paralysis and after recovery at each 
degree of stretch.  
As expected, no contraction was elicited in the relaxed mutant in response to the single 
twitch electrical stimuli (0.5ms) and the tetanic stimulation (200ms 200Hz). In skinned 
relaxed mutant embryos contraction can be elicited by exposure to Caffeine (Zhou et al., 
2006). However, in this study, intact relaxed mutant embryos were assessed and 80mM 
KCl or 20mM Caffeine did not elicit contraction. In contrast, carriers did develop a typical 
contractile response to electrical stimulation with an increase of active force relative to 
stretch, peaking at 40% (Figure 5.8 A). At 5dpf, during paralysis, Tricaine-BTS treated 
larvae showed an absence of active force (less than 4% of the DMSO control value). At 
7dpf, in Tricaine-BTS recovered larvae, the active tension was partially rescued to 
approximately 60% of that in the DMSO control larvae (Figure 5.8 B). Furthermore, 
Tricaine recovered larvae active tension was fully rescued to EM control values, with an 
optimal length at 40% stretch (Figure 5.8 C).  
Further, using active tension recordings and sarcomere length measurements, a 
sarcomeric optimal length of 1.99 ±0.097µm value established for motile carriers and of 
1.66 ±0.082 µm at 40% stretch was established in Tricaine-BTS recovered larvae. 
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Figure 5.8: Active tension measurements recordings. [A] Relaxed mutants and carriers.  
No contraction could be elicited in the relaxed mutant group with a single twitch stimulus. [B] 
Tricaine-BTS treated larvae during paralysis and after recovery. At 5dpf a significant 
reduction in active tension, to less than 4% of the control values, was observed, at all degrees of 
stretch, in Tricaine-BTS treated larvae (BTS 5d). At 7dpf, when BTS was removed for 2 days 
recovery, the larvae muscles recovered about 60% of their active tension, at all degrees of stretch 
(BTS recovered 7d). [C] Tricaine recovered. At 7dpf, Tricaine recovered larvae displayed an 
active tension similar to EM controls. 
 
In summary, at 5dpf active tension could not be induced in the immotile relaxed mutants, 
and the immotile Tricaine-BTS treated larvae. At 7dpf the active tension in the muscle of 
recovered motile larvae, treated with Tricaine-BTS for 5 days, was partially restored. 
Whilst the active tension in the muscle of recovered motile larvae, treated with Tricaine 
only from 17-24hpf, was fully restored to control values.  
 
5.2.5 Recovery of swimming behaviour after drug induced paralysis 
 
The recovery of movement after pharmacological immobilisation was shown to be 
accompanied by a recovery of the muscle structure and function. Ultimately, the role of 
skeletal muscle is to generate locomotion, therefore the swimming behaviour of Tricaine 
and Tricaine-BTS recovered larvae was assessed.  
Tricaine treated embryos were allowed to recover, after 17-24hpf paralysis, and their 
swimming behaviour, namely distance covered and rotation frequency, was tested 
against controls at 3, 5, 7 days and 1 month. No difference in swimming behaviour was 
observed between controls and Tricaine recovered fish from 3dpf onwards (Figure 5.9A). 
Tricaine-BTS larvae were allowed to recover, after 5 days of paralysis, and their 
swimming behaviour, namely distance covered and rotation frequency, was tested 
against DMSO controls at 3 months. No difference in swimming behaviour was observed 
between DMSO controls and Tricaine-BTS recovered fish at 3 month (Figure 5.9 B). 
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Figure 5.9: Swimming behaviour analysis. [A] Tricaine recovered fish swimming behaviour, 
distance and rotations, was assessed at 3, 5, 7 days and 1 month. No difference was observed. 
[B] Tricaine-BTS recovered fish swimming behaviour, distance and rotations, was assessed at 
3 months. No difference was observed. 
 
In summary, results show that larvae, after an initial period of paralysis and associated 
myofibril disorganisation, recover their muscle mobility, and subsequently normal 
swimming behaviour. 
 
5.3 Discussion 
 
Skeletal muscle has both passive and active mechanical properties. Passive properties 
relate to the ability of muscle both to stretch and to generate passive tension, whereas 
the active properties relates to active tension. 
At 5dpf, paralysis in immotile relaxed mutants leads to an increase in stretch but not 
passive tension which plateaus, whereas in Tricaine-BTS treated larvae stretch is 
accompanied by a continuous increase in passive tension. At 7dpf, Tricaine-BTS 
recovered larvae show an increase in stretch accompanied by a continuous increase in 
passive tension, whereas in Tricaine recovered larvae passive tension is increased from 
30% stretch and plateaus during stretch increase (60% stretch onwards). Furthermore, 
sarcomere shortening was also observed as a result of paralysis. In addition, paralysis 
inhibits active tension, which recovers progressively once contractile recovery is 
restored, ultimately resulting in normal swimming behaviour.  
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(1) Movement-dependent regulation of passive tension 
 
In this chapter, paralysis was shown to disrupt the passive properties of the muscle, 
mainly its increased ability to stretch. Sarcomere length was also found to be affected by 
paralysis, with a significant reduction of sarcomeric optimal length in motile Tricaine-BTS 
recovered larvae (1.66 ±0.082 µm) compared to the 2.1µm value previously established 
by Li et al. in wildtype larvae (Li et al., 2013). Furthermore, this result is supported by 
previous studies that have shown sarcomere shortening in immotile mutant (nic1) 
disorganised myofibrils (Brennan et al., 2005). The movement dependent increase in 
stretch and sarcomere shortening correlates with the fact that myofibril organisation is a 
movement-dependent mechanism. This hypothesis is strengthened by the fact that 
paralysis did not impair muscle size nor sarcomere elasticity. Therefore, we propose that 
paralysis-induced myofibril lengthening is the factor allowing further stretch of the muscle 
fibres, with stretch ‘taking up’ the slack of these long myofibrils, rather than gross muscle 
size or sarcomere elasticity itself. Thus, skeletal muscle passive tension is a movement-
regulated mechanism. Overall, movement regulates myofibril organisation which in turn 
regulates the passive property of the skeletal muscle, this demonstrates the positive 
feedback between structure and function in muscle. 
It was proposed that the earliest embryonic movements are crucial for subsequent 
organisation of muscle structure (Chapter 3). The observation that Tricaine recovered 
larvae, paralysed between 17-24hpf, display an increase in passive tension despite 
movement recovery indicates that this event is also key for establishing functional 
properties of the muscle. This increase in passive tension translates into an increase 
stiffness of the muscle. Titin is an early, crucial, multifunctional sarcomeric component, 
notably it is a molecular spring that generates the main source of myofibrillar stiffness, 
i.e. passive tension (Clark et al., 2002; Gautel, 2011). One interpretation of the increased 
passive tension observed in Tricaine recovered larvae is that early paralysis disrupts the 
titin recruitment process during myofibrillogenesis. Titin is also a strain sensor involved 
in muscle cell signalling, its enzymatic function is thought to be modulated by 
mechanically induced conformational changes (Sparrow and Schöck, 2009; Gautel, 
2011). We propose based on the data from the Tricaine recovered larvae, that during 
myofibril assembly titin relies on its mechanosensing properties, to adjust its structural 
organisation within the sarcomere and regulate its mechanical passive property. 
Therefore, one possible explanation is that when paralysis occurs during 
myofibrillogenesis, the positive mechanical feedback (contractile activity) is suppressed 
and titin generates an extra level of passive tension, resulting in the increased stiffness 
observed in Tricaine recovered larvae. However, data from the paralysed relaxed 
mutants and Tricaine-BTS treated larvae, in which skeletal muscle passive tension was 
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found to be similar to control larvae, did not support the theory that early paralysis causes 
an increase in stiffness. Therefore, this part of the project is difficult to interpret without 
further work and the link between paralysis and increased stiffness remains uncertain. 
 
(2) Movement-independent regulation of active tension 
 
In this chapter, the active property of skeletal muscle was also examined in drug treated 
recovered larvae. A striking observation was that Tricaine recovered larvae, paralysed 
from 17-24hpf, displayed an active tension that was comparable to control values. 
Skeletal muscle active tension hinges on the ability of myofilaments to form cross-
bridges, and this in turn relies on the correct myofilament spacing. The organisation of 
the myofilament lattice was shown to be a movement-independent process in Chapter 
3. Therefore, the potential of paralysed muscle to generate active tension is also likely 
to be independent of movement. This hypothesis is supported by the ability of immotile 
relaxed mutants to reach rigor when exposed to cyanide (Chapter 3). Thus, the ability of 
the skeletal muscle to generate active force is not determined by the initial spontaneous 
contractile event in zebrafish embryos. 
Observations also showed that Tricaine-BTS recovered larvae, paralysed for 5 days (due 
to mechanical assessment technique limitations), displayed a significant reduction in 
force production. This result is in contrast with the Tricaine data described above, as it 
suggests that active tension may be affected by paralysis. However, experiments with 
BTS could be interpreted differently to those performed with Tricaine, due to technical 
issues. BTS wash out after short exposure leads to rapid recovery (Dou et al., 2008), 
whereas here after long term treatment active tension is only partially restored. We 
propose that this lowering of active tension is due to structural changes, i.e. 
reorganisation and reestablishment of the contractile apparatus. BTS treatment was 
shown to disrupt myofilament spacing, reducing the lateral distance in between actin and 
myosin filaments (Chapter 3). This disruption might be the result of a BTS-induced 
alteration of a Ca2+ driven feedback mechanism. BTS is the only paralysis treatment 
used that blocks the E-C coupling downstream of Ca2+ release, both Tricaine treated and 
relaxed mutants cannot generate Ca2+ release. Therefore, myofilament lattice shrinkage 
might be the result of BTS treated muscle Ca2+ transients failing to generate contraction. 
Furthermore, active force development was previously shown to be inhibited by 
compression of the myofilament lattice in osmotically compressed skinned frog muscle 
fibres (Maughan and Godt, 1981). However, experiments performed in zebrafish showed 
that osmotic swelling of BTS treated larvae did not improve active tension (Li, personal 
communication). Interestingly, at 5dpf, upon BTS wash out, larvae started to swim even 
111 
 
if their lattice had not recovered by then. Furthermore, structural and functional paralysis-
induced muscle disruption did not impact on long term swimming behaviour patterns. 
 
5.4 Conclusion 
 
Our results show that the passive properties of skeletal muscle are disrupted by 
paralysis, which always induced an increase in stretch. This has been linked to paralysis 
induced structural defects, namely myofibril elongation. Conversely, our results show 
that the active properties of skeletal muscle are not disrupted by paralysis and correlates 
with the correct spacing of myofilaments. As it has been established that myofibril 
elongation is a movement dependent process and that myofilament spacing is not, we 
propose that passive tension is regulated by movement but not active tension. Therefore, 
there is a link between skeletal muscle structure and function, that is the ability of 
myofibril length to determine stretch. 
 
5.5 Future work 
 
Induction of a rigor state in the relaxed mutants established that the myofilament spacing 
in the paralysed muscle is unaltered and allows the formation of cross bridges (Chapter 
3). However, what remains to be determined is the level of active tension produced 
during rigor in the relaxed mutant and whether it is comparable to control larvae. Rigor 
can be induced using a number of chemical approaches including exposure to cyanide 
(as used in Chapter 3), the ionophore ionomycin or triton. This technique could be 
applied in the mechanical studies in order to determine active tension in a rigor state in 
the relaxed mutant larvae. The limitation of this experimental protocol, is that active 
tension and rigor would be elicited without subsequent relaxation, thus making it difficult 
to assess whether the relaxed mutants myofibrils are capable of generating a proper 
power stroke. One experiment design that could remediate this problem, would be to use 
a drug capable of reading through premature stop codons, ataluren (PTC124), as the 
relaxed mutant line carries a G-A non-sense point mutation in exon 13 of the gene 
CACNB1. This drug is already in the phase 2b of clinical trial in human Duchenne 
Muscular Dystrophy (DMD) clinical studies (Finkel, 2010; Peltz et al., 2013). 
Furthermore, it was also shown to efficiently rescue movement in the zebrafish DMD 
model, sapje, with an identical dose effect as the one observed in humans (Li et al., 
2014). During my 6 weeks visit in Pr. Arner laboratory, I worked with Dr. Li and did a 
preliminary experiment to attempt motile rescue of relaxed mutant larvae, however the 
dose used for sapje larvae proved lethal for relaxed. 
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Another area that requires further work is the establishment of the mechanism that 
causes the myofilament shrinkage and active tension disruption observed exclusively in 
the Tricaine-BTS treated compared to Tricaine-treated and relaxed mutant larvae. As 
this Tricaine-BTS treatment is the only method that inhibits movement downstream of 
the calcium transients, it could be that the contraction is linked to a feedback mechanism 
that regulates calcium levels. In this scenario, the lack of contraction could potentially 
lead to a disruption of calcium signalling that would then lead to myofilament lattice 
shrinkage and subsequent active tension disruption. This paradigm could be tested by 
exposing relaxed mutant larvae to BTS, as their muscle is unable to generate Ca2+ 
transients their myofilament lattice should be protected from the BTS shrinking effect, 
which would verify our hypothesis. Furthermore, measurement of calcium levels in 
control and Tricaine-BTS treated larvae would determine whether there are significant 
changes that potentially drive myofilament lattice shrinkage.  
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CHAPTER 6 
 
DISCUSSION 
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6. Discussion 
 
The aim of this project was to determine the role of contraction in skeletal muscle 
development. To that effect the role of the initial contractile event observed in zebrafish 
embryos from 17 to 24hpf was examined. Both genetic and pharmacological approaches 
were used to study paralysis-induced disruption of skeletal muscle structure and function 
in the zebrafish model and ultimately determine the role of contraction during skeletal 
muscle development. It was established that, in zebrafish, the structural and the 
functional aspects of the developing skeletal muscles were regulated by dual 
mechanisms, involving both movement-dependent and movement-independent 
processes. 
The work presented in this thesis has demonstrated that skeletal muscle structure and 
function are interdependent, myofibril length contributes to the ability of the skeletal 
muscle to stretch and this mechanism is regulated by movement. Previous work has 
shown that paralysis leads to an increase in myofibril length (Brennan et al., 2005); this 
study has now shown that recovery of contraction restores length. Taken together this 
proves that there is a contraction-driven myofibril organisation pathway (Figure 6.1 C-D). 
This is consistent with the findings of a recent study in Xenopus, that suggest a role for 
contractility in sarcomere maturation in vivo (Geach et al., 2015). The mechanism 
through which myofibril length is established is likely to occur at the sarcomere level. 
Paralysis induced actin lengthening along with shorter sarcomeres, will result in an 
increase amount of overlap between actin and myosin myofilaments. This disruption will 
affect active force production (contraction) and lead to the lengthening of myofibril. This 
elongation process might be due to the addition of extra sarcomeres, triggered by the 
lack of contraction, as suggested in previous studies (Williams and Goldspink, 1978; 
Lahne et al., 2009). Novel data from this study demonstrates that contraction can control 
sarcomere remodelling, namely the regulation of actin length, via movement driven 
localisation of the actin capping protein, Tropmodulin 1. Myofibril length was shown to 
be linked to the mechanical passive property, stretch, with lengthening leading to an 
increase of the muscle’s ability to stretch. In summary, this work has shown that a 
movement dependent process links the structural organisation, namely myofibril length, 
with the functional mechanics of the skeletal muscle, specifically stretch.  
In addition to the movement-dependent process described above, work presented in this 
thesis has also demonstrated that movement-independent processes are implicated in 
the regulation of developing skeletal muscle structure. Indeed, at the structural level, the 
initial paralysis-induced reduction of myofibril bundling, fully recovers despite a complete 
absence of movement over time. This finding was supported by sub-structural data 
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demonstrating that the myofilament lattice spacing is unaffected by paralysis in zebrafish. 
The lattice spacing is an underlying factor in the myofilaments ability to form cross-
bridges, thus the capacity of the immotile relaxed mutant to reach rigor when exposed to 
cyanide, confirmed that the correct spacing of myofilaments is a movement-independent 
process. Developing skeletal muscle function, specifically their mechanical active 
property, active tension, rests on cross-bridge generated active force (Figure 6.1 A-B). 
Therefore, it was predicted that, recovery of movement after pharmacological paralysis 
of larvae, would lead to the restoration of active tension. This hypothesis was confirmed 
in Tricaine treated larvae, whose active tension was restored to a level comparable with 
control values after recovery of movement. Furthermore, in Tricaine-BTS treated larvae 
the paralysis protocol was shown to induce a compression of the myofilament lattice and 
as predicted led to an associated disruption of active tension. Recordings of the Tricaine-
BTS active tension showed a reduced level of recovery. This finding is supported by the 
fact that the disruption of active tension in compressed myofilament lattice is known to 
be due to the hindrance of myosin head power stroke movement (Maughan and Godt, 
1981; Adhikari and Fajer, 1996). Thus, the generation of the developing skeletal muscle 
function, active tension, was shown to be a movement-independent process, and 
myofilament lattice spacing determines the ability of the skeletal muscle to generate 
active tension. 
The close interaction of skeletal muscle structure and function during development was 
established. It is particularly interesting to note that the mechanism leading to active force 
generation and eventually movement is robust and persists despite paralysis. 
Furthermore, as this mechanism generates the contractile activity, it regulates the 
movement-dependent mechanism linking myofibril length and passive tension 
generation. Finally, passive tension closes the feedback loop by determining the optimal 
force at which the muscle operates within their force-length relationship (Figure 6.1 E) 
(Azizi, 2014). This paradigm is supported by the idea that function, rather than form, is a 
robust evolutionary determinant, and that form follows function (Russell et al., 2000). 
The role of contraction in skeletal muscle development was investigated further by 
exploring the signalling of the contraction-driven myofibril organisation pathway. 
Mechanosensing is typically considered to occur primarily through specialised 
transmembrane linkages, the costameres and myotendinous junctions, as reviewed by 
Burkholder (Burkholder, 2007). Focal adhesion complexes (FAC) are key components 
of these linkages and, in mammals, focal adhesion kinase (Fak) is known to be central 
to their mechanotransduction activity. In this study, it was established that the 
mechanisms of mechanosensitive signalling of the contraction-driven myofibril 
organisation pathway, were different in zebrafish and appeared to revolve around the 
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Src protein kinase rather than Fak (Figure 6.1). This shift of the role of the FAC signalling 
proteins shown in this thesis, is proposed to be due to a remodelling of FAC following on 
the teleost genome duplication and protein functional divergence (Jaillon et al., 2004). 
Furthermore, the description of Src localisation and sensing role in zebrafish skeletal 
muscle is novel. This finding could lead to a better understanding of the role of 
contraction in the developing skeletal muscle and ultimately enhance medical research 
in humans. 
 
Figure 6.1: Skeletal muscle structure and function feedback loop. Skeletal myofilament 
lattice correct spacing [A] leads to the generation of active tension and movement [B]. This 
contractile activity is sensed by the Src protein within costameres and myotendinous junction and 
drives myofibril organisation. Correct myofibril length [C] leads to the generation of passive 
tension [D], which in turn determines the operational range [E] of the active tension of skeletal 
muscle. This optimal functional window, varies with the type of muscle and their respective 
stiffness. 
In summary, the role of contraction in the developing zebrafish skeletal muscle was 
established as a critical driver of myofibril organisation and resulting passive tension, 
which in turn regulates the ‘fine-tuning’ of muscle function and gives it its plasticity to 
ensure the complex needs of locomotion are met. Furthermore, the investigation of the 
signalling pathway involved in the developing skeletal muscle contractile activity led to 
the discovery of a novel role for Src in zebrafish skeletal muscle development. These 
two findings (i) that contraction is a driver of myofibril organisation and (ii) that Src is a 
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key protein of the skeletal muscle development could be further explored, for therapeutic 
purposes as described below. 
The importance of contraction in skeletal muscle development, the direct impact on 
passive and subsequently active properties, could be important in understanding the role 
of foetal movements in humans. This could lead to a better understanding of the 
mechanism of foetal akinesia (absence, poverty or loss of movement) leading to 
amyoplasia, which is the most common form of arthrogryposis multiplex congenital 
(AMC). This sporadic condition, of heterogeneous etiology, is characterised by a 
generalised lack of skeletal muscle development which is replaced by dense fatty-fibrous 
tissue, leading to contractures and deformity of most joints in new-borns (Filges and Hall, 
2013). This syndrome is the result of a lack of foetal movement in the womb. This lack 
of movement can be the result of maternal abnormalities restricting the foetal 
movements, for example a lack of amniotic fluid (oligohydramnios) or an abnormal shape 
of the uterus (bicornuate). In other cases, the foetal akinesia is due to foetal myogenic 
disruptions, such as muscular dystrophy. However, in many cases, the cause of this 
contractile disruption is still unknown, as reviewed by Hall et al. (Hall et al., 2014). In this 
study, we determined that movements in the developing zebrafish embryo led to the 
correct establishment of skeletal muscle passive tension, which then impacts on the 
determination of skeletal muscle operational ranges, necessary to the differentiation of 
diversified locomotive skeletal muscles. Perhaps this is also the case in human foetuses 
and zebrafish could be used as a model to study this akinesia-induced syndrome. 
Another therapeutic aspect relating to the importance of contraction in skeletal muscle, 
would be to re-impose movement to paralysed muscles to prevent myofibril 
disorganisation and muscle stiffness. This idea is already implemented in the treatments 
of spasticity and hemiplegia following on from stroke, in humans. Several approaches 
have shown the efficiency of this mobility based treatment, namely with the application 
of localized 100Hz vibrations (Casale et al., 2014) or the constraint induced movement 
therapy after botulin toxin injection (Amano et al., 2015). Both these therapies reduce 
muscle spasticity and improve function, furthermore these non-pharmacological 
approaches could lead to a reduction of the cost of stroke treatments. 
Recent techniques are also developing the idea of mobility based treatment by 
introducing the use of robotic training. This is either done in combination with 
conventional physiotherapy (Dundar et al., 2014), or following on from botulin toxin 
injection (in more severe cases) (Pennati et al., 2014) and effectively reduces muscle 
spasticity and improves function. Finally, these studies led to the development of lower 
limb exoskeletons to facilitate the recovery of walking after stroke (Murray et al., 2015) 
and of the Hybrid Assistiv Limb (HAL) robot suit for hemiplegic patients. This robot is 
able to realise spontaneous symmetric gait by storing the motion of the 
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unaffected limb during swing and providing motion support on the affected limb during 
the subsequent swing using the stored pattern to realize symmetric gait based on 
spontaneous limb swing (Kawamoto et al., 2014). However, the cost of these robotic 
training approaches are limiting.  
Finally, the role of Src in skeletal muscle development could be explored further in the 
Duchenne muscular dystrophy (DMD) zebrafish model, sapje (Bassett et al., 2003; 
Bassett and Currie, 2004; Berger et al., 2010), as Src was shown to be involved in the 
mechanism of this muscle disease in the mdx mouse, model of DMD. Namely, it was 
shown that the ROS-Src-TRPC1/caveolin-3 pathway enhanced Ca2+ influx through 
stretch-activated channels and induced muscle-cell damage in the mdx mouse.  PP2, 
the Src inhibitor also used on zebrafish in this study, reduced stretch-induced Ca2+ entry 
and increased force recovery (Gervasio et al., 2008). This experiment could be easily 
reproduced in the zebrafish sapje mutants, to determine whether stretch induced muscle 
damaged could be rescued using PP2. Exploring the mechanisms of DMD in multiple 
animal models, would allow a comparative approach and could lead to some novel 
findings. Furthermore, as seen in this study, zebrafish is a very advantageous vertebrate 
model, which allows rapid and robust high throughput studies. 
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7. APPENDICES  
 
APPENDIX A - Spacing of the 1.1 reflection 
 
 
 
Figure A1: 1.1 reflection at different degrees of stretch 
Small angle X-ray diffraction of larvae treated with Tricaine between 17 and 24hpf and recovered 
until 6dpf (black circles), their controls kept in embryo medium until 6dpf (white circles), immotile 
relaxed mutants (black squares), and their motile siblings (white squares) at 6dpf. The graph 
shows the spacing of the 1.1 reflection (d11) determined at different degrees of stretch, expressed 
as length (L) relative to slack length (Ls). The spacing of the 1.1 reflection was similar in the four 
groups at all degrees of stretch. 
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APPENDIX B - Experimental considerations for the molecular biology work 
 
PCR vs. qPCR 
The RTPCR pilot study initially conducted showed a down-regulation of fak1a and an 
absence of fak1b expression in immotile relaxed mutant embryos suggesting that these 
genes might be linked to the mechanotransduction pathway regulating myofibril 
organisation. To further explore these findings we set out to determine the exact nucleic 
acid concentrations of fak1a and fak1b in motile controls (carriers and wildtype embryos) 
and in immotile relaxed mutant zebrafish embryos using qRTPCR. This highly sensitive 
technique measures PCR amplification as it occurs, rather than to collect the results 
once the reaction is complete as in traditional PCR, and allows to determine the starting 
concentration of nucleic acid in the sample. Opposite results were obtained, highlighting 
the unreliability and the limit of the original PCR technique. 
 
Choosing the right negative control 
In zebrafish research, heterozygote motile carriers are commonly used as negative 
control for the analysis of homozygous mutant lines. This practice ensures that both the 
mutant, in which homozygous genotype affects the phenotype, and the heterozygous 
carrier which present a normal unaffected phenotype (in the case of recessive mutation), 
are from the same batch and therefore at the exact same developmental stage (age 
matched). This is particularly important when considering that zebrafish have a rapid 
development rate, and are sensitive to environmental conditions, especially temperature. 
Experimental timing has to be very precise in order to capture developmental stages 
accurately. The gene expression levels vary throughout development with the 
establishment of specific tissues and structures, therefore it is particularly important to 
stage the embryos very accurately. However, this study shows that the heterozygous 
genotype is not a reliable control for molecular biology studies. When comparing the 
motile relaxed carrier genes expression levels to the wildtype and the immotile relaxed 
mutant, it appears that the carriers followed either the expression pattern of the wildtype 
(foxm1) or the one of the relaxed mutant (fak1a). Indeed, in some cases, it would have 
given contradictive results compared to those obtained when using the wildtype as 
control. It is necessary to determine the experimental priorities when dealing with relaxed 
mutant embryos, and recessive mutants in general. In some cases, a perfectly aged 
matched negative control might prevail, but in the case of a molecular studies, comparing 
the mutant recessive homozygous genotype to a wildtype homozygous genotype is 
crucial as it ensures that there will be no ‘residual’ effect due to a carrier heterozygous 
genotype. Based on the work on this thesis, the motile relaxed carrier is not an 
appropriate negative control when assessing the gene expression levels in the immotile 
relaxed mutant, and wildtypes should be used as controls. 
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APPENDIX C - PP2 treatment did not affect zebrafish embryos survival 
 
 
 
 
 
Figure C1: Survival rate of zebrafish in PP2 treatment. 17hpf embryos were incubated in their 
respective concentrations of PP2, and their survival was monitored at 24hpf, 42hpf and 48hpf (8 
embryos/treatment, n=6). The treated embryos showed no significant change in the survival of 
the embryos, compared to the control embryos (F(6,121) = 0.506 p = 0.803). 
 
Previous work showed that PP2 was an efficient Src inhibitor in zebrafish, despite a 5% 
increase of embryonic death at high concentrations (50‐100μM) (Ashworth & Punn, 
personal communication). The toxicity of PP2 and its effect on survival in zebrafish 
embryos was determined in more detail. A maximum concentration was set at 100μM 
and serial dilutions were made down to a minimum concentration of 6.25μM. Incubation 
was started at 17hpf and at 24hpf no significant difference in embryo survival was 
observed. By 42hpf variation of embryo survival across the treatments was observed, 
although none was significant (F(6,121) = 0.506 p = 0.803). At 48hpf, survival rate in all 
PP2 treated embryos was comparable to controls. The reason behind the increased 
variance at 6.25μM remains unknown. In summary, PP2 treatments at a concentration 
range of 6.25‐100μM administered between 17 and 24hpf does not affect zebrafish 
embryo survival rate. This concentration range was then used in the experiment testing 
of Src function in zebrafish developing skeletal muscle. 
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APPENDIX D - Interpretation of gene expression data at 96hpf 
 
Evidence from this study and others (Crawford et al., 2003) has shown that there is a 
differential expression of the two Fak isoforms suggestive of divergences in function. 
Therefore, the levels of fak expression were analysed throughout the first four days of 
development to examine patterns of fak1a versus fak1b expression and whether these 
are affected by paralysis in motile versus non motile fish. A switch in the prevalence of 
fak1a and fak1b expression during development was observed and suggests that fak1b 
plays a role in early development, whereas fak1a might be involved in later 
developmental processes. At 96hpf a significant decrease in expression levels of fak1a 
was detected in carrier and relaxed mutant compared to wildtypes. This suggested that 
fak1a expression was affected in this mutant line. However, foxm1 an important mitotic 
division and cell proliferation gene (Teh et al., 2002), displayed an expected steep 
decrease of its expression level in all three genotypes over the first 96hpf and also 
showed a significantly lower expression for the immotile relaxed mutant at 96hpf. This 
reduced mitotic division rate suggests that the metabolism of the immotile relaxed mutant 
is slowing down. These observations coincide with the arrival of embryonic death at 
around 120hpf. Zebrafish embryos rely on the yolk sac until 5dpf, after which they start 
to feed actively. Free feeding involves jaw movement and requires functional skeletal 
muscles, which these mutants do not have. Therefore the diminished level of fak1a 
expression observed in the relaxed mutants at 96hpf is probably due to the slowing down 
of their basal metabolism, as they are unable to feed and start to die. The low level of 
fak1a expression observed for the motile relaxed carrier remains however more difficult 
to explain. Perhaps, their survival rate is not as high as wildtype embryos, i.e. they are 
less robust and some are dying (which would explain the large error bars). This is 
supported by the fact that carriers of mutant lines are commonly known to be less healthy 
and to have a diminished life expectancy, compared to wildtype, even as adults. 
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APPENDIX E - Microarray study 
 
Rationale 
One approach that can be used to examine the expression levels of a large number of 
genes simultaneously is DNA microarray. This high throughput approach enables 
comparison of gene expression levels between treatments. Prior to the commencement 
of this thesis, a microarray study had been performed using relaxed homozygous 
mutants compared to control heterozygous embryos at 24hpf. Initial work in the thesis 
examined the microarray data in order to identify potential candidate genes that may be 
affected by muscle paralysis and could be important in skeletal muscle development. 
 
Method  
A total of 300 heterozygotes and 150 homozygotes zebrafish embryos aged 24hpf were 
pooled and snap frozen in lysis buffer, then stored at -80°C until use. The RNA extraction 
and microarray analysis was performed by UK Bioinformatics Ltd. mRNA was extracted 
from the pooled samples and its quality checked. cDNA synthesis was then performed  
in quadruplicates prior to conduct the microarray analysis. The Affymetrix GeneChip® 
Zebrafish Genome Array was used to study gene expression from over 14.900 
transcripts. Analysis of the microarray data using normalisation algorithms, both MAS 
and RMA techniques, identified a total of 574 genes that were statistically different in the 
two populations (Chambers and Lumsden 2008). 
 
Results 
In order to establish which genes were of interest for this project, an initial screen of 
GenBank numbers was made, and selected genes were further checked on the PubMed 
database for structural and functional information. The initial 574 genes were narrowed 
down to a pool of 21 identified genes candidate, 8 down-regulated and 13 up-regulated 
(Table E1a and E1b). However, 170 genes remained unidentified, due to the incomplete 
annotation of the zebrafish genome, and further study will be necessary to complete this 
set of data. 
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GenBank 
Number 
                                                   Annotation 
AL912811 Xtriqk protein, developmental body patterning  
AF487540 RICK, promote caspase-8 activation potentiated induces apoptosis 
AW128322 Putative protein tyrosine phosphatase 
BC045953 GIPC1 scaffolding protein regulates receptor expression and trafficking 
BC045961 ARP6, actin related protein, binds nucleosomes 
BC049461 
CAPG, gelsolin/villin actin regulatory protein, block F-actin, controling motility in non-
muscle cells 
AI957700 Protein tyrosine kinase 9, binding actin monomer  
BM777236 
Tyrosine phosphatase, enzyme involved in cellular signal transduction, perturbation 
implicates many disease 
 
Table E1a: Down-regulated potential gene candidates. 
 
 
Table E1b: Up-regulated potential gene candidates.  
 
Differential expression was assessed at system level by classifying genes according to 
their tissue distribution. Using normalised data generated by both algorithms (MAS and 
RMA), up-regulated genes candidates were found within the ubiquitous proteins (22%), 
the nervous system (21%), the kidney (14%) and the retina (11%) (Figure E1A), whilst 
the 20 most up-regulated genes candidates were mainly found in the retina (15%), the 
ubiquitous proteins (10%) and the testis (10%) (Figure E1B). Down-regulated genes 
candidates were found within the ubiquitous proteins (36%), the kidney (14%), the ovary 
(13%) and the nervous system (11%) (Figure E1C), whilst the 20 most down-regulated 
GenBank  
Number 
                                                  Annotation 
BI882775 Plectin involved in Alexander neuro-degenerative disease 
BC049492 Protein involved in Bardet-Biedl syndrome, Hereditary Spastic Paraparesis 
AI794329 Stimulatory factor involved in transcriptional activation and cell proliferation 
BC047809 Hsp40 3A, involved in the regulation Hsp70 ATPase activity 
BQ169327 Segmentation stage. 
NM_175082 MAD, regulating growth and size of tissues, necessary for correct patterning 
BC052476 Protein implicated in apoptosis control and Hsp regulation 
BG302953 May act cooperatively with GRB10 to regulate tyrosine kinase receptor signalling. 
BC044138 PAK1 cell survival and proliferation, expressed in brain, spleen and skeletal muscle 
NM_131715 
Embryonic nuclear C-term binding protein 2,transcriptional repressor of E-cadherin 
promoter   
BC047184 cullin-associated & neddylation-dissociated 1, inhibiting ubiquitination in mammals  
AF430842 neural cadherin required for establishment of left-right asymmetry during gastrulation 
BI845700 synaptotagmin C, neurotransmitter release and hormone secretion Ca2+sensors 
126 
 
genes candidates were mainly found in the nervous system (20%), the kidney (20%) and 
the ubiquitous proteins (20%) (Figure E1D). No obvious gene candidates that could be 
directly attributed to skeletal muscle were identified. It is worth noting that many of the 
most up and down-regulated genes were still unidentified (35% and 15% respectively) 
(Figure E1 B, D). 
Figure E1: Deviated gene tissue distribution. [A&C] Up and down-regulated gene distribution 
and [B&D] 20 most up and down deviated genes distribution. 
Analysis 
Previous studies in motility mutants has revealed differential muscle specific gene 
expression (van der Meulen et al., 2005). However, in this study comparison of gene 
expression in relaxed homozygous compared to heterozygote embryos did not show any 
obvious muscle specific changes in gene expression. This result may reflect the 
difference in the two approaches of gene expression analysis, high throughput 
microarray of a wide range of preselected genes versus qRT-PCR of chosen candidates.   
Furthermore, given our finding in appendix C that showed that heterozygotes siblings 
are not the most appropriate controls for molecular studies, it would be beneficial to 
repeat the microarray comparing homozygous relaxed mutant embryos to wildtype 
controls. 
Nonetheless a couple of gene candidates were identified, namely Alexander 
neurodegenerative disease and Bardet-Biedl syndrome, that have been linked to 
conditions associated with muscle weakness and paraparesis in humans. The two genes 
were not found in the group that displayed the most significant deviation in expression 
levels; therefore, further examination was not performed at this time. However, 
investigations of these genes in zebrafish could potentially inform medical studies on 
these human conditions. 
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APPENDIX F – Tricaine-BTS vs. Tricaine treatments effectiveness and survival rate 
 
 
 
 
 
Figure F1: Tricaine-BTS and Tricaine treatments effectiveness and survival rate. Tricaine-
BTS treatment, was shown to be a more effective reversible paralysing agent and to have a better 
survival rate (without sickness) compared to Tricaine treatment from 29hpf up to 5dpf. 
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